<?xml version='1.0' encoding='UTF-8'?><?xml-stylesheet href="http://www.blogger.com/styles/atom.css" type="text/css"?><feed xmlns='http://www.w3.org/2005/Atom' xmlns:openSearch='http://a9.com/-/spec/opensearchrss/1.0/' xmlns:blogger='http://schemas.google.com/blogger/2008' xmlns:georss='http://www.georss.org/georss' xmlns:gd="http://schemas.google.com/g/2005" xmlns:thr='http://purl.org/syndication/thread/1.0'><id>tag:blogger.com,1999:blog-8936337794651081205</id><updated>2024-11-05T21:10:02.802-06:00</updated><category term="HIV/AIDS policy"/><category term="MSM"/><category term="rectal microbicide"/><category term="HIV transmission"/><category term="gay men"/><category term="anal sex"/><category term="IRMA"/><category term="research"/><category term="Africa"/><category term="HIV/AIDS"/><category term="new prevention technologies"/><category term="advocacy"/><category term="PrEP"/><category term="homophobia"/><category term="LGBT rights"/><category term="behavioral research"/><category term="homosexuality"/><category term="HIV"/><category term="sexual behavior"/><category term="vaginal microbicide"/><category term="human rights"/><category term="condoms"/><category term="women"/><category term="Meet a Friendly Rectal Microbicide Advocate"/><category term="South Africa"/><category term="Uganda"/><category term="hiv prevention"/><category term="prevention"/><category term="Treatment"/><category term="anal health"/><category term="stigma"/><category term="Microbicides"/><category term="lubricant"/><category term="criminalization"/><category term="United States"/><category term="ARV"/><category term="funding"/><category term="Kenya"/><category term="lgbt community"/><category term="vaccine"/><category term="Gay"/><category term="Truvada"/><category term="Tenofovir"/><category term="safer sex"/><category term="sex work"/><category term="HPV"/><category term="sexual health"/><category term="circumcision"/><category term="men"/><category term="India"/><category term="anal cancer"/><category term="clinical trials"/><category term="heterosexuality"/><category term="AVAC"/><category term="MTN"/><category term="Project ARM"/><category term="anal intercourse"/><category term="risk"/><category term="pre-exposure prophylaxis"/><category term="UNAIDS"/><category term="Nigeria"/><category term="USA"/><category term="STI"/><category term="NIH"/><category term="iPrEx"/><category term="AIDS 2008"/><category term="FDA"/><category term="IAS"/><category term="transgendered"/><category term="AIDS 2012"/><category term="Treatment as Prevention"/><category term="ARVs"/><category term="CDC"/><category term="Global Forum on MSM and HIV"/><category term="HIV/AIDS. pre-exposure prophylaxis"/><category term="PEPFAR"/><category term="antiretroviral therapy"/><category term="Global Campaign for Microbicides"/><category term="Microbicide Trials Network"/><category term="STD"/><category term="United Nations"/><category term="heterosexual epidemic"/><category term="CROI"/><category term="WHO"/><category term="teleconference"/><category term="Asia"/><category term="Dr. Ian McGowan"/><category term="M2010"/><category term="Mexico City"/><category term="safety"/><category term="Australia"/><category term="Malawi"/><category term="Peru"/><category term="female condom"/><category term="sub-saharan Africa"/><category term="CAPRISA"/><category term="Gilead"/><category term="sexual pleasure"/><category term="AIDS Foundation of Chicago"/><category term="China"/><category term="MTN 017"/><category term="Vienna"/><category term="AIDS 2010"/><category term="Bisexual"/><category term="Cape Town"/><category term="Infections"/><category term="International AIDS Conference"/><category term="Thailand"/><category term="amfAR"/><category term="IAS 2011"/><category term="IRMA-ALC"/><category term="Zimbabwe"/><category term="M2008"/><category term="Pittsburgh"/><category term="discrimination"/><category term="resistance"/><category term="GLAM"/><category term="Jim Pickett"/><category term="President Barack Obama"/><category term="gay black men"/><category term="Jamaica"/><category term="Anti-Homosexuality Bill"/><category term="Chicago"/><category term="Citizen News Service"/><category term="Europe"/><category term="Microbicides 2010"/><category term="New Delhi"/><category term="Spanish/español"/><category term="UK"/><category term="Women&#39;s Health"/><category term="community"/><category term="culture"/><category term="female health"/><category term="serosorting"/><category term="testing"/><category term="Asia Pacific"/><category term="FEM-PrEP"/><category term="Microbicides 2012"/><category term="Partners PrEP"/><category term="activists"/><category term="immigration"/><category term="rectal transmission"/><category term="sexual identity"/><category term="Gardasil"/><category term="Gay Men&#39;s Health Crisis"/><category term="Global Forum on MSM"/><category term="IRMA Nigeria"/><category term="IRMA Steering Committee"/><category term="comprehensive sex education"/><category term="injection drug use"/><category term="prevalence"/><category term="public health"/><category term="rectal douche"/><category term="religion"/><category term="seroadaptation"/><category term="ART"/><category term="Bill and Melinda Gates Foundation"/><category term="Caribbean"/><category term="Dr. Alex Carballo-Dieguez"/><category term="Elizabeth Pisani"/><category term="Global Fund to Fight AIDS Tuberculosis and Malaria"/><category term="HIV strain"/><category term="IAC"/><category term="IPM"/><category term="IRMA ALC"/><category term="IRMA-Nigeria"/><category term="Kadiri Audu"/><category term="Lima"/><category term="PEP"/><category term="Senegal"/><category term="Sydney"/><category term="acceptability"/><category term="lesbians"/><category term="video"/><category term="viral load"/><category term="2008 National Gay Men&#39;s Health Summit"/><category term="Canada"/><category term="Global Lube Access Mobilisation"/><category term="ICASA"/><category term="Mexico"/><category term="Rome"/><category term="Salim S. Abdool Karim"/><category term="drugs"/><category term="education"/><category term="immune response"/><category term="CHARM"/><category term="Cameroon"/><category term="Delhi Dynamos"/><category term="Dr. Anthony Fauci"/><category term="Fenway community healthhiv prevention"/><category term="HPTN052"/><category term="HSV-2"/><category term="Islam"/><category term="M2012"/><category term="MTN 007"/><category term="Middle East"/><category term="National AIDS Strategy"/><category term="New York"/><category term="Rectal Revolution"/><category term="South America"/><category term="South Asia"/><category term="UCLA"/><category term="VOICE"/><category term="Washington D.C."/><category term="barebacking"/><category term="law"/><category term="male sexuality"/><category term="media"/><category term="oral sex"/><category term="porn"/><category term="prevention campaign"/><category term="youth"/><category term="2009 LGBTI Health Summit"/><category term="African American"/><category term="And Lube"/><category term="Ayoo Proscovia"/><category term="Bangkok"/><category term="Botswana"/><category term="Desmond Tutu"/><category term="Dr. Peter Anton"/><category term="Ethiopia"/><category term="Ghana"/><category term="Johns Hopkins"/><category term="Larry Misedah"/><category term="Latin America"/><category term="MARPs"/><category term="Marc-André LeBlanc"/><category term="NIAID"/><category term="Namibia"/><category term="Naz Foundation International"/><category term="Obama"/><category term="Pakistan"/><category term="Pope"/><category term="Rwanda"/><category term="The Lancet"/><category term="UK African Microbicides Working Group"/><category term="biomedical"/><category term="click &#39;n learn"/><category term="community engagement"/><category term="cure"/><category term="enema"/><category term="gender"/><category term="healthcare"/><category term="history"/><category term="incidence"/><category term="modeling"/><category term="pleasure"/><category term="rectal chlamydia"/><category term="sodomy"/><category term="survey"/><category term="unprotected sex"/><category term="Cambodia"/><category term="Epicentro"/><category term="Germany"/><category term="HIV Prevention Justice Alliance"/><category term="IRMA-Lagos"/><category term="International AIDS Society"/><category term="Iran"/><category term="Nepal"/><category term="Netherlands"/><category term="Shivananda Khan"/><category term="Sholotan Abdulrahaman Oladimeji"/><category term="Soweto"/><category term="TDF2"/><category term="UNDP"/><category term="World AIDS Day"/><category term="World Bank"/><category term="Zambia"/><category term="adherence"/><category term="anus"/><category term="blood ban"/><category term="concurrency"/><category term="drug development"/><category term="government"/><category term="minority"/><category term="partners"/><category term="pregnancy"/><category term="prison"/><category term="prostitution"/><category term="rectum"/><category term="social marketing"/><category term="standards of care"/><category term="study"/><category term="teenagers"/><category term="30 years"/><category term="Afghanistan"/><category term="Be Heard"/><category term="Boston"/><category term="Brazil"/><category term="CD4"/><category term="CONRAD"/><category term="Cuba"/><category term="David Munar"/><category term="Dr. Jim Turpin"/><category term="Dr. Martin Cranage"/><category term="Dr. Ross Cranston"/><category term="Dr. Sharon Hillier"/><category term="Ecuador"/><category term="France"/><category term="Huffington Post"/><category term="John Shaw Memorial Scholarship Fund"/><category term="Kampala"/><category term="Laos"/><category term="Los Angeles"/><category term="MSF"/><category term="MSMGF"/><category term="Microbicides Development Programme"/><category term="New Enlgand Journal of Medicine"/><category term="PLWHA"/><category term="POZ"/><category term="Population Council"/><category term="Spain"/><category term="Stephen Lewis"/><category term="TLC+"/><category term="Tanzania"/><category term="Treatment Action Campaign"/><category term="USAID"/><category term="Vietnam"/><category term="abstinence"/><category term="childhood sexual abuse"/><category term="contraception"/><category term="counseling"/><category term="couples"/><category term="disclosure"/><category term="efficacy"/><category term="herpes"/><category term="maraviroc"/><category term="nonhuman primate"/><category term="penis"/><category term="placebo"/><category term="presentation"/><category term="reproductive health"/><category term="thirtieth anniversary"/><category term="transmission probability"/><category term="white house"/><category term="2008 election"/><category term="2012"/><category term="AIDS conspiracy"/><category term="AMAG"/><category term="African Union"/><category term="Bangladesh"/><category term="Burundi"/><category term="Colombia"/><category term="Congress"/><category term="David Kato"/><category term="DfID"/><category term="Dr. Anna Foss"/><category term="Dr. Chris Beyrer"/><category term="Dr. Ken Mayer"/><category term="Dr. Pamina Gorbach"/><category term="Dr. Rowena Johnston"/><category term="Egypt"/><category term="Elton John AIDS Foundation"/><category term="FTC"/><category term="French/francais"/><category term="From Promise to Product"/><category term="Geneva"/><category term="Global Equality Network"/><category term="HAART"/><category term="Heartland Alliance"/><category term="Hepatitis B"/><category term="International Lesbian"/><category term="Ishtar MSM"/><category term="Johannesburg"/><category term="Kate Morrow"/><category term="Lanre Onigbogi"/><category term="Leo Colemon"/><category term="Lori Heise"/><category term="Medicine"/><category term="NHVMAS"/><category term="Northern Africa"/><category term="Northwestern"/><category term="Omolulu Falobi"/><category term="Peter Piot"/><category term="Planeta Salud"/><category term="Project Gel"/><category term="Sudan"/><category term="Swaziland"/><category term="Thabo Mbeki"/><category term="Tia IRMA"/><category term="UNFPA"/><category term="Vanessa Marquez"/><category term="Viagra"/><category term="WSW"/><category term="adolescent"/><category term="anal Pap smear"/><category term="anal gonorrhoea"/><category term="cervical cancer"/><category term="communications"/><category term="disease progression"/><category term="empowerment"/><category term="family planning"/><category term="fidelity"/><category term="fraudulent claims"/><category term="girls"/><category term="hepatitis C"/><category term="hijra"/><category term="iPrEx OLE"/><category term="infectivity"/><category term="medical circumcision"/><category term="rape"/><category term="saliva"/><category term="semen"/><category term="serial monogamy"/><category term="social conditions"/><category term="superinfection"/><category term="technology"/><category term="therapeutic vaccine"/><category term="2009 LGBT"/><category term="2011 National LGBTI Health Summit"/><category term="AIDS 2011"/><category term="AIDS denialism"/><category term="AIDSTAR-One"/><category term="ASIL"/><category term="Amy Stapleford Jackson"/><category term="Arwa Meijer"/><category term="Aziga"/><category term="Bali"/><category term="Baltimore"/><category term="Becca Cadoff"/><category term="Bill Gates"/><category term="Bill O&#39;Brien"/><category term="Bisexual Health Summit"/><category term="Bisi Alimi"/><category term="Bonnie Goldman"/><category term="Brian Kanyemba"/><category term="Bristol Myers Squibb"/><category term="Burkina Faso"/><category term="Bush Administration"/><category term="Buzz Cafe"/><category term="C. Everett Koop"/><category term="CCR5"/><category term="CHAARM"/><category term="CHAMP"/><category term="CIA"/><category term="Calabar"/><category term="CamFrog"/><category term="Carraguard"/><category term="Cervarix"/><category term="Chapel Hill"/><category term="Christine Ondoa"/><category term="Cindra Feuer"/><category term="Cleveland"/><category term="DAIDS"/><category term="DNA"/><category term="DSMB"/><category term="Dakar"/><category term="Dan Resnic"/><category term="Daniel Nunez"/><category term="Delta 32"/><category term="Denmark"/><category term="Denver Principles"/><category term="Dr. Ana Ventuneac"/><category term="Dr. Badri Saxena"/><category term="Dr. Betsy Herold"/><category term="Dr. Craig Hendrix"/><category term="Dr. David Holtgrave"/><category term="Dr. Jorge Sanchez"/><category term="Dr. Jose Bauermeister"/><category term="Dr. Ruben F. del Prado"/><category term="Dr. Sheena McCormack"/><category term="Dubai"/><category term="Durban"/><category term="Ed Fuchs"/><category term="Eric Goosby"/><category term="European Commission"/><category term="Facebook"/><category term="Farrah Fawcett"/><category term="Feast of Fun"/><category term="Forum for Collaborative HIV Research"/><category term="GPP"/><category term="George Oundo"/><category term="Give OUT"/><category term="Gladstone"/><category term="God"/><category term="Good Participatory Practice"/><category term="Guayaquil"/><category term="Harare"/><category term="Health and Human Services"/><category term="Hitler"/><category term="ICAAP"/><category term="IDP"/><category term="ILGA"/><category term="IRMA Stem-cell transplant"/><category term="Ian Lemieux"/><category term="Illinois"/><category term="Iraq"/><category term="Isentriss"/><category term="J-FLAG"/><category term="Japan"/><category term="Jessyca Dudley"/><category term="Joel Nana"/><category term="Kevin Frost"/><category term="Khayelitsha"/><category term="Kinsey Institute"/><category term="Koran"/><category term="Kothi"/><category term="Latifa Boyce"/><category term="Lifelube"/><category term="Luis Fernando Galarza"/><category term="MDP 301"/><category term="MMCI"/><category term="Maheswar Satpathy"/><category term="March"/><category term="Mardi Gras"/><category term="Margaret Onah"/><category term="Mark Heywood"/><category term="Mark Hubbard"/><category term="Martin Delaney"/><category term="Michel Sidibe"/><category term="Mississippi"/><category term="Mumbai"/><category term="NAPWA"/><category term="NFI"/><category term="NGOs"/><category term="NPR"/><category term="NRTI"/><category term="NSFG"/><category term="Nashville"/><category term="Nature Medicine"/><category term="Nature Outlook"/><category term="Nesha Z. Haniff"/><category term="New Zealand"/><category term="ORIGAMI"/><category term="OraQuick"/><category term="Oxfam"/><category term="PIAF"/><category term="PRO 2000"/><category term="Papua  New Guinea"/><category term="Paul Semugoma"/><category term="Peter Duesberg"/><category term="Playboy"/><category term="Project Inform"/><category term="Pukaar"/><category term="Pune"/><category term="R300m"/><category term="RNA interference"/><category term="Rockefeller Foundation"/><category term="Roy Wadia"/><category term="Rush Limbaugh"/><category term="Russia"/><category term="Ryan White"/><category term="SIV"/><category term="SWEAT"/><category term="Sam Ongeri"/><category term="Scotland"/><category term="Scott Wilfong"/><category term="Selzentry"/><category term="Shaleena Theophilus"/><category term="Slavic Pride"/><category term="Somalia"/><category term="Sooty Mangabeys"/><category term="St. Petersburg"/><category term="T Cells"/><category term="TAG"/><category term="TASO"/><category term="TB"/><category term="Tachi Yamada"/><category term="Taiwan"/><category term="Tcells"/><category term="TheBody.com"/><category term="Timothy Brown"/><category term="Trans and Intersex Association"/><category term="Turning the Tide Together"/><category term="UCSF"/><category term="UCT"/><category term="US HIV"/><category term="USCA2013"/><category term="Vatican"/><category term="Zackie Achmat"/><category term="Zoe Duby"/><category term="advertising"/><category term="alcohol"/><category term="applicator"/><category term="bacteria"/><category term="blogging"/><category term="bottom"/><category term="brothel"/><category term="cellphone"/><category term="cervical fluid"/><category term="criminal trial"/><category term="deaths"/><category term="dry sex"/><category term="education. reproductive health services"/><category term="erectile dysfunction"/><category term="event"/><category term="ex-gay"/><category term="frica"/><category term="g8"/><category term="gene expression"/><category term="genes"/><category term="guidelines"/><category term="infectious disease"/><category term="internship"/><category term="investments"/><category term="katheoy"/><category term="kitchen gardens"/><category term="lemon juice"/><category term="leukemia"/><category term="lgbt"/><category term="lime juice"/><category term="literature"/><category term="methamphetamines"/><category term="orphans"/><category term="petition"/><category term="pigtailed macague"/><category term="polio"/><category term="politicians"/><category term="prayer"/><category term="pre-cancerous"/><category term="pride"/><category term="prostate"/><category term="proteins"/><category term="raltegravir"/><category term="reading list"/><category term="reports"/><category term="review"/><category term="sex"/><category term="sign"/><category term="social networking"/><category term="stonewall riots"/><category term="substance use"/><category term="sugar daddies"/><category term="suppository"/><category term="syphilis"/><category term="syringe exchange"/><category term="taboo"/><category term="torture"/><category term="virginity pledge"/><category term="virgins"/><category term="virus"/><category term="whoonga"/><category term="yoga"/><category term="zombies"/><title type='text'>IRMA - Rectal Microbicide Advocacy</title><subtitle type='html'>The bottom line in HIV prevention</subtitle><link rel='http://schemas.google.com/g/2005#feed' type='application/atom+xml' href='http://irma-rectalmicrobicides.blogspot.com/feeds/posts/default'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/8936337794651081205/posts/default?max-results=20&amp;redirect=false'/><link rel='alternate' type='text/html' href='http://irma-rectalmicrobicides.blogspot.com/'/><link rel='hub' href='http://pubsubhubbub.appspot.com/'/><link rel='next' type='application/atom+xml' href='http://www.blogger.com/feeds/8936337794651081205/posts/default?start-index=21&amp;max-results=20&amp;redirect=false'/><author><name>NewPrevTech</name><uri>http://www.blogger.com/profile/05705781012925480028</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><generator version='7.00' uri='http://www.blogger.com'>Blogger</generator><openSearch:totalResults>1583</openSearch:totalResults><openSearch:startIndex>1</openSearch:startIndex><openSearch:itemsPerPage>20</openSearch:itemsPerPage><entry><id>tag:blogger.com,1999:blog-8936337794651081205.post-2876552087727631704</id><published>2014-07-30T09:13:00.001-05:00</published><updated>2014-07-30T09:13:42.943-05:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="advocacy"/><category scheme="http://www.blogger.com/atom/ns#" term="Africa"/><category scheme="http://www.blogger.com/atom/ns#" term="And Lube"/><category scheme="http://www.blogger.com/atom/ns#" term="GLAM"/><category scheme="http://www.blogger.com/atom/ns#" term="Global Lube Access Mobilisation"/><category scheme="http://www.blogger.com/atom/ns#" term="hiv prevention"/><category scheme="http://www.blogger.com/atom/ns#" term="IRMA"/><category scheme="http://www.blogger.com/atom/ns#" term="lubricant"/><category scheme="http://www.blogger.com/atom/ns#" term="Project ARM"/><category scheme="http://www.blogger.com/atom/ns#" term="safer sex"/><title type='text'>IRMA-led Global Collaboration Supports Lubricant Advocacy Projects in Africa</title><content type='html'>&lt;div dir=&quot;ltr&quot; style=&quot;text-align: left;&quot; trbidi=&quot;on&quot;&gt;
&lt;table align=&quot;center&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; class=&quot;tr-caption-container&quot; style=&quot;margin-left: auto; margin-right: auto; text-align: center;&quot;&gt;&lt;tbody&gt;
&lt;tr&gt;&lt;td style=&quot;text-align: center;&quot;&gt;&lt;a href=&quot;https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjo3kUNdJZfitFGTGTkBYRCTGfa3lne6Hxlgagbm0S9SkbIe2iPdUgQlxtUIcLBYsTe9MDAjNRhvH1AQCl0CXB9qE44CM5htD8fnQR-Wg72XzD96ELg03Pthjfb_S300_ofhWVkICLLfjs/s1600/sticker+blue1.jpg&quot; imageanchor=&quot;1&quot; style=&quot;margin-left: auto; margin-right: auto;&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjo3kUNdJZfitFGTGTkBYRCTGfa3lne6Hxlgagbm0S9SkbIe2iPdUgQlxtUIcLBYsTe9MDAjNRhvH1AQCl0CXB9qE44CM5htD8fnQR-Wg72XzD96ELg03Pthjfb_S300_ofhWVkICLLfjs/s1600/sticker+blue1.jpg&quot; height=&quot;146&quot; width=&quot;400&quot; /&gt;&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;tr-caption&quot; style=&quot;text-align: center;&quot;&gt;Social marketing material developed by Centre for Popular Education and Human Rights, a 2014 GLAM grantee in Ghana&lt;/td&gt;&lt;/tr&gt;
&lt;/tbody&gt;&lt;/table&gt;
&lt;strong&gt;&lt;br /&gt;&lt;a href=&quot;http://www.avac.org/&quot; target=&quot;_blank&quot;&gt;AVAC&lt;/a&gt;&lt;/strong&gt;, &lt;a href=&quot;http://www.amfar.org/&quot; target=&quot;_blank&quot;&gt;&lt;strong&gt;amfar&lt;/strong&gt;&lt;/a&gt;, &lt;strong&gt;&lt;a href=&quot;http://www.coc.nl/engels&quot; target=&quot;_blank&quot;&gt;COC Netherlands&lt;/a&gt;&lt;/strong&gt; and &lt;strong&gt;&lt;a href=&quot;http://www.rectalmicrobicides.org/&quot; target=&quot;_blank&quot;&gt;International Rectal Microbicide Advocates&lt;/a&gt;&lt;/strong&gt; (IRMA) are pleased to announce seven Global Lube Access Mobilisation (GLAM) awards to projects in Africa. &lt;br /&gt;&lt;br /&gt;&lt;a href=&quot;https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhMlSrGUAhtfWRtuF-sNdYTFOLEfy23h0tQEHEzM-wReYhOW08-fIxiKgYD1WstXAGqMCCnw0yLEu_d1fBjFdS3njlLqQCtXGVKpuFUiPE1S442iDypF774yMt1_8g25W_wzw26X7FfjUI/s1600/COVER+2.jpg&quot; imageanchor=&quot;1&quot; style=&quot;clear: left; float: left; margin-bottom: 1em; margin-right: 1em;&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhMlSrGUAhtfWRtuF-sNdYTFOLEfy23h0tQEHEzM-wReYhOW08-fIxiKgYD1WstXAGqMCCnw0yLEu_d1fBjFdS3njlLqQCtXGVKpuFUiPE1S442iDypF774yMt1_8g25W_wzw26X7FfjUI/s1600/COVER+2.jpg&quot; height=&quot;200&quot; width=&quot;133&quot; /&gt;&lt;/a&gt;GLAM, an initiative of IRMA’s &lt;strong&gt;&lt;a href=&quot;http://www.irma-rectalmicrobicides.blogspot.com/p/project-arm-africa-for-rectal.html&quot; target=&quot;_blank&quot;&gt;Project ARM&lt;/a&gt;&lt;/strong&gt; (Africa for Rectal Microbicides) in collaboration with amfAR, AVAC, and COC Netherlands, promotes advocacy in support of increased access to safe, condom-compatible lubricants for all Africans who engage in anal and vaginal intercourse, including GMT (gay men and other men who have sex with men, and transgender individuals) and heterosexual men and women. &lt;br /&gt;&lt;br /&gt;In response to a request for proposals widely disseminated in February 2014, GLAM partners received 36 proposals representing 17 African countries (Botswana, Cameroun, Côte d’Ivoire, Democratic Republic of Congo, Ghana, Kenya, Lesotho, Malawi, Namibia, Nigeria, Rwanda, South Africa, Tanzania, Togo, Uganda, Zambia and Zimbabwe). A diverse team of 20 advocates and public health professionals with an interest in lubricant access in Africa (from Nigeria, Uganda, Kenya, Zambia, Liberia, South Africa, Rwanda, Benin, Canada, Netherlands and the United States) reviewed the proposals. &lt;br /&gt;&lt;br /&gt;Seven projects were selected for funding. These projects began in early July 2014 and will complete their efforts in December 2014. Following is a list of these projects.&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;Alternatives  Cameroun  (Douala, Cameroun)&lt;/strong&gt;&lt;br /&gt;Working in collaboration with other organizations in Douala and Yaoundé, Alternatives Cameroun plans to organize meetings  and workshops with health officials and other HIV stakeholders in the country. The meetings and workshops will underscore the importance of providing safe, condom-compatible lubricant as part of comprehensive HIV and STI prevention programming. These activities support the ultimate goal of developing and securing a channel for the distribution of safe, condom-compatible lubricant throughout Cameroun.&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;Centre for Popular Education and Human Rights (Accra, Ghana)&lt;/strong&gt;&lt;br /&gt;Centre for Popular Education and Human Rights (CEPEHRG) will campaign to increase access, availability, and use of safe, affordable, condom-compatible lubricant by all who engage in sexual intercourse in Ghana, with special attention given to the LGBT community. The group will call for the inclusion of condom-compatible lubricant in the national essential drug list. Educational and social marketing efforts will take place at the community outreach level and through CEPEHRG’s national advocacy work. &lt;br /&gt;&lt;br /&gt;&lt;strong&gt;Centre Stage Media Arts Foundation (Bulawayo, Zimbabwe)&lt;/strong&gt;&lt;br /&gt;Centre Stage Media Arts Foundation (CSMA) will convene policy advisory seminars to engage stakeholders from the Ministry of Health, legislators and members of civil society in support of three goals. One, integrate access to safe, condom-compatible lubricant in the Zimbabwe National HIV/AIDS Strategic Plan. Two, advocate for inclusion of lube as a line item in the national HIV prevention budget. Three, campaign for policy and program changes to allow for the distribution of lube through the same public health distribution channels that condoms are distributed through.  A policy brief on the integration of lube access into national HIV prevention policies and programs will be produced. Traditional and social media will be utilized.&lt;br /&gt;
&lt;br /&gt;
&lt;strong&gt;Community Health Education Services &amp;amp; Advocacy (Dar es Salaam, Tanzania)&lt;/strong&gt;Securing government leadership and commitment to amend the national condom policy and include the provision of safe, condom-compatible lubricant in public health facilities is the chief goal of Community Health Education Services &amp;amp; Advocacy (CHESA). The group will work to build multi-sectorial awareness of the importance of lubricant and will engage the Minister of Health and Social Welfare, health care practitioners, community based organizations, as well as members of the GMT community. The public health message will be “Condom Compatible Lubricant Reduces New HIV Infections.”&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;Men Against AIDS Youth Group (Kisumu, Kenya)&lt;/strong&gt;&lt;br /&gt;Men Against AIDS Youth Group (MAAYGO) seeks to increase access to safe, condom-compatible lubricants through several methods. The group will conduct a needs assessment and implement a targeted advocacy campaign in Kisumu County for the GMT community, health care workers, and policy makers. Educational workshops will be conducted with the goal of developing a cadre of lube access advocates who will work to improve government policies and programs. A print/social marketing campaign highlighting the importance of lubricant access in HIV/STI prevention programming will be launched.&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;New HIV Vaccine and Microbicide Advocacy Society (Lagos, Nigeria)&lt;/strong&gt;&lt;br /&gt;The strategy New HIV Vaccine and Microbicide Advocacy Society (NHVMAS) will take to improve lubricant access in Nigeria will be to create public demand for these important products for both men and women. Advocacy will be conducted at the state and national levels to promote government investment in lube access.  NHVMAS will utilize its listserv, engage the media, and conduct trainings to enhance community awareness of the importance of safe, condom-compatible lubricant in HIV/STI prevention programming.&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;Partners in Health Research and Development (Thika, Kenya)&lt;/strong&gt; &lt;br /&gt;The work of Partners in Health Research and Development (PHRD) will seek to improve knowledge of and access to condoms and safe, condom-compatible lubricant among key populations in Kenya. In addition, the group will undertake actions in support of the establishment of a sustainable condom and lubricant delivery system.  Sensitisation sessions will be conducted for stakeholders including HIV prevention advocates, civil society coalitions, policy makers, government officials, donors, condom distributors and the media. The inclusion of safe, condom-compatible lubricant in the National Strategic Plan is one of the project’s key projected milestones.&lt;br /&gt;
&lt;br /&gt;
&lt;a href=&quot;https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiBmf0PEazvIYD4WxImXgGwGhNcvVpSTK3Z8iVjncTuosvJaoVU6-hfneKBj1tdCWGV_BVhqxr9jIAPteacSGMI4mN5Kqhf_U7dQZmtuRPvLq8Bp-NuFsNvOmFlaFG2DZKxpckPfRpjnX8/s1600/GLAM_Tookit+E+cover.jpg&quot; imageanchor=&quot;1&quot; style=&quot;clear: right; float: right; margin-bottom: 1em; margin-left: 1em;&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiBmf0PEazvIYD4WxImXgGwGhNcvVpSTK3Z8iVjncTuosvJaoVU6-hfneKBj1tdCWGV_BVhqxr9jIAPteacSGMI4mN5Kqhf_U7dQZmtuRPvLq8Bp-NuFsNvOmFlaFG2DZKxpckPfRpjnX8/s1600/GLAM_Tookit+E+cover.jpg&quot; height=&quot;200&quot; width=&quot;155&quot; /&gt;&lt;/a&gt;&lt;br /&gt;
Related materials:&lt;br /&gt;
&lt;br /&gt;
Click here for the GLAM Toolkit in &lt;strong&gt;&lt;a href=&quot;http://www.rectalmicrobicides.org/docs/GLAM_Tookit%20E%20060313.pdf&quot; target=&quot;_blank&quot;&gt;English&lt;/a&gt;&lt;/strong&gt;&amp;nbsp;in &lt;strong&gt;&lt;a href=&quot;http://www.rectalmicrobicides.org/docs/GLAM_Tookit_F_060313.pdf&quot; target=&quot;_blank&quot;&gt;French&lt;/a&gt;&lt;/strong&gt;.&lt;br /&gt;
&lt;br /&gt;
The GLAM initiative supported three&amp;nbsp;African projects&amp;nbsp;in 2013. Click &lt;strong&gt;&lt;a href=&quot;http://www.rectalmicrobicides.org/docs/AMSHeRpreconfICASA_13_IRMA_AVAC.pptx&quot; target=&quot;_blank&quot;&gt;here&lt;/a&gt;&lt;/strong&gt; for a GLAM PowerPoint presentation that includes information on these projects. &lt;br /&gt;
&lt;br /&gt;
Click &lt;strong&gt;&lt;a href=&quot;http://www.rectalmicrobicides.org/ProjectARMreport2012.pdf&quot; target=&quot;_blank&quot;&gt;here&lt;/a&gt;&lt;/strong&gt; to access the Project ARM report, &quot;On the Map: Ensuring Africa&#39;s Place in Rectal Microbicide Research and Advocacy&quot;, published in 2012.&lt;br /&gt;
&lt;br /&gt;
------------------- &lt;br /&gt;
&lt;br /&gt;




*Join IRMA&#39;s robust, highly-active. moderated, global listserv addressing rectal microbicide research and advocacy as well as other interesting new HIV prevention technologies by contacting us at &lt;a href=&quot;mailto:rectalmicro@gmail.com&quot;&gt;&lt;strong&gt;rectalmicro@gmail.com&lt;/strong&gt;&lt;/a&gt;. Joining our listserv automatically makes you a member of IRMA - a network of more than 1,100 advocates, scientists, policy makers and funders from all over the world.


&lt;br /&gt;
&lt;br /&gt;
*Please look for us on Facebook: &lt;strong&gt;&lt;a href=&quot;http://www.facebook.com/InternationalRectalMicrobicideAdvocates&quot;&gt;www.facebook.com/InternationalRectalMicrobicideAdvocates&lt;/a&gt;&lt;/strong&gt;, and you can follow us on Twitter: &lt;a href=&quot;https://twitter.com/RectalMicro&quot; target=&quot;_blank&quot;&gt;&lt;strong&gt;@rectalmicro&lt;/strong&gt;&lt;/a&gt;&lt;strong&gt;.&lt;/strong&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;nbsp;

*Also, please note that shared news items from other sources posted on this blog, Facebook, and Twitter&amp;nbsp;do not necessarily mean IRMA has taken any position on the article&#39;s content.
&lt;br /&gt;
&lt;br /&gt;
&amp;nbsp;


-------------------&lt;/div&gt;
</content><link rel='replies' type='application/atom+xml' href='http://irma-rectalmicrobicides.blogspot.com/feeds/2876552087727631704/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment/fullpage/post/8936337794651081205/2876552087727631704?isPopup=true' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/8936337794651081205/posts/default/2876552087727631704'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/8936337794651081205/posts/default/2876552087727631704'/><link rel='alternate' type='text/html' href='http://irma-rectalmicrobicides.blogspot.com/2014/07/irma-led-global-collaboration-supports.html' title='IRMA-led Global Collaboration Supports Lubricant Advocacy Projects in Africa'/><author><name>NewPrevTech</name><uri>http://www.blogger.com/profile/05705781012925480028</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjo3kUNdJZfitFGTGTkBYRCTGfa3lne6Hxlgagbm0S9SkbIe2iPdUgQlxtUIcLBYsTe9MDAjNRhvH1AQCl0CXB9qE44CM5htD8fnQR-Wg72XzD96ELg03Pthjfb_S300_ofhWVkICLLfjs/s72-c/sticker+blue1.jpg" height="72" width="72"/><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-8936337794651081205.post-801351595669264312</id><published>2014-02-04T19:09:00.003-06:00</published><updated>2014-02-04T19:09:48.737-06:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="And Lube"/><category scheme="http://www.blogger.com/atom/ns#" term="GLAM"/><category scheme="http://www.blogger.com/atom/ns#" term="hiv prevention"/><category scheme="http://www.blogger.com/atom/ns#" term="IRMA"/><category scheme="http://www.blogger.com/atom/ns#" term="lubricant"/><category scheme="http://www.blogger.com/atom/ns#" term="Project ARM"/><title type='text'>Those Lube Stickers Aren’t Just For Show!</title><content type='html'>&lt;div dir=&quot;ltr&quot; style=&quot;text-align: left;&quot; trbidi=&quot;on&quot;&gt;
&lt;div class=&quot;separator&quot; style=&quot;clear: both; text-align: center;&quot;&gt;
&lt;a href=&quot;https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEh14c6ZDg-eRyz-xJf2R12lldUU6J0SMrdfyomig6a_Z_KC5gEKakwpx3Rv9jh_oJG18lZExeQLUnBQOWxDlJRwFLxXwPIFGxfU7LxJ3KBc-vXVQhhFYeMNqrNMA_Vf0w8ApmafK4Fr4tA/s1600/andlube.jpg&quot; imageanchor=&quot;1&quot; style=&quot;clear: left; float: left; margin-bottom: 1em; margin-right: 1em;&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEh14c6ZDg-eRyz-xJf2R12lldUU6J0SMrdfyomig6a_Z_KC5gEKakwpx3Rv9jh_oJG18lZExeQLUnBQOWxDlJRwFLxXwPIFGxfU7LxJ3KBc-vXVQhhFYeMNqrNMA_Vf0w8ApmafK4Fr4tA/s1600/andlube.jpg&quot; height=&quot;218&quot; width=&quot;320&quot; /&gt;&lt;/a&gt;&lt;/div&gt;
by Mike Wilson&lt;br /&gt;(former IRMA intern,&amp;nbsp;IRMA advocate forever)&lt;br /&gt;&lt;br /&gt;&amp;nbsp;Hello IRMA!  It feels like I have not said that greeting in ages.  I may not be an intern with the &lt;strong&gt;&lt;a href=&quot;http://www.aidschicago.org/&quot; target=&quot;_blank&quot;&gt;AIDS Foundation of Chicago&lt;/a&gt;&lt;/strong&gt;, but I have certainly not left behind my engagement with (and love of) &lt;strong&gt;&lt;a href=&quot;http://www.rectalmicrobicides.org/&quot; target=&quot;_blank&quot;&gt;IRMA&lt;/a&gt;&lt;/strong&gt; and other HIV prevention organizations.&lt;br /&gt;&lt;br /&gt;Since leaving the IRMA internship I have been working as a Youth Advocate for a teen center in the greater Chicago area.  While I will honestly attest to the fact that working with the teens at the center and local community has been a rewarding experience, it has not come without its fair share of awkwardness - most notably the “pearl clutching” that occurs when people ask me what I did before working at the teen center.&lt;br /&gt;&lt;br /&gt;And to be fair, it hasn’t all been “pearl clutching.”  The community in this area is absolutely fantastic, I have been surprised time and time again at how committed this community is to its teens and families.  And as my husband and I move to upstate New York, we can only hope that we find ourselves in a community as dedicated to the concept of community.  Particularly among the teens there has been a surprising interest in discussing HIV prevention methods - so hopefully the seeds of future activism are being planted.&lt;br /&gt;&lt;br /&gt;Along with this surprising interest, there has been confusion and silence as I get the feeling that many of the teens (and members of the community) are ignorant of the HIV/AIDS battle being fought not even a mile away in the city of Chicago.  Though the mostly white, fairly wealthy families of this area are privileged enough to not be the face of the HIV/AIDS epidemic in Chicago, but within that privilege they often find themselves shut off from understanding how real and close this epidemic is.  Perhaps the best way to explain this is by discussing what happened last weekend.&lt;br /&gt;&lt;br /&gt;In an effort to get teens involved in volunteer work, our center leads monthly trips into Chicago to a soup kitchen to let the teens learn about experiences other than their own and to learn the importance of community engagement and volunteerism.  These trips involve meeting at the center and then piling into the cars of various staff members.  &lt;br /&gt;&lt;br /&gt;However, this time, as I was closing up the center doors, teens had began to make their way into the parking lot.  A group of four teens happened to notice a small blue Neon that has a few (too many) bumper stickers on the back.  Interestingly enough, these teens didn’t know that this was my car.  As I approached the group to let them in my car, I could hear them laughing and one of them saying “And Lube?  And Lube?  What the hell?”  To which, the group continued to laugh more than I thought someone could at the concept of lubricant.&lt;br /&gt;&lt;br /&gt;Not sure how to proceed I walked through the group and unlocked the car.  There was this awkward pause as the teens looked at me, in shock that they were making fun of bumper stickers on a car that they didn’t know was mine.  I opened my door to get in and the teens still stood, seeming hesitant.  To which I just said, “well lube matters” and quickly followed that with “ok, now come on.  We’re going to be late”.  And they hurried into the car.&lt;br /&gt;&lt;br /&gt;Even with the radio on, there was an awkward silence in the car.  The teens were clearly worried that I may have been upset and I was attempting to figure out how to best explain that I wasn’t upset with them, but still reinforce some message about &lt;strong&gt;&lt;a href=&quot;http://www.irma-rectalmicrobicides.blogspot.com/p/project-arm-africa-for-rectal.html&quot; target=&quot;_blank&quot;&gt;GLAM (Global Lube Access Mobilization)&lt;/a&gt;&lt;/strong&gt;&amp;nbsp;and the “And Lube” campaign.&lt;br /&gt;&lt;br /&gt;Suddenly, the silence was broken.  “So, uh, Mike... yeah... we weren’t making fun of your car.  It’s just, having a sticker about lube isn’t something you see everyday”.&lt;br /&gt;&lt;br /&gt;To which I laughed a bit.  “Oh please, I wouldn’t care if you made fun of this car.  I’m a grad student, of course my car isn’t wonderful.”&lt;br /&gt;&lt;br /&gt;To which a teen perked up in his seat.  “So what?  Do the stickers hold the car together?”  The teens laughed, I couldn’t help but join in a bit.&lt;br /&gt;&lt;br /&gt;“More or less,” I responded.  “And really guys, don’t worry about it.”&lt;br /&gt;&lt;br /&gt;“So I have to ask, what does ‘And Lube’ mean?”&lt;br /&gt;&lt;br /&gt;“Well, the ‘And Lube’ campaign is exactly what it sounds like.  It’s about advocating for proper lubricant along with condoms in the fight against HIV/AIDS.”&lt;br /&gt;&lt;br /&gt;“Why would you need that?”&lt;br /&gt;&lt;br /&gt;“Well, as I’m sure you’ve discussed in health classes.  Condoms can break, or slip, or tear.  And that can make them problematic for HIV/AIDS prevention.  Having proper lubricant along with condoms helps prevent those issues and thus helps to prevent new HIV infections.”&lt;br /&gt;&lt;br /&gt;And then the most wonderful reply came: “makes sense.”&lt;br /&gt;&lt;br /&gt;There were many ways that I could have handled this situation.  My first instinct, honestly, was to just say something along the lines of “lube access isn’t funny,” but I didn’t want to come across as overly judgmental.  And in all honesty, before I worked with IRMA, I don’t think I would have thought any differently than this group of teens that I already know are well-engaged.&lt;br /&gt;&lt;br /&gt;Yes, this situation may have been awkward at first.  But it was a great opportunity to explore that awkwardness and get in some activism.  It is surprising how much a sticker can get someone talking and it is even more surprising to see someone engage with that humor and to then be reminded that activism is about education and engagement after all.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
------------------- 



&lt;br /&gt;
&lt;br /&gt;
*Join IRMA&#39;s robust, highly-active. moderated, global listserv addressing rectal microbicide research and advocacy as well as other interesting new HIV prevention technologies by contacting us at rectalmicro@gmail.com. Joining our listserv automatically makes you a member of IRMA - a network of more than 1,200 advocates, scientists, policy makers and funders from all over the world.&lt;br /&gt;
&lt;br /&gt;



*Please look for us on Facebook: www.facebook.com/InternationalRectalMicrobicideAdvocates, and you can follow us on Twitter: @rectalmicro.
 

&lt;br /&gt;
&lt;br /&gt;
*Also, please note that shared news items from other sources posted on this blog do not necessarily mean IRMA has taken any position on the article&#39;s content.
&lt;br /&gt;
&lt;br /&gt;
&amp;nbsp;


-------------------&lt;/div&gt;
</content><link rel='replies' type='application/atom+xml' href='http://irma-rectalmicrobicides.blogspot.com/feeds/801351595669264312/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment/fullpage/post/8936337794651081205/801351595669264312?isPopup=true' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/8936337794651081205/posts/default/801351595669264312'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/8936337794651081205/posts/default/801351595669264312'/><link rel='alternate' type='text/html' href='http://irma-rectalmicrobicides.blogspot.com/2014/02/those-lube-stickers-arent-just-for-show.html' title='Those Lube Stickers Aren’t Just For Show!'/><author><name>NewPrevTech</name><uri>http://www.blogger.com/profile/05705781012925480028</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEh14c6ZDg-eRyz-xJf2R12lldUU6J0SMrdfyomig6a_Z_KC5gEKakwpx3Rv9jh_oJG18lZExeQLUnBQOWxDlJRwFLxXwPIFGxfU7LxJ3KBc-vXVQhhFYeMNqrNMA_Vf0w8ApmafK4Fr4tA/s72-c/andlube.jpg" height="72" width="72"/><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-8936337794651081205.post-429720781981655440</id><published>2013-10-02T08:00:00.000-05:00</published><updated>2013-10-02T08:00:08.367-05:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="advocacy"/><category scheme="http://www.blogger.com/atom/ns#" term="clinical trials"/><category scheme="http://www.blogger.com/atom/ns#" term="IRMA"/><category scheme="http://www.blogger.com/atom/ns#" term="Microbicide Trials Network"/><category scheme="http://www.blogger.com/atom/ns#" term="MTN"/><category scheme="http://www.blogger.com/atom/ns#" term="MTN 017"/><category scheme="http://www.blogger.com/atom/ns#" term="rectal microbicide"/><category scheme="http://www.blogger.com/atom/ns#" term="research"/><category scheme="http://www.blogger.com/atom/ns#" term="Tenofovir"/><title type='text'>Advocates Applaud Launch of MTN-017, World’s First Phase II Rectal Microbicide Study</title><content type='html'>&lt;div dir=&quot;ltr&quot; style=&quot;text-align: left;&quot; trbidi=&quot;on&quot;&gt;
&lt;div class=&quot;separator&quot; style=&quot;clear: both; text-align: center;&quot;&gt;
[IRMA press release]&lt;/div&gt;
&lt;div class=&quot;separator&quot; style=&quot;clear: both; text-align: center;&quot;&gt;
&amp;nbsp;&lt;/div&gt;
&lt;strong&gt;Trial Design Significantly Enhanced By Strong Community Input&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href=&quot;https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj9YZ1qXLLnQAFb0cIViK2TUPI-UWSf4eiv5lXC2_LagHh5qALFPcPBiCykeG4EedvHpqO8zaQz78WeVpoLjsijc7P05ml6v_ErpZrLPj4PBlnBK3iWQPbp-Ju01MdwjzwyVqg0wA7s1_g/s1600/MTN_017_IRMA_webinar_PICKETT.jpg&quot; imageanchor=&quot;1&quot; style=&quot;clear: left; float: left; margin-bottom: 1em; margin-right: 1em;&quot;&gt;&lt;img border=&quot;0&quot; height=&quot;150&quot; src=&quot;https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj9YZ1qXLLnQAFb0cIViK2TUPI-UWSf4eiv5lXC2_LagHh5qALFPcPBiCykeG4EedvHpqO8zaQz78WeVpoLjsijc7P05ml6v_ErpZrLPj4PBlnBK3iWQPbp-Ju01MdwjzwyVqg0wA7s1_g/s200/MTN_017_IRMA_webinar_PICKETT.jpg&quot; width=&quot;200&quot; /&gt;&lt;/a&gt;October 2, 2013 – IRMA applauds the launch of the world’s first-ever Phase II rectal microbicide trial. The Microbicide Trial Network’s study, called MTN-017, will test a reduced glycerin formulation of tenofovir gel applied rectally. Volunteers consisting of gay men, other men who have sex with men, and transgender women will participate in the study at sites in the United States and in Thailand, South Africa, and Peru.&lt;br /&gt;&lt;br /&gt;“Today feels like every holiday imaginable rolled into one,” said Jim Pickett, chair of International Rectal Microbicide Advocates (IRMA.) “The launch of the MTN-017 study is a milestone long in the making and marks a giant leap forward in the development of safe, effective, acceptable, and accessible products that could be used to prevent HIV during anal intercourse.”&lt;br /&gt;&lt;br /&gt;IRMA is pleased to have participated in an intensive community input process with the Microbicide Trials Network that included in-person consultations with advocates and key stakeholders in Thailand, South Africa, Peru and the United States. “The dreams and desires of many men, women, and transgender individuals the world over can be heard loud and clear in the design of the MTN-017 trial. This deep collaboration between scientists and community members is key to the success of this trial and to the rectal microbicide field in general,” said Pickett.&lt;br /&gt;&lt;br /&gt;When microbicides were first imagined, they were “vagina-centric.”  While many embraced the notion of creating vaginal products women could control, the majority of the HIV/AIDS community— scientists and advocates alike— dismissed the possibility of developing rectal microbicides for use during anal intercourse as an HIV prevention method. It was not considered feasible and the pursuit was seen as hopeless, even laughable.  At best, the rectal microbicide field would consist of testing vaginal microbicides for rectal safety, because these products would undoubtedly end up in the rectum despite their intended destination. &lt;br /&gt;&lt;br /&gt;IRMA thanks the visionary scientists, advocates and funders like the U.S. National Institutes of Health who bucked prevailing “wisdom” and have remained steadfast in their commitment to developing new HIV prevention methods for use during anal intercourse.&lt;br /&gt;&lt;br /&gt;“I feel like we are taking two giant leaps forward today. One in the fight against HIV, and the other in the fight against ignorance and small thinking,” said Pickett.&lt;br /&gt;&lt;br /&gt;# # # #&lt;br /&gt;&lt;br /&gt;International Rectal Microbicide Advocates (IRMA) is a global network, housed at AIDS Foundation of Chicago, comprised of more than 1,200 advocates, scientists, policy makers and funders focused on rectal microbicide research and advocacy and related issues such as access to safe, condom-compatible lubricants.&lt;br /&gt;&lt;br /&gt;Learn more about the MTN-017 study &lt;strong&gt;&lt;a href=&quot;http://www.mtnstopshiv.org/news/studies/mtn017&quot; target=&quot;_blank&quot;&gt;here&lt;/a&gt;&lt;/strong&gt;.&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;a href=&quot;http://www.youtube.com/user/IRMAadvocacy/videos&quot; target=&quot;_blank&quot;&gt;Watch this video&lt;/a&gt;&lt;/strong&gt; “The Rectal Revolution is Here: An introduction to rectal microbicide clinical trials” in English, Spanish, or Thai.&lt;br /&gt;
&lt;br /&gt;
------------------- 



&lt;br /&gt;
&lt;br /&gt;
*Join IRMA&#39;s robust, highly-active. moderated, global listserv addressing rectal microbicide research and advocacy as well as other interesting new HIV prevention technologies by contacting us at rectalmicro@gmail.com. Joining our listserv automatically makes you a member of IRMA - a network of more than 1,100 advocates, scientists, policy makers and funders from all over the world.


&lt;br /&gt;
&lt;br /&gt;
*Please look for us on Facebook: www.facebook.com/InternationalRectalMicrobicideAdvocates, and you can follow us on Twitter: @rectalmicro.
 

&lt;br /&gt;
&lt;br /&gt;

 


-------------------&lt;/div&gt;
</content><link rel='replies' type='application/atom+xml' href='http://irma-rectalmicrobicides.blogspot.com/feeds/429720781981655440/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment/fullpage/post/8936337794651081205/429720781981655440?isPopup=true' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/8936337794651081205/posts/default/429720781981655440'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/8936337794651081205/posts/default/429720781981655440'/><link rel='alternate' type='text/html' href='http://irma-rectalmicrobicides.blogspot.com/2013/10/advocates-applaud-launch-of-mtn-017.html' title='Advocates Applaud Launch of MTN-017, World’s First Phase II Rectal Microbicide Study'/><author><name>NewPrevTech</name><uri>http://www.blogger.com/profile/05705781012925480028</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj9YZ1qXLLnQAFb0cIViK2TUPI-UWSf4eiv5lXC2_LagHh5qALFPcPBiCykeG4EedvHpqO8zaQz78WeVpoLjsijc7P05ml6v_ErpZrLPj4PBlnBK3iWQPbp-Ju01MdwjzwyVqg0wA7s1_g/s72-c/MTN_017_IRMA_webinar_PICKETT.jpg" height="72" width="72"/><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-8936337794651081205.post-6393918619977874036</id><published>2013-09-08T16:34:00.000-05:00</published><updated>2013-09-08T16:34:33.390-05:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="anal health"/><category scheme="http://www.blogger.com/atom/ns#" term="anal sex"/><category scheme="http://www.blogger.com/atom/ns#" term="hiv prevention"/><category scheme="http://www.blogger.com/atom/ns#" term="HIV/AIDS"/><category scheme="http://www.blogger.com/atom/ns#" term="rectal microbicide"/><category scheme="http://www.blogger.com/atom/ns#" term="Rectal Revolution"/><category scheme="http://www.blogger.com/atom/ns#" term="safer sex"/><category scheme="http://www.blogger.com/atom/ns#" term="United States"/><category scheme="http://www.blogger.com/atom/ns#" term="USCA2013"/><title type='text'>Sept 10 at #USCA2013 - Everything You Need to Know About #Anal Health</title><content type='html'>&lt;div dir=&quot;ltr&quot; style=&quot;text-align: left;&quot; trbidi=&quot;on&quot;&gt;
This Tuesday, September 10 at the &lt;a href=&quot;http://nmac.org/events/2013-u-s-conference-on-aids/2013-usca-agenda-overview/&quot; target=&quot;_blank&quot;&gt;&lt;b&gt;United States Conference on AIDS&lt;/b&gt;&lt;/a&gt; in New Orleans  join IRMA and friends from 4:30 p.m. to 6 p.m. for this fun workshop on anal health and rectal microbicide research and advocacy.&lt;br /&gt;
&lt;br /&gt;
Session 5: Imperial 9, Level 4. See ya there - show your rectal pride!&lt;br /&gt;
&lt;br /&gt;
&lt;div class=&quot;separator&quot; style=&quot;clear: both; text-align: center;&quot;&gt;
&lt;/div&gt;
&lt;div class=&quot;separator&quot; style=&quot;clear: both; text-align: center;&quot;&gt;
&lt;a href=&quot;https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEi_Me7_HDU3DOBOCoDwOxg3eHUlCTW5Qxp4TPfJUfzCfURI2-39HtqrWcFC2mXu2w2QQuC7GvZES9-s1g1IcgK_tcUDtKB9BRpzB0aUBXFzEsDAcMIfi8TVuW5Ai7uyEQN44IbLIdnalfQ/s1600/analhealth.jpg&quot; imageanchor=&quot;1&quot; style=&quot;margin-left: 1em; margin-right: 1em;&quot;&gt;&lt;img border=&quot;0&quot; height=&quot;257&quot; src=&quot;https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEi_Me7_HDU3DOBOCoDwOxg3eHUlCTW5Qxp4TPfJUfzCfURI2-39HtqrWcFC2mXu2w2QQuC7GvZES9-s1g1IcgK_tcUDtKB9BRpzB0aUBXFzEsDAcMIfi8TVuW5Ai7uyEQN44IbLIdnalfQ/s400/analhealth.jpg&quot; width=&quot;400&quot; /&gt;&lt;/a&gt;&lt;/div&gt;
&lt;br /&gt;
-------------------&lt;br /&gt;
&lt;br /&gt;
&amp;nbsp;*Join IRMA&#39;s robust, highly-active. moderated, global listserv addressing rectal microbicide research and advocacy as well as other interesting new HIV prevention technologies by contacting us at rectalmicro@gmail.com. Joining our listserv automatically makes you a member of IRMA - a network of more than 1,200 advocates, scientists, policy makers and funders from all over the world.&lt;br /&gt;
&lt;br /&gt;
*Please look for us on Facebook: www.facebook.com/InternationalRectalMicrobicideAdvocates, and you can follow us on Twitter: @rectalmicro.&lt;br /&gt;
&lt;br /&gt;
&amp;nbsp;*Also, please note that shared news items from other sources posted on this blog do not necessarily mean IRMA has taken any position on the article&#39;s content.&lt;br /&gt;
&lt;br /&gt;
&amp;nbsp;-------------------&lt;/div&gt;
</content><link rel='replies' type='application/atom+xml' href='http://irma-rectalmicrobicides.blogspot.com/feeds/6393918619977874036/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment/fullpage/post/8936337794651081205/6393918619977874036?isPopup=true' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/8936337794651081205/posts/default/6393918619977874036'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/8936337794651081205/posts/default/6393918619977874036'/><link rel='alternate' type='text/html' href='http://irma-rectalmicrobicides.blogspot.com/2013/09/sept-10-at-usca2013-everything-you-need.html' title='Sept 10 at #USCA2013 - Everything You Need to Know About #Anal Health'/><author><name>NewPrevTech</name><uri>http://www.blogger.com/profile/05705781012925480028</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEi_Me7_HDU3DOBOCoDwOxg3eHUlCTW5Qxp4TPfJUfzCfURI2-39HtqrWcFC2mXu2w2QQuC7GvZES9-s1g1IcgK_tcUDtKB9BRpzB0aUBXFzEsDAcMIfi8TVuW5Ai7uyEQN44IbLIdnalfQ/s72-c/analhealth.jpg" height="72" width="72"/><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-8936337794651081205.post-6888458572122758106</id><published>2013-07-15T09:48:00.003-05:00</published><updated>2013-07-15T09:49:54.584-05:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="anal intercourse"/><category scheme="http://www.blogger.com/atom/ns#" term="anal sex"/><category scheme="http://www.blogger.com/atom/ns#" term="clinical trials"/><category scheme="http://www.blogger.com/atom/ns#" term="gay men"/><category scheme="http://www.blogger.com/atom/ns#" term="IAS"/><category scheme="http://www.blogger.com/atom/ns#" term="MSM"/><category scheme="http://www.blogger.com/atom/ns#" term="placebo"/><category scheme="http://www.blogger.com/atom/ns#" term="Project Gel"/><category scheme="http://www.blogger.com/atom/ns#" term="rectal microbicide"/><title type='text'>Adherence to rectal microbicide use among mainly ethnic minority young MSM: lessons from a 3-month placebo gel trial at three US sites [IAS 2013]</title><content type='html'>&lt;div dir=&quot;ltr&quot; style=&quot;text-align: left;&quot; trbidi=&quot;on&quot;&gt;
&lt;!--[if gte mso 9]&gt;&lt;xml&gt;
 &lt;w:WordDocument&gt;
  &lt;w:View&gt;Normal&lt;/w:View&gt;
  &lt;w:Zoom&gt;0&lt;/w:Zoom&gt;
  &lt;w:TrackMoves/&gt;
  &lt;w:TrackFormatting/&gt;
  &lt;w:PunctuationKerning/&gt;
  &lt;w:ValidateAgainstSchemas/&gt;
  &lt;w:SaveIfXMLInvalid&gt;false&lt;/w:SaveIfXMLInvalid&gt;
  &lt;w:IgnoreMixedContent&gt;false&lt;/w:IgnoreMixedContent&gt;
  &lt;w:AlwaysShowPlaceholderText&gt;false&lt;/w:AlwaysShowPlaceholderText&gt;
  &lt;w:DoNotPromoteQF/&gt;
  &lt;w:LidThemeOther&gt;EN-US&lt;/w:LidThemeOther&gt;
  &lt;w:LidThemeAsian&gt;X-NONE&lt;/w:LidThemeAsian&gt;
  &lt;w:LidThemeComplexScript&gt;X-NONE&lt;/w:LidThemeComplexScript&gt;
  &lt;w:Compatibility&gt;
   &lt;w:BreakWrappedTables/&gt;
   &lt;w:SnapToGridInCell/&gt;
   &lt;w:WrapTextWithPunct/&gt;
   &lt;w:UseAsianBreakRules/&gt;
   &lt;w:DontGrowAutofit/&gt;
   &lt;w:SplitPgBreakAndParaMark/&gt;
   &lt;w:DontVertAlignCellWithSp/&gt;
   &lt;w:DontBreakConstrainedForcedTables/&gt;
   &lt;w:DontVertAlignInTxbx/&gt;
   &lt;w:Word11KerningPairs/&gt;
   &lt;w:CachedColBalance/&gt;
  &lt;/w:Compatibility&gt;
  &lt;w:BrowserLevel&gt;MicrosoftInternetExplorer4&lt;/w:BrowserLevel&gt;
  &lt;m:mathPr&gt;
   &lt;m:mathFont m:val=&quot;Cambria Math&quot;/&gt;
   &lt;m:brkBin m:val=&quot;before&quot;/&gt;
   &lt;m:brkBinSub m:val=&quot;&amp;#45;-&quot;/&gt;
   &lt;m:smallFrac m:val=&quot;off&quot;/&gt;
   &lt;m:dispDef/&gt;
   &lt;m:lMargin m:val=&quot;0&quot;/&gt;
   &lt;m:rMargin m:val=&quot;0&quot;/&gt;
   &lt;m:defJc m:val=&quot;centerGroup&quot;/&gt;
   &lt;m:wrapIndent m:val=&quot;1440&quot;/&gt;
   &lt;m:intLim m:val=&quot;subSup&quot;/&gt;
   &lt;m:naryLim m:val=&quot;undOvr&quot;/&gt;
  &lt;/m:mathPr&gt;&lt;/w:WordDocument&gt;
&lt;/xml&gt;&lt;![endif]--&gt;&lt;a href=&quot;http://pag.ias2013.org/Abstracts.aspx?AID=2784&quot; target=&quot;_blank&quot;&gt;&lt;strong&gt;Oral paper presented by Alex Carballo-Diéguez at IAS 2013.&lt;/strong&gt;&lt;/a&gt;&lt;br /&gt;
&lt;br /&gt;
&lt;div class=&quot;separator&quot; style=&quot;clear: both; text-align: left;&quot;&gt;
&lt;img border=&quot;0&quot; height=&quot;240&quot; src=&quot;https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEik0XICIgr72poqwUp0K0hKK0Ut7si3IZ1u-8PQUNvhL2EbjPSy6H39C8DxzZNxjsx5EGFIOtdoVig4AV_Z3Ubd7YjBLWY1XQvFoQkKuHsVvTgHb2mOQjr4IrKqNVRhvJkjMzUZXs-bkI8/s320/ACD_Project_Gel_IAS_2013.jpg&quot; width=&quot;320&quot; /&gt;&lt;strong&gt;&lt;/strong&gt;&lt;/div&gt;
&lt;div class=&quot;separator&quot; style=&quot;clear: both; text-align: left;&quot;&gt;
&lt;strong&gt;&lt;/strong&gt;&amp;nbsp;&lt;/div&gt;
&lt;div class=&quot;separator&quot; style=&quot;clear: both; text-align: left;&quot;&gt;
&lt;strong&gt;&lt;a href=&quot;http://www.rectalmicrobicides.org/docs/ACD_Project_Gel_IAS_2013.pptx&quot; target=&quot;_blank&quot;&gt;Click for slides.&lt;/a&gt;&lt;/strong&gt; &lt;/div&gt;
&lt;br /&gt;
&lt;strong&gt;Abstract:&lt;/strong&gt;&lt;br /&gt;
&lt;br /&gt;
&lt;span id=&quot;lAbsText&quot;&gt;&lt;b&gt;Background: &lt;/b&gt; Adherence to product use is the cornerstone of microbicide studies. This is the first study to assess how frequently mainly ethnic minority MSM, ages 18-30, with a history of unprotected receptive anal intercourse (RAI) in the prior year, would self-administer gel using a rectal-specific applicator prior to RAI in their everyday lives. &lt;/span&gt;&lt;br /&gt;
&lt;br /&gt;&lt;b&gt;Methods: &lt;/b&gt; Recruitment took place in Boston, MA; Pittsburgh, PA, and San Juan, PR. Participants received 40 applicators prefilled with 4mL of hydroxyethylcellulose placebo gel that they could use over 12 weeks. They were asked to self-administer a dose within 90 minutes prior to RAI and report RAI and gel use at least weekly through an interactive voice response system (IVRS). At week 12, they responded to a Computer Assisted Self Interview (CASI) and underwent an in-depth interview. Participants were repeatedly counseled that the study focused on product adherence and that the gel would not protect against HIV. &lt;br /&gt;
&lt;br /&gt;&lt;b&gt;Results: &lt;/b&gt; 124 MSM were enrolled (Mean age 23.1; 41% White, 40% Latino, 8% African American, 11% mixed/other). 95 participants completed the trial (18 were lost to follow up and 11 withdrew). Based on the IVRS, (n=94, 1 missing data), 88 participants had RAI (Median 10 occasions) using gel on 81.1% of occasions (SD 23.3, range 0-100). Based on CASI, (n=86, 9 refused to answer RAI question) 83 participants had RAI (Median 12 occasions) using gel on 81.7% of occasions (SD 26.7; 0-100). Based on CASI, 69% of men typically applied gel immediately before RAI; 40 inconsistent users gave as reasons not having gel with them (85%), forgetting to use it (48%), not wanting to use it (13%), partner refusal (10%) and gel messiness (10%). &lt;br /&gt;
&lt;br /&gt;&lt;b&gt;Conclusions: &lt;/b&gt; Ethnically diverse young MSM with a history of unprotected RAI showed high adherence to gel use. Adherence to product use could potentially be enhanced by improving portability, facilitating the development of routines to counteract forgetfulness, and improving motivation and partner negotiation skills. Participant retention was challenging and needs further study. Two different self-report methods provided convergent results. Limitation: A product of known efficacy could have different uptake than the placebo used in this study.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;strong&gt;&lt;a href=&quot;http://www.rectalmicrobicides.org/docs/ACD_Project_Gel_IAS_2013.pptx&quot; target=&quot;_blank&quot;&gt;Click for slides.&lt;/a&gt;&lt;/strong&gt; &lt;br /&gt;
&lt;br /&gt;
&amp;nbsp; &lt;br /&gt;
------------------- 



&lt;br /&gt;
&lt;br /&gt;
*Join IRMA&#39;s robust, highly-active. moderated, global listserv addressing rectal microbicide research and advocacy as well as other interesting new HIV prevention technologies by contacting us at rectalmicro@gmail.com. Joining our listserv automatically makes you a member of IRMA - a network of more than 1,200 advocates, scientists, policy makers and funders from all over the world.&lt;br /&gt;
&lt;br /&gt;
*Please look for us on Facebook: www.facebook.com/InternationalRectalMicrobicideAdvocates, and you can follow us on Twitter: @rectalmicro.&lt;br /&gt;
&lt;br /&gt;
*Also, please note that shared news items from other sources posted on this blog do not necessarily mean IRMA has taken any position on the article&#39;s content.
&lt;br /&gt;
&lt;br /&gt;
&amp;nbsp;


-------------------&lt;/div&gt;
</content><link rel='replies' type='application/atom+xml' href='http://irma-rectalmicrobicides.blogspot.com/feeds/6888458572122758106/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment/fullpage/post/8936337794651081205/6888458572122758106?isPopup=true' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/8936337794651081205/posts/default/6888458572122758106'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/8936337794651081205/posts/default/6888458572122758106'/><link rel='alternate' type='text/html' href='http://irma-rectalmicrobicides.blogspot.com/2013/07/adherence-to-rectal-microbicide-use.html' title='Adherence to rectal microbicide use among mainly ethnic minority young MSM: lessons from a 3-month placebo gel trial at three US sites [IAS 2013]'/><author><name>NewPrevTech</name><uri>http://www.blogger.com/profile/05705781012925480028</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEik0XICIgr72poqwUp0K0hKK0Ut7si3IZ1u-8PQUNvhL2EbjPSy6H39C8DxzZNxjsx5EGFIOtdoVig4AV_Z3Ubd7YjBLWY1XQvFoQkKuHsVvTgHb2mOQjr4IrKqNVRhvJkjMzUZXs-bkI8/s72-c/ACD_Project_Gel_IAS_2013.jpg" height="72" width="72"/><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-8936337794651081205.post-201610018476069227</id><published>2013-07-11T12:58:00.000-05:00</published><updated>2013-07-11T12:58:56.633-05:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="advocacy"/><category scheme="http://www.blogger.com/atom/ns#" term="Gay"/><category scheme="http://www.blogger.com/atom/ns#" term="HIV"/><category scheme="http://www.blogger.com/atom/ns#" term="hiv prevention"/><category scheme="http://www.blogger.com/atom/ns#" term="Meet a Friendly Rectal Microbicide Advocate"/><category scheme="http://www.blogger.com/atom/ns#" term="Microbicides"/><category scheme="http://www.blogger.com/atom/ns#" term="MSM"/><category scheme="http://www.blogger.com/atom/ns#" term="prevention"/><title type='text'>Meet Octavio Vallejo, A Friendly Rectal Microbicide Advocate</title><content type='html'>&lt;div dir=&quot;ltr&quot; style=&quot;text-align: left;&quot; trbidi=&quot;on&quot;&gt;
Check out this interesting mini-bio of&amp;nbsp; Octavio Vallejo, the latest in IRMA&#39;s 
&quot;Meet a Friendly Rectal Microbicide Advocate&quot; series on the IRMA website &lt;a href=&quot;http://rectalmicrobicides.org/advocates.php&quot;&gt;&lt;b&gt;&lt;span style=&quot;color: #660000;&quot;&gt;here&lt;/span&gt;&lt;/b&gt;&lt;/a&gt;.&amp;nbsp; Octavio is one of five new bios 
posted this week.&lt;br /&gt;
&lt;br /&gt;
&lt;div class=&quot;separator&quot; style=&quot;clear: both; text-align: left;&quot;&gt;
&lt;a href=&quot;https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEijsCweUYr7UYU0-c-lb108iDoU3m7a-U7okVxlvvLGHFBMFK4cb9kY6nOERusemZqp4ZDhlflDvVxfkaYDBuxLCE3HAc8HPw2RR0LDEwkFG3VWHqwjvQbTEduQ-g5o3LCA1KvMRh8SlFM/s395/Advocate+-+Octavio+Vallejo.JPG&quot; imageanchor=&quot;1&quot; style=&quot;margin-left: 1em; margin-right: 1em;&quot;&gt;&lt;img border=&quot;0&quot; height=&quot;320&quot; src=&quot;https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEijsCweUYr7UYU0-c-lb108iDoU3m7a-U7okVxlvvLGHFBMFK4cb9kY6nOERusemZqp4ZDhlflDvVxfkaYDBuxLCE3HAc8HPw2RR0LDEwkFG3VWHqwjvQbTEduQ-g5o3LCA1KvMRh8SlFM/s320/Advocate+-+Octavio+Vallejo.JPG&quot; width=&quot;181&quot; /&gt;&lt;/a&gt;&lt;/div&gt;
&lt;br /&gt;
&lt;b&gt;Octavio Vallejo&lt;/b&gt;&lt;br /&gt;
&lt;b&gt;Los Angeles, California, USA&lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
Octavio Vallejo has been working in the HIV prevention field for more
 than 22 years.  As an HIV+ gay Latino man, Octavio has long recognized 
the need for additional methods of protection for young gay men and 
other men who have sex with men.  His involvement with rectal 
microbicides came through his interactions with scientists such as Dr. 
Ian McGowan and Dr. Ross Cranston.  Their passion for this issue was 
contagious and soon Octavio became involved with IRMA&#39;s active body of 
passionate researchers and advocates. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Octavio was drawn to IRMA by its spirit of inclusion and the resolve,
 resilience, and passion shown by the advocates connected with IRMA. He 
works for the Capacity Building Assistance program at &lt;a href=&quot;http://www.apla.org/&quot; target=&quot;_blank&quot;&gt;AIDS Project Los Angeles&lt;/a&gt;
 as a Biomedical Prevention Specialist.  This role have given Octavio 
more opportunities to share evidence-based information to all parties 
interested in changing the course of the HIV epidemic and educate them 
about the new generation of prevention tools and approaches.&lt;br /&gt;
&lt;br /&gt;
Currently, Octavio and his fellow staff members are in the process of
 creating the platform to bring microbicide advocacy to the forefront of
 all their trainings, educational endeavors and prevention discussions.&lt;br /&gt;
&lt;br /&gt;
Thank you Octavio for your continued dedication to HIV/AIDS prevention advocacy!&lt;b&gt;&amp;nbsp;&lt;/b&gt; &lt;br /&gt;
&lt;br /&gt;
------------------- 



*Join IRMA&#39;s robust, highly-active. moderated, global listserv addressing rectal microbicide research and advocacy as well as other interesting new HIV prevention technologies by contacting us at rectalmicro@gmail.com. Joining our listserv automatically makes you a member of IRMA - a network of more than 1,100 advocates, scientists, policy makers and funders from all over the world.&lt;br /&gt;
&lt;br /&gt;
*Please look for us on Facebook: www.facebook.com/InternationalRectalMicrobicideAdvocates, and you can follow us on Twitter: @rectalmicro.&lt;br /&gt;
&lt;br /&gt;
*Also, please note that shared news items from other sources posted on this blog do not necessarily mean IRMA has taken any position on the article&#39;s content.
 


-------------------&lt;/div&gt;
</content><link rel='replies' type='application/atom+xml' href='http://irma-rectalmicrobicides.blogspot.com/feeds/201610018476069227/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment/fullpage/post/8936337794651081205/201610018476069227?isPopup=true' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/8936337794651081205/posts/default/201610018476069227'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/8936337794651081205/posts/default/201610018476069227'/><link rel='alternate' type='text/html' href='http://irma-rectalmicrobicides.blogspot.com/2013/07/meet-octavio-vallejo-friendly-rectal.html' title='Meet Octavio Vallejo, A Friendly Rectal Microbicide Advocate'/><author><name>NewPrevTech</name><uri>http://www.blogger.com/profile/05705781012925480028</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEijsCweUYr7UYU0-c-lb108iDoU3m7a-U7okVxlvvLGHFBMFK4cb9kY6nOERusemZqp4ZDhlflDvVxfkaYDBuxLCE3HAc8HPw2RR0LDEwkFG3VWHqwjvQbTEduQ-g5o3LCA1KvMRh8SlFM/s72-c/Advocate+-+Octavio+Vallejo.JPG" height="72" width="72"/><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-8936337794651081205.post-2556619944876422630</id><published>2013-07-10T13:17:00.000-05:00</published><updated>2013-07-10T13:17:24.396-05:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="Bisexual"/><category scheme="http://www.blogger.com/atom/ns#" term="condoms"/><category scheme="http://www.blogger.com/atom/ns#" term="Gay"/><category scheme="http://www.blogger.com/atom/ns#" term="HIV"/><category scheme="http://www.blogger.com/atom/ns#" term="hiv prevention"/><category scheme="http://www.blogger.com/atom/ns#" term="Jim Pickett"/><category scheme="http://www.blogger.com/atom/ns#" term="Meet a Friendly Rectal Microbicide Advocate"/><category scheme="http://www.blogger.com/atom/ns#" term="Microbicides"/><category scheme="http://www.blogger.com/atom/ns#" term="research"/><title type='text'>Meet Javier Lopez, A Friendly Rectal Microbicide Advocate</title><content type='html'>&lt;div dir=&quot;ltr&quot; style=&quot;text-align: left;&quot; trbidi=&quot;on&quot;&gt;
Check out Javier Lopez&#39;s mini-bio, the latest in IRMA&#39;s 
&quot;Meet a Friendly Rectal Microbicide Advocate&quot; series on the IRMA website &lt;a href=&quot;http://rectalmicrobicides.org/advocates.php&quot;&gt;&lt;b&gt;&lt;span style=&quot;color: #660000;&quot;&gt;here&lt;/span&gt;&lt;/b&gt;&lt;/a&gt;.&amp;nbsp; Javier is one of five new bios 
posted this week.&lt;br /&gt;
&lt;br /&gt;
&lt;div class=&quot;separator&quot; style=&quot;clear: both; text-align: left;&quot;&gt;
&lt;a href=&quot;https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhEtaZz9Jipw-i4rmJujdoInQS0IKXOSzxQlshAeVGwyj06163GKwapo4twxDc5x6D63kaeqmcWSXEMD59AC7IHrsze2633NDwbdE11xEu16ui0k__fnYCQPSI6Lkb1kzRZJliXFQKht0A/s433/Advocate+-+Javier+Lopez.JPG&quot; imageanchor=&quot;1&quot; style=&quot;margin-left: 1em; margin-right: 1em;&quot;&gt;&lt;img border=&quot;0&quot; height=&quot;320&quot; src=&quot;https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhEtaZz9Jipw-i4rmJujdoInQS0IKXOSzxQlshAeVGwyj06163GKwapo4twxDc5x6D63kaeqmcWSXEMD59AC7IHrsze2633NDwbdE11xEu16ui0k__fnYCQPSI6Lkb1kzRZJliXFQKht0A/s320/Advocate+-+Javier+Lopez.JPG&quot; width=&quot;167&quot; /&gt;&amp;nbsp;&lt;/a&gt;&lt;/div&gt;
&lt;div class=&quot;separator&quot; style=&quot;clear: both; text-align: left;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;separator&quot; style=&quot;clear: both; text-align: left;&quot;&gt;
&lt;b&gt;Javier Lopez&lt;/b&gt;&lt;/div&gt;
&lt;div class=&quot;separator&quot; style=&quot;clear: both; text-align: left;&quot;&gt;
&lt;b&gt;New York City, USA&lt;/b&gt;&lt;/div&gt;
&lt;div class=&quot;separator&quot; style=&quot;clear: both; text-align: left;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
Javier Lopez first learned about rectal microbicides when his partner worked for &lt;a href=&quot;http://microbicides.us/&quot; target=&quot;_blank&quot;&gt;Project Gel&lt;/a&gt;
 in Puerto Rico.  Javier was immediately impressed by the creativity of 
this approach to HIV prevention as promotion of condoms alone is often 
difficult in all populations.&lt;br /&gt;
&lt;br /&gt;
Soon after, he attended a &lt;a href=&quot;http://www.youtube.com/watch?v=XIJBFcTMfiQ&quot; target=&quot;_blank&quot;&gt;talk on rectal microbicides&lt;/a&gt; by IRMA&#39;s Jim Pickett at &lt;a href=&quot;http://www.rectalmicrobicides.org/www.gmhc.org&quot; target=&quot;_blank&quot;&gt;Gay Men&#39;s Health Crisis&lt;/a&gt;
 (GMHC) in New York City.  Then he was hooked and snatched up a few 
&quot;Rectal Pride&quot; stickers that now fabulously adorn his Ipad cover.&lt;br /&gt;
&lt;br /&gt;
Javier has long been an advocate for HIV testing and for years has 
been involved in the HIV prevention fight in Puerto Rico.  During his 
undergraduate studies he took part in numerous educational sessions for 
HIV/STI prevention in gay men.  Currently, Javier is working as an 
assistant research scientist at the HIV Center for Clinical and 
Behavioral Studies that seeks to improve intervention screening 
practices for acute HIV infection in primary care setting in New York 
City.  Soon Javier will be taking his education further as he enters the
 Masters of Public Health program at Hunter College in New York City.&lt;br /&gt;
&lt;br /&gt;
Javier is also proud to have been a part of the recently launched HIV
 testing campaign for the CDC called &quot;Reasons/Razones&quot; which targets 
Latino gay and bisexual men to consider their reasons for getting 
tested.  More information about this exciting campaign is available &lt;a href=&quot;http://hivtest.cdc.gov/reasons&quot; target=&quot;_blank&quot;&gt;here&lt;/a&gt;.&lt;br /&gt;
&lt;br /&gt;
Javier is excited to be a rectal microbicide advocate because he 
believes that it is important for this research to continue and that 
youth of all backgrounds should get involved.&lt;br /&gt;
&lt;br /&gt;
Thank you Javier!&lt;br /&gt;
&lt;div class=&quot;separator&quot; style=&quot;clear: both; text-align: left;&quot;&gt;
&lt;b&gt;&amp;nbsp;&lt;/b&gt; &lt;/div&gt;
&lt;br /&gt;
------------------- 



*Join IRMA&#39;s robust, highly-active. moderated, global listserv addressing rectal microbicide research and advocacy as well as other interesting new HIV prevention technologies by contacting us at rectalmicro@gmail.com. Joining our listserv automatically makes you a member of IRMA - a network of more than 1,100 advocates, scientists, policy makers and funders from all over the world.&lt;br /&gt;
&lt;br /&gt;
*Please look for us on Facebook: www.facebook.com/InternationalRectalMicrobicideAdvocates, and you can follow us on Twitter: @rectalmicro.&lt;br /&gt;
&lt;br /&gt;
*Also, please note that shared news items from other sources posted on this blog do not necessarily mean IRMA has taken any position on the article&#39;s content.
 


-------------------&lt;/div&gt;
</content><link rel='replies' type='application/atom+xml' href='http://irma-rectalmicrobicides.blogspot.com/feeds/2556619944876422630/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment/fullpage/post/8936337794651081205/2556619944876422630?isPopup=true' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/8936337794651081205/posts/default/2556619944876422630'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/8936337794651081205/posts/default/2556619944876422630'/><link rel='alternate' type='text/html' href='http://irma-rectalmicrobicides.blogspot.com/2013/07/meet-javier-lopez-friendly-rectal.html' title='Meet Javier Lopez, A Friendly Rectal Microbicide Advocate'/><author><name>NewPrevTech</name><uri>http://www.blogger.com/profile/05705781012925480028</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhEtaZz9Jipw-i4rmJujdoInQS0IKXOSzxQlshAeVGwyj06163GKwapo4twxDc5x6D63kaeqmcWSXEMD59AC7IHrsze2633NDwbdE11xEu16ui0k__fnYCQPSI6Lkb1kzRZJliXFQKht0A/s72-c/Advocate+-+Javier+Lopez.JPG" height="72" width="72"/><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-8936337794651081205.post-3046166652978945734</id><published>2013-07-09T13:52:00.000-05:00</published><updated>2013-07-09T13:52:01.939-05:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="Africa"/><category scheme="http://www.blogger.com/atom/ns#" term="condoms"/><category scheme="http://www.blogger.com/atom/ns#" term="GLAM"/><category scheme="http://www.blogger.com/atom/ns#" term="Global Lube Access Mobilisation"/><category scheme="http://www.blogger.com/atom/ns#" term="HIV"/><category scheme="http://www.blogger.com/atom/ns#" term="hiv prevention"/><category scheme="http://www.blogger.com/atom/ns#" term="HIV/AIDS"/><category scheme="http://www.blogger.com/atom/ns#" term="lubricant"/><category scheme="http://www.blogger.com/atom/ns#" term="Meet a Friendly Rectal Microbicide Advocate"/><category scheme="http://www.blogger.com/atom/ns#" term="Microbicides"/><category scheme="http://www.blogger.com/atom/ns#" term="sub-saharan Africa"/><title type='text'>Meet Stephen McGill, A Friendly Rectal Microbicide Advocate</title><content type='html'>&lt;div dir=&quot;ltr&quot; style=&quot;text-align: left;&quot; trbidi=&quot;on&quot;&gt;
Find out a little about Stephen McGill in his mini-bio, the latest in IRMA&#39;s 
&quot;Meet a Friendly Rectal Microbicide Advocate&quot; series on the IRMA website &lt;a href=&quot;http://rectalmicrobicides.org/advocates.php&quot;&gt;&lt;b&gt;&lt;span style=&quot;color: #660000;&quot;&gt;here&lt;/span&gt;&lt;/b&gt;&lt;/a&gt;.&amp;nbsp; Stephen is one of five new bios 
posted in the past week.&lt;br /&gt;
&lt;br /&gt;
&lt;div class=&quot;separator&quot; style=&quot;clear: both; text-align: left;&quot;&gt;
&lt;a href=&quot;https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgDxvSKC-X_mmmhrhwWewvxHm8TdPM3WuSuB4X7spARhnX4nWYeRCq77ciJisVaZyobqqO6KMVhgJbirM28YgLraO430qE4CXvV9v5LDk_i1WPe81BUm9pVWyjOrEqybOwjoobK2LdEsAU/s725/Advocate+-+Stephen+McGill.JPG&quot; imageanchor=&quot;1&quot; style=&quot;margin-left: 1em; margin-right: 1em;&quot;&gt;&lt;img border=&quot;0&quot; height=&quot;200&quot; src=&quot;https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgDxvSKC-X_mmmhrhwWewvxHm8TdPM3WuSuB4X7spARhnX4nWYeRCq77ciJisVaZyobqqO6KMVhgJbirM28YgLraO430qE4CXvV9v5LDk_i1WPe81BUm9pVWyjOrEqybOwjoobK2LdEsAU/s200/Advocate+-+Stephen+McGill.JPG&quot; width=&quot;175&quot; /&gt;&amp;nbsp;&lt;/a&gt;&lt;/div&gt;
&lt;div class=&quot;separator&quot; style=&quot;clear: both; text-align: left;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;separator&quot; style=&quot;clear: both; text-align: left;&quot;&gt;
&lt;b&gt;Stephen McGill&lt;/b&gt;&lt;/div&gt;
&lt;div class=&quot;separator&quot; style=&quot;clear: both; text-align: left;&quot;&gt;
&lt;b&gt;Monrovia, Liberia&amp;nbsp;&lt;/b&gt;&lt;/div&gt;
&lt;div class=&quot;separator&quot; style=&quot;clear: both; text-align: left;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
Stephen McGill, with an extensive background in public health, 
HIV/AIDS prevention, and human rights advocacy, first came into contact 
with rectal microbicide advocacy when he joined the highly-active IRMA listserv through the help of &lt;a href=&quot;http://www.actupphilly.org/&quot; target=&quot;_blank&quot;&gt;&lt;strong&gt;ACT UP Philadelphia&lt;/strong&gt;&lt;/a&gt; and &lt;a href=&quot;http://healthgap.org/&quot; target=&quot;_blank&quot;&gt;&lt;strong&gt;Health GAP&lt;/strong&gt;&lt;/a&gt;.
  As an active member on the listserv, Stephen is able to engage with 
experts, researchers, and activists on the potential of rectal 
microbicide research in combating HIV/AIDS in sub-Saharan Africa, 
notably his native Liberia.&lt;br /&gt;
&lt;br /&gt;
Stephen is founder of &lt;a href=&quot;http://www.stopaidsinliberia.org/StopAidsInLiberia/Welcome.html&quot; target=&quot;_blank&quot;&gt;&lt;strong&gt;Stop AIDS in Liberia&lt;/strong&gt;&lt;/a&gt; (SAIL), one of three organizations that received small &lt;a href=&quot;http://tinyurl.com/andlube&quot; target=&quot;_blank&quot;&gt;&lt;strong&gt;Global Lube Access Mobilisation&lt;/strong&gt;&lt;/a&gt;
 (GLAM) grants to advocate for improved access to safe, condom- 
compatible lubricant  So far, Stephen and SAIL have organized 
stakeholders meetings to promote condom compatible lubricants with other
 local organizations in Liberia, Sierra&amp;nbsp; Leone, Guinea, Gambia, and Cote d&#39;Ivoire.  In Liberia, Stephen has 
met with many organizations and media outlets including the Ministry of 
Gender and Development and the Ministry of Justice.&lt;br /&gt;
&lt;br /&gt;
Stephen would also like to tell IRMA&#39;s followers to keep up the great
 work promoting diversity in advocacy, policy, and research.  We are all
 looking forward to hearing more about Stephen and SAIL&#39;s advocacy 
efforts to improve lube access.&lt;br /&gt;
&lt;br /&gt;
Thanks Stephen!&amp;nbsp; &lt;br /&gt;
&lt;div class=&quot;separator&quot; style=&quot;clear: both; text-align: left;&quot;&gt;
&lt;b&gt;&amp;nbsp;&lt;/b&gt; &lt;/div&gt;
------------------- 



*Join IRMA&#39;s robust, highly-active. moderated, global listserv addressing rectal microbicide research and advocacy as well as other interesting new HIV prevention technologies by contacting us at rectalmicro@gmail.com. Joining our listserv automatically makes you a member of IRMA - a network of more than 1,100 advocates, scientists, policy makers and funders from all over the world.&lt;br /&gt;
&lt;br /&gt;
*Please look for us on Facebook: www.facebook.com/InternationalRectalMicrobicideAdvocates, and you can follow us on Twitter: @rectalmicro.&lt;br /&gt;
&lt;br /&gt;
*Also, please note that shared news items from other sources posted on this blog do not necessarily mean IRMA has taken any position on the article&#39;s content.
 


-------------------&lt;/div&gt;
</content><link rel='replies' type='application/atom+xml' href='http://irma-rectalmicrobicides.blogspot.com/feeds/3046166652978945734/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment/fullpage/post/8936337794651081205/3046166652978945734?isPopup=true' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/8936337794651081205/posts/default/3046166652978945734'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/8936337794651081205/posts/default/3046166652978945734'/><link rel='alternate' type='text/html' href='http://irma-rectalmicrobicides.blogspot.com/2013/07/meet-stephen-mcgill-friendly-rectal.html' title='Meet Stephen McGill, A Friendly Rectal Microbicide Advocate'/><author><name>NewPrevTech</name><uri>http://www.blogger.com/profile/05705781012925480028</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgDxvSKC-X_mmmhrhwWewvxHm8TdPM3WuSuB4X7spARhnX4nWYeRCq77ciJisVaZyobqqO6KMVhgJbirM28YgLraO430qE4CXvV9v5LDk_i1WPe81BUm9pVWyjOrEqybOwjoobK2LdEsAU/s72-c/Advocate+-+Stephen+McGill.JPG" height="72" width="72"/><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-8936337794651081205.post-8473795586834135013</id><published>2013-07-08T13:46:00.001-05:00</published><updated>2013-07-08T13:46:55.568-05:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="HIV"/><category scheme="http://www.blogger.com/atom/ns#" term="hiv prevention"/><category scheme="http://www.blogger.com/atom/ns#" term="HIV/AIDS"/><category scheme="http://www.blogger.com/atom/ns#" term="Meet a Friendly Rectal Microbicide Advocate"/><category scheme="http://www.blogger.com/atom/ns#" term="Microbicide Trials Network"/><category scheme="http://www.blogger.com/atom/ns#" term="Microbicides"/><category scheme="http://www.blogger.com/atom/ns#" term="MTN 017"/><category scheme="http://www.blogger.com/atom/ns#" term="PrEP"/><category scheme="http://www.blogger.com/atom/ns#" term="prevention"/><category scheme="http://www.blogger.com/atom/ns#" term="rectal microbicide"/><category scheme="http://www.blogger.com/atom/ns#" term="sexual health"/><title type='text'>Meet Hailey Gilmore, A Friendly Rectal Microbicide Advocate</title><content type='html'>&lt;div dir=&quot;ltr&quot; style=&quot;text-align: left;&quot; trbidi=&quot;on&quot;&gt;
Find out a little about Hailey Gilmore in her interesting mini-bio, the latest in IRMA&#39;s 
&quot;Meet a Friendly Rectal Microbicide Advocate&quot; series on the IRMA website &lt;a href=&quot;http://rectalmicrobicides.org/advocates.php&quot;&gt;&lt;b&gt;&lt;span style=&quot;color: #660000;&quot;&gt;here&lt;/span&gt;&lt;/b&gt;&lt;/a&gt;.&amp;nbsp; Hailey is one of five new bios we are featuring.&lt;br /&gt;
&amp;nbsp; &lt;br /&gt;
&lt;div class=&quot;separator&quot; style=&quot;clear: both; text-align: left;&quot;&gt;
&lt;a href=&quot;https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhnwMe-4x3tT-gHzzf_yFhzq7fDfiPB5vCHMKfNXUW9NwwcSdTVDVBnEsXtUE-Osaa2vY9bcYNFzO44mvukK93BwS_YeJP-8gEBFdIR917Sobqj4MLYAW756_-1jVH88-9F_L18vWIQqdE/s1600/Advocate+-+Hailey+Gilmore.JPG&quot; imageanchor=&quot;1&quot; style=&quot;margin-left: 1em; margin-right: 1em;&quot;&gt;&lt;img border=&quot;0&quot; height=&quot;320&quot; src=&quot;https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhnwMe-4x3tT-gHzzf_yFhzq7fDfiPB5vCHMKfNXUW9NwwcSdTVDVBnEsXtUE-Osaa2vY9bcYNFzO44mvukK93BwS_YeJP-8gEBFdIR917Sobqj4MLYAW756_-1jVH88-9F_L18vWIQqdE/s320/Advocate+-+Hailey+Gilmore.JPG&quot; width=&quot;240&quot; /&gt;&lt;/a&gt;&lt;/div&gt;
&lt;br /&gt;
&lt;b&gt;Hailey Gilmore&lt;/b&gt;&lt;br /&gt;
&lt;b&gt;San Francisco, California, USA&lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
Hailey Gilmore studied international development in college and was 
always interested in sexual health promotion and education.  While in 
school she interned at a local non-profit and developed a sex-ed 
workshop for youth in trade school.  During this time she also became a 
volunteer HIV test counselor.  This introduction to sexual health work 
opened the door for her current position as the Assistant Director of 
HIV Prevention Intervention Studies at &lt;a href=&quot;http://www.bridgehiv.org/&quot; target=&quot;_blank&quot;&gt;&lt;strong&gt;Bridge HIV&lt;/strong&gt;&lt;/a&gt;
 at the San Francisco Department of Public Health.  She has been with 
Bridge HIV, supporting and coordinating clinical trials, for over four 
years.&lt;br /&gt;
&lt;br /&gt;
Her organization conducts HIV prevention clinical trials testing HIV 
vaccines and pre-exposure prophylaxis (PrEP), and soon, rectal 
microbicides. Bridge HIV also studies behavioral interventions.&lt;br /&gt;
&lt;br /&gt;
A little over a year ago, her organization was approached by the Microbicide Trials Network about conducting &lt;a href=&quot;http://www.mtnstopshiv.org/news/studies/mtn017&quot; target=&quot;_blank&quot;&gt;&lt;strong&gt;MTN-017&lt;/strong&gt;&lt;/a&gt;,
 a phase II safety and acceptability study of rectally applied tenofovir
 gel among gay men, men who have sex with men, and transwomen in the US,
 Peru, Thailand, and South Africa.  Hailey and her colleagues are 
incredibly excited for the MTN-017 launch later this year.&lt;br /&gt;
&lt;br /&gt;
Hailey is also busy with the HPTN 069 study, or &lt;a href=&quot;http://www.nextprepstudy.org/&quot; target=&quot;_blank&quot;&gt;&lt;strong&gt;NEXT-PrEP&lt;/strong&gt;&lt;/a&gt;,
 which is looking at the safety and tolerability of four daily oral 
regimens of PrEP. She is also analyzing qualitative data about people&#39;s 
 motivations to take PrEP to better address advocacy strategies.&lt;br /&gt;
&lt;br /&gt;
Hailey and her group will also soon be hosting a screening of &lt;strong&gt;&quot;&lt;/strong&gt;&lt;a href=&quot;http://tinyurl.com/rectalvid&quot; target=&quot;_blank&quot;&gt;&lt;strong&gt;The Rectal Revolution is Here&quot;&lt;/strong&gt;&lt;/a&gt; in July to engage the San Francisco community on the topic of rectal microbicides. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Hailey would like to encourage  IRMA to continue to find additional 
community allies to partner with  - rectal microbicides are just too 
exciting to not talk about!&lt;br /&gt;
&lt;br /&gt;
Thank you Hailey!&lt;b&gt;&amp;nbsp;&lt;/b&gt; &lt;br /&gt;
&lt;br /&gt;
------------------- 



*Join IRMA&#39;s robust, highly-active. moderated, global listserv addressing rectal microbicide research and advocacy as well as other interesting new HIV prevention technologies by contacting us at rectalmicro@gmail.com. Joining our listserv automatically makes you a member of IRMA - a network of more than 1,100 advocates, scientists, policy makers and funders from all over the world.&lt;br /&gt;
&lt;br /&gt;
*Please look for us on Facebook: www.facebook.com/InternationalRectalMicrobicideAdvocates, and you can follow us on Twitter: @rectalmicro.&lt;br /&gt;
&lt;br /&gt;
*Also, please note that shared news items from other sources posted on this blog do not necessarily mean IRMA has taken any position on the article&#39;s content.
 


-------------------&lt;/div&gt;
</content><link rel='replies' type='application/atom+xml' href='http://irma-rectalmicrobicides.blogspot.com/feeds/8473795586834135013/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment/fullpage/post/8936337794651081205/8473795586834135013?isPopup=true' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/8936337794651081205/posts/default/8473795586834135013'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/8936337794651081205/posts/default/8473795586834135013'/><link rel='alternate' type='text/html' href='http://irma-rectalmicrobicides.blogspot.com/2013/07/meet-hailey-gilmore-friendly-rectal.html' title='Meet Hailey Gilmore, A Friendly Rectal Microbicide Advocate'/><author><name>NewPrevTech</name><uri>http://www.blogger.com/profile/05705781012925480028</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhnwMe-4x3tT-gHzzf_yFhzq7fDfiPB5vCHMKfNXUW9NwwcSdTVDVBnEsXtUE-Osaa2vY9bcYNFzO44mvukK93BwS_YeJP-8gEBFdIR917Sobqj4MLYAW756_-1jVH88-9F_L18vWIQqdE/s72-c/Advocate+-+Hailey+Gilmore.JPG" height="72" width="72"/><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-8936337794651081205.post-261618124234248056</id><published>2013-07-03T12:41:00.002-05:00</published><updated>2013-07-03T15:09:18.520-05:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="clinical trials"/><category scheme="http://www.blogger.com/atom/ns#" term="Gay"/><category scheme="http://www.blogger.com/atom/ns#" term="HIV"/><category scheme="http://www.blogger.com/atom/ns#" term="hiv prevention"/><category scheme="http://www.blogger.com/atom/ns#" term="HIV/AIDS"/><category scheme="http://www.blogger.com/atom/ns#" term="lgbt"/><category scheme="http://www.blogger.com/atom/ns#" term="Meet a Friendly Rectal Microbicide Advocate"/><category scheme="http://www.blogger.com/atom/ns#" term="Microbicides"/><category scheme="http://www.blogger.com/atom/ns#" term="PrEP"/><category scheme="http://www.blogger.com/atom/ns#" term="research"/><category scheme="http://www.blogger.com/atom/ns#" term="safer sex"/><category scheme="http://www.blogger.com/atom/ns#" term="youth"/><title type='text'>Meet Coco Alinsug, A Friendly Rectal Microbicide Advocate</title><content type='html'>&lt;div dir=&quot;ltr&quot; style=&quot;text-align: left;&quot; trbidi=&quot;on&quot;&gt;
Check out this interesting mini-bio of&amp;nbsp; Coco Alinsug, the latest in IRMA&#39;s 
&quot;Meet a Friendly Rectal Microbicide Advocate&quot; series on the IRMA website &lt;a href=&quot;http://rectalmicrobicides.org/advocates.php&quot;&gt;&lt;b&gt;&lt;span style=&quot;color: #660000;&quot;&gt;here&lt;/span&gt;&lt;/b&gt;&lt;/a&gt;.&amp;nbsp; Coco is one of five new bios 
posted this week.&lt;br /&gt;
&lt;br /&gt;
&lt;div class=&quot;separator&quot; style=&quot;clear: both; text-align: left;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;separator&quot; style=&quot;clear: both; text-align: left;&quot;&gt;
&lt;a href=&quot;https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjlgq75Gyv76_g6G-JDohxVYmbu6VCqfwdnHpEBt3Ew9lkjcnuHwbSquPlWcTcqaRlIDFD6iRkgCN2o8GEiWK63QCGCuZBsbEwGoAwl_TKMknMMiOH8LXgC_1k22x0mORO3yn9a0f2auTE/s250/Advocate+_Coco+Alinsug_site.jpg&quot; imageanchor=&quot;1&quot; style=&quot;margin-left: 1em; margin-right: 1em;&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjlgq75Gyv76_g6G-JDohxVYmbu6VCqfwdnHpEBt3Ew9lkjcnuHwbSquPlWcTcqaRlIDFD6iRkgCN2o8GEiWK63QCGCuZBsbEwGoAwl_TKMknMMiOH8LXgC_1k22x0mORO3yn9a0f2auTE/s250/Advocate+_Coco+Alinsug_site.jpg&quot; /&gt;&lt;/a&gt;&lt;/div&gt;
&amp;nbsp;&lt;b&gt;&amp;nbsp;&lt;/b&gt;&lt;br /&gt;
&lt;b&gt;Coco Alinsung&lt;/b&gt;&lt;br /&gt;
&lt;b&gt;Boston, Massachusettes, USA&lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
A native of the Philippines and a resident of Lynn, Massachusetts 
with his partner, Coco Alinsug has made a lifelong commitment to devote 
his time and energy to social justice, HIV/AIDS prevention, and issues 
facing LGBT youth.&lt;br /&gt;
&lt;br /&gt;
Coco started his career as an HIV Counselor and Tester at the Gay and
 Bi Men&#39;s Health Program in Beverly, MA and later was appointed as the 
Executive Director of the &lt;a href=&quot;http://www.nagly.org/&quot; target=&quot;_blank&quot;&gt;North Shore Alliance on GLBT Youth&lt;/a&gt;
 which is funded by the Massachusetts Department of Public Health to 
provide HIV/STI education to youth 14-24 years old  - a position he has 
held for eight years.&lt;br /&gt;
&lt;br /&gt;
Currently Coco works as the Clinical Trials Field Recruitment Manager at &lt;a href=&quot;http://www.fenwayhealth.org/site/PageServer?pagename=FCHC_ins_fenway_home&quot; target=&quot;_blank&quot;&gt;The Fenway Institute&lt;/a&gt;
 where he has been for nearly seven years.  It was in this role that 
Coco first came into contact with rectal microbicide advocacy as he was 
tasked with recruitment for all clinical trials, including the rectal 
microbicide study called &lt;a href=&quot;http://microbicides.us/&quot; target=&quot;_blank&quot;&gt;Project Gel&lt;/a&gt;.&lt;br /&gt;
&lt;br /&gt;
In his role at Fenway, Coco oversees outreach and recruitment for 
research studies looking at everything from possible HIV vaccines to 
microbicides to the use of pre-exposure prophylaxis (PrEP) to prevent 
HIV transmission.  Coco and his team travel around New England, 
educating people about HIV and STD transmission and safer sex practices 
while also recruiting potential study participants.&lt;br /&gt;
&lt;br /&gt;
Coco is also Chair for Community Education and Recruitment group for both &lt;a href=&quot;http://www.hvtn.org/&quot; target=&quot;_blank&quot;&gt;HIV Vaccine Trials Network&lt;/a&gt; (HVTN) and &lt;a href=&quot;http://www.hptn.org/&quot; target=&quot;_blank&quot;&gt;HIV Prevention Trials Network&lt;/a&gt;
 (HPTN) and sits as a member of the protocol team for two studies, 
HVTN505 and HPTN069.  Coco also is a consultant for various HIV and STD 
Outreach Programs both in the North Shore and Boston, and sometimes 
organizes and hosts shows in several clubs.&lt;br /&gt;
&lt;br /&gt;
Coco would also like to encourage IRMA to keep up the good work and 
always stay fabulous.&lt;br /&gt;
&lt;br /&gt;
Thank you for all your work Coco, and you stay 
fabulous too!&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
------------------- 



*Join IRMA&#39;s robust, highly-active. moderated, global listserv addressing rectal microbicide research and advocacy as well as other interesting new HIV prevention technologies by contacting us at rectalmicro@gmail.com. Joining our listserv automatically makes you a member of IRMA - a network of more than 1,100 advocates, scientists, policy makers and funders from all over the world.&lt;br /&gt;
&lt;br /&gt;
*Please look for us on Facebook: www.facebook.com/InternationalRectalMicrobicideAdvocates, and you can follow us on Twitter: @rectalmicro.&lt;br /&gt;
&lt;br /&gt;
*Also, please note that shared news items from other sources posted on this blog do not necessarily mean IRMA has taken any position on the article&#39;s content.
 


-------------------&lt;/div&gt;
</content><link rel='replies' type='application/atom+xml' href='http://irma-rectalmicrobicides.blogspot.com/feeds/261618124234248056/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment/fullpage/post/8936337794651081205/261618124234248056?isPopup=true' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/8936337794651081205/posts/default/261618124234248056'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/8936337794651081205/posts/default/261618124234248056'/><link rel='alternate' type='text/html' href='http://irma-rectalmicrobicides.blogspot.com/2013/07/meet-coco-alinsung-friendly-rectal.html' title='Meet Coco Alinsug, A Friendly Rectal Microbicide Advocate'/><author><name>NewPrevTech</name><uri>http://www.blogger.com/profile/05705781012925480028</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjlgq75Gyv76_g6G-JDohxVYmbu6VCqfwdnHpEBt3Ew9lkjcnuHwbSquPlWcTcqaRlIDFD6iRkgCN2o8GEiWK63QCGCuZBsbEwGoAwl_TKMknMMiOH8LXgC_1k22x0mORO3yn9a0f2auTE/s72-c/Advocate+_Coco+Alinsug_site.jpg" height="72" width="72"/><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-8936337794651081205.post-147491165233287548</id><published>2013-06-18T12:50:00.002-05:00</published><updated>2013-06-18T12:50:41.060-05:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="anal sex"/><category scheme="http://www.blogger.com/atom/ns#" term="And Lube"/><category scheme="http://www.blogger.com/atom/ns#" term="gay men"/><category scheme="http://www.blogger.com/atom/ns#" term="GLAM"/><category scheme="http://www.blogger.com/atom/ns#" term="HIV"/><category scheme="http://www.blogger.com/atom/ns#" term="hiv prevention"/><category scheme="http://www.blogger.com/atom/ns#" term="HIV/AIDS"/><category scheme="http://www.blogger.com/atom/ns#" term="HIV/AIDS policy"/><category scheme="http://www.blogger.com/atom/ns#" term="IRMA"/><category scheme="http://www.blogger.com/atom/ns#" term="lubricant"/><category scheme="http://www.blogger.com/atom/ns#" term="Marc-André LeBlanc"/><category scheme="http://www.blogger.com/atom/ns#" term="research"/><category scheme="http://www.blogger.com/atom/ns#" term="safety"/><category scheme="http://www.blogger.com/atom/ns#" term="sexual health"/><title type='text'>Soooooooo..... Are Lubes Safe?</title><content type='html'>&lt;div dir=&quot;ltr&quot; style=&quot;text-align: left;&quot; trbidi=&quot;on&quot;&gt;
&lt;b&gt;&lt;a href=&quot;http://www.positivelite.com/component/zoo/item/are-lubes-safe&quot;&gt;via Positive Lite, by Marc-André LeBlanc&lt;/a&gt;&lt;/b&gt;&lt;br /&gt;
&lt;blockquote class=&quot;tr_bq&quot;&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span lang=&quot;EN-US&quot;&gt;&quot;This situation 
is unacceptable. We’re in 2013, for the love of all that is wet and wild! How 
can we not know the answer to such a fundamental question—are lubes 
safe?&quot;&lt;/span&gt;&amp;nbsp;&lt;b&gt;&lt;/b&gt;&lt;/div&gt;
&lt;/blockquote&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&amp;nbsp;&lt;b&gt;Here I am again&lt;/b&gt;, 
standing in front of a giant wall of lube options at a local store.&lt;/div&gt;
&lt;div class=&quot;separator&quot; style=&quot;clear: both; text-align: center;&quot;&gt;
&lt;a href=&quot;https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEh4MHWxeM6HIyTC7H2DiArGAHp62MFXSNPlpHyKs0jBcl8hT9RbRSUo97tduHYgVE_mX9alsMOmA-MQF9rr6o1JlC42agt-c52la1BKCxRbO2r-xDAlaKTkDhSCRSguUIgCgcMxeNyRK9w/s1600/lube2.jpg&quot; imageanchor=&quot;1&quot; style=&quot;clear: left; float: left; margin-bottom: 1em; margin-right: 1em;&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEh4MHWxeM6HIyTC7H2DiArGAHp62MFXSNPlpHyKs0jBcl8hT9RbRSUo97tduHYgVE_mX9alsMOmA-MQF9rr6o1JlC42agt-c52la1BKCxRbO2r-xDAlaKTkDhSCRSguUIgCgcMxeNyRK9w/s1600/lube2.jpg&quot; /&gt;&lt;/a&gt;&lt;/div&gt;
&lt;ul&gt;
&lt;li&gt;Water-based, silicone-based, oil-based, hybrid.&lt;/li&gt;
&lt;li&gt;Bottles, tubs, tubes, vats, vials, sachets, packets, pouches, pillows, 
mix-it-at-home kits.&lt;/li&gt;
&lt;li&gt;Pumpable, flippable, squeezable, scoopable, squirtable, spritzable, 
speadable.&lt;/li&gt;
&lt;li&gt;Regular, warming, cooling, tingling, numbing.&lt;/li&gt;
&lt;li&gt;Thick, thin, goopy, watery, greasy, sticky, slippery, silky, slick.&lt;/li&gt;
&lt;li&gt;Long lists of unpronounceable chemicals, claims of being organic or 
all-natural.&lt;/li&gt;
&lt;li&gt;Scents. Flavours. Colours.&lt;/li&gt;
&lt;li&gt;Formulated to look like cum!&lt;/li&gt;
&lt;li&gt;And of course, wildly varying prices.&lt;/li&gt;
&lt;/ul&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span lang=&quot;EN-US&quot;&gt;&lt;br /&gt;I’m glad I’m not 
meeting that guy for another three hours.&amp;nbsp;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span lang=&quot;EN-US&quot;&gt;So which lube 
should I get? Which ones are safe? Which ones should I avoid?&amp;nbsp;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span lang=&quot;EN-US&quot;&gt;Who 
knows!&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span lang=&quot;EN-US&quot;&gt;No, seriously. 
Who knows? If I don’t, I can only assume nobody else does. After all, I 
coordinate the global Lube Safety Working Group for &lt;a href=&quot;http://www.rectalmicrobicides.org/&quot;&gt;&lt;strong&gt;IRMA—International Rectal microbicide 
Advocates&lt;/strong&gt;&lt;/a&gt;&lt;strong&gt;.&lt;/strong&gt;&amp;nbsp;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span lang=&quot;EN-US&quot;&gt;This is the 
shocking reality: more than 30 years into the HIV pandemic, we still have no 
clear answers on whether sexual lubricants (lubes) increase, decrease, or have 
no impact on the risk of acquiring HIV and other STIs sexually transmitted 
infections (STIs).&amp;nbsp;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span lang=&quot;EN-US&quot;&gt;Many men, women 
and transgender individuals all across the globe use sexual lubricants for both 
vaginal and anal intercourse. We have long promoted the use of male or female 
condoms with condom-compatible water-based or silicone-based lubes to prevent 
HIV and other STIs. Lubricants help ensure that condoms don’t break, and that 
condoms stay on during sex. So, it’s pretty critical we understand if any of 
these condom-compatible lubes could actually be putting people in harm’s way.&amp;nbsp;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span lang=&quot;EN-US&quot;&gt;One thing is 
clear: we will not get an answer to the lube safety question without advocacy.&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;span lang=&quot;EN-US&quot;&gt;&lt;b&gt;&lt;a href=&quot;http://www.positivelite.com/component/zoo/item/are-lubes-safe&quot;&gt;Read the rest.&lt;/a&gt;&lt;/b&gt; &lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
-------------------&lt;br /&gt;
&lt;br /&gt;
&amp;nbsp;



*Join IRMA&#39;s robust, highly-active. moderated, global listserv addressing rectal microbicide research and advocacy as well as other interesting new HIV prevention technologies by contacting us at rectalmicro@gmail.com. Joining our listserv automatically makes you a member of IRMA - a network of more than 1,100 advocates, scientists, policy makers and funders from all over the world.


&lt;br /&gt;
&lt;br /&gt;
*Please look for us on Facebook: www.facebook.com/InternationalRectalMicrobicideAdvocates, and you can follow us on Twitter: @rectalmicro.
 

&lt;br /&gt;
&lt;br /&gt;
*Also, please note that shared news items from other sources posted on this blog do not necessarily mean IRMA has taken any position on the article&#39;s content.
&lt;br /&gt;
&lt;br /&gt;
&amp;nbsp;


-------------------&lt;/div&gt;
</content><link rel='replies' type='application/atom+xml' href='http://irma-rectalmicrobicides.blogspot.com/feeds/147491165233287548/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment/fullpage/post/8936337794651081205/147491165233287548?isPopup=true' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/8936337794651081205/posts/default/147491165233287548'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/8936337794651081205/posts/default/147491165233287548'/><link rel='alternate' type='text/html' href='http://irma-rectalmicrobicides.blogspot.com/2013/06/soooooooo-are-lubes-safe.html' title='Soooooooo..... Are Lubes Safe?'/><author><name>NewPrevTech</name><uri>http://www.blogger.com/profile/05705781012925480028</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEh4MHWxeM6HIyTC7H2DiArGAHp62MFXSNPlpHyKs0jBcl8hT9RbRSUo97tduHYgVE_mX9alsMOmA-MQF9rr6o1JlC42agt-c52la1BKCxRbO2r-xDAlaKTkDhSCRSguUIgCgcMxeNyRK9w/s72-c/lube2.jpg" height="72" width="72"/><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-8936337794651081205.post-7370420551522320649</id><published>2013-06-12T09:17:00.001-05:00</published><updated>2013-06-12T09:17:43.335-05:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="advocacy"/><category scheme="http://www.blogger.com/atom/ns#" term="hiv prevention"/><category scheme="http://www.blogger.com/atom/ns#" term="HIV transmission"/><category scheme="http://www.blogger.com/atom/ns#" term="IRMA"/><category scheme="http://www.blogger.com/atom/ns#" term="lubricant"/><category scheme="http://www.blogger.com/atom/ns#" term="research"/><category scheme="http://www.blogger.com/atom/ns#" term="safer sex"/><title type='text'>Press Release: More than 500 Endorsers Demand Answers on Lubricant Safety</title><content type='html'>&lt;div class=&quot;separator&quot; style=&quot;clear: both; text-align: center;&quot;&gt;
&lt;a href=&quot;https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgekAaiUmkXG49uQJeBTcyMuszCl4Bh1cUt1aLPe4kNSGdbL3fVTi5NEhAg3XYWJrKzHCiNUPxJY6YlbGt7wcgapLthGaH9YXHE2II3Fpdcf36XgV-3cj55MAQUPdbf9vzADy2gUuF85oKt/s1600/New+IRMA+logo+FINAL.jpg&quot; imageanchor=&quot;1&quot; style=&quot;clear: left; float: left; margin-bottom: 1em; margin-right: 1em;&quot;&gt;&lt;/a&gt;&lt;a href=&quot;https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgekAaiUmkXG49uQJeBTcyMuszCl4Bh1cUt1aLPe4kNSGdbL3fVTi5NEhAg3XYWJrKzHCiNUPxJY6YlbGt7wcgapLthGaH9YXHE2II3Fpdcf36XgV-3cj55MAQUPdbf9vzADy2gUuF85oKt/s1600/New+IRMA+logo+FINAL.jpg&quot; imageanchor=&quot;1&quot; style=&quot;clear: left; float: left; margin-bottom: 1em; margin-right: 1em;&quot;&gt;&amp;nbsp;&lt;/a&gt;&lt;br /&gt;
&lt;div class=&quot;separator&quot; style=&quot;clear: both; text-align: center;&quot;&gt;
&lt;a href=&quot;https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjU3XmPGDVEwjx2uBaKfTW37jK_WFhaOTSY7DpOvBTjmksOE5Jx2KcuP_fXEoXiZNtPgPJpcMrYvpPp46JqEy6VnrnD-qnpPaMyriFHDVTPTmPAHNuc8tE5Op0MnE2fK4M5wP-PWK8cCm_a/s1600/AFC_Logo.jpg.jpg&quot; imageanchor=&quot;1&quot; style=&quot;margin-left: 1em; margin-right: 1em;&quot;&gt;&lt;img border=&quot;0&quot; height=&quot;70&quot; src=&quot;https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjU3XmPGDVEwjx2uBaKfTW37jK_WFhaOTSY7DpOvBTjmksOE5Jx2KcuP_fXEoXiZNtPgPJpcMrYvpPp46JqEy6VnrnD-qnpPaMyriFHDVTPTmPAHNuc8tE5Op0MnE2fK4M5wP-PWK8cCm_a/s200/AFC_Logo.jpg.jpg&quot; width=&quot;200&quot; /&gt;&lt;/a&gt;&lt;/div&gt;
&lt;div style=&quot;margin-left: 1em; margin-right: 1em;&quot;&gt;
&lt;img border=&quot;0&quot; height=&quot;120&quot; src=&quot;https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgekAaiUmkXG49uQJeBTcyMuszCl4Bh1cUt1aLPe4kNSGdbL3fVTi5NEhAg3XYWJrKzHCiNUPxJY6YlbGt7wcgapLthGaH9YXHE2II3Fpdcf36XgV-3cj55MAQUPdbf9vzADy2gUuF85oKt/s320/New+IRMA+logo+FINAL.jpg&quot; width=&quot;320&quot; /&gt;&lt;/div&gt;
&lt;br /&gt;
&lt;h3 style=&quot;text-align: left;&quot;&gt;
Global coalition of organizations and individuals calls for research agenda to determine safety of sexual lubricants&lt;/h3&gt;
&lt;div style=&quot;text-align: left;&quot;&gt;
&lt;br /&gt;&lt;strong&gt;For Immediate Release&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;June 12, 2013 – Over 500 organizations and individuals from nearly 60 countries have &lt;strong&gt;&lt;a href=&quot;http://issuu.com/jimpickett/docs/indiv_org_endorsers_lubesafety?e=2000058/3302319&quot;&gt;endorsed a Global Call to Action on Lubricant Safety&lt;/a&gt;&lt;/strong&gt;. They all demand answers on whether sexual lubricants are safe for vaginal and anal intercourse. As the Call to Action points out, there are more questions than answers about the safety of sexual lubricants, and there are concerns that some of the products available on store shelves and at community-based organizations worldwide may actually cause harm.&lt;br /&gt; &lt;br /&gt;&lt;strong&gt;&lt;a href=&quot;http://www.rectalmicrobicides.org/&quot;&gt;International Rectal Microbicide Advocates (IRMA)&lt;/a&gt;&lt;/strong&gt; launched the call to action, which prominent organizations across the globe subsequently endorsed, including the International Planned Parenthood Federation (IPPF), the Global Network of People Living with HIV (GNP+), the Global Network of Sex Work Projects, the Johns Hopkins Center for Public Health and Human Rights in the U.S., the Microbicide Trials Network, the Gay Men’s Health Crisis, National Black Gay Men’s Advocacy Coalition, Chicago Women’s AIDS Project, Woodhull Sexual Freedom Alliance, the Desmond Tutu HIV Foundation, African Men for Sexual Health and Rights, Terrence Higgins Trust, the Canadian AIDS Society, Asia Pacific Coalition on Male Sexual Health, and numerous other organizations devoted to sexual health and HIV prevention. &lt;br /&gt; &lt;br /&gt;Several lubricant manufacturers—such as Trigg Laboratories (makers of WET), Davryan Laboratories (PROBE), Gel Works Pty (Wet Stuff), The Yes Yes Company (Yes), and Abra Advanced Research International Pte (SuperSlyde)—also joined this overwhelming global demand for answers on lubricant safety. &lt;br /&gt;&lt;br /&gt;“After more than thirty years of the HIV pandemic, we still have no clear answers on whether sexual lubricants increase, decrease, or have no impact on the risk of acquiring HIV and other STIs,” said Marc-André LeBlanc, coordinator of IRMA’s International Lubricant Safety Working Group. “This is unacceptable. We urgently need a Lubricant Safety Research Agenda that will provide answers on lubricant safety.”&lt;/div&gt;
&lt;div style=&quot;text-align: left;&quot;&gt;
&lt;br /&gt;“Many men, women and transgender individuals all across the globe use sexual lubricants for both vaginal and anal intercourse,&quot; said Jim Pickett, IRMA chair. “Public health has long promoted the use of condoms with condom-compatible water-based or silicone-based lubricants to prevent HIV and other STIs. Lubricants help ensure condoms don’t break, and that condoms stay on during sex. So, it’s pretty critical we understand if any of these condom-compatible lubricants could actually be putting people in harm’s way.” &lt;/div&gt;
&lt;div style=&quot;text-align: left;&quot;&gt;
&lt;br /&gt;There are hundreds of different sexual lubricants on the market; however, researchers have only tested a few for tissue damage and to preliminarily assess potential impact on HIV and STIs. Because of this and relatively inconclusive results, it is nearly impossible to recommend or argue against specific brands of water-based or silicone-based lubricants. &lt;br /&gt; &lt;br /&gt;While releasing this list of endorsers, IRMA continues to promote the development of a lubricant safety research agenda in partnership with advocates, researchers, and manufacturers across the globe. IRMA is working closely with key partners, such as the U.S. Centers for Disease Control and Prevention (CDC), which is conducting lube safety research, and the United States President’s Emergency Plan for AIDS Relief (PEPFAR), which is developing a Lube Safety Research Agenda with its Scientific Advisory Board.&lt;br /&gt; &lt;br /&gt;IRMA eagerly awaits the release of data from the CDC’s latest study and PEPFAR’s Lube Safety Research Agenda. The new data and a PEPFAR -endorsed research agenda will move the lube safety issue forward. &lt;br /&gt; &lt;br /&gt;“As a lubricant manufacturer, we are committed to working with advocates, funders, researchers and regulators to develop the safest possible products,” stated Sarah Brooks, CEO of Yes Yes Company Ltd. “That is why we enthusiastically endorse the Global Call to Action on Lubricant Safety. We want to be active partners by lending our expertise as a lubricant manufacturer.”&lt;br /&gt; &lt;br /&gt;# # # #&lt;br /&gt;&lt;br /&gt;Founded in 1985 by community activists and physicians, the &lt;a href=&quot;http://www.aidschicago.org/&quot;&gt;&lt;strong&gt;AIDS Foundation of Chicago&lt;/strong&gt;&lt;/a&gt; (AFC) is a catalyst for local, national, and international action against HIV/AIDS.&lt;br /&gt;&lt;br /&gt;International Rectal Microbicide Advocates (IRMA) is a global network, housed at AFC, comprised of more than 1,200 advocates, scientists, policy makers and funders focused on rectal microbicide research and advocacy and related issues such as the safety of sexual lubricants.&lt;br /&gt;&lt;br /&gt;See the Global Call to Action on Lubricant Safety and the complete list of endorsers &lt;strong&gt;&lt;a href=&quot;http://issuu.com/jimpickett/docs/indiv_org_endorsers_lubesafety?e=2000058/3302319&quot;&gt;here.&lt;/a&gt;&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;Learn more about lubricant safety &lt;strong&gt;&lt;a href=&quot;http://irma-rectalmicrobicides.blogspot.com/p/lube-safety-info.html&quot;&gt;here&lt;/a&gt;&lt;/strong&gt;.&lt;/div&gt;
&lt;div style=&quot;text-align: left;&quot;&gt;
&amp;nbsp;&lt;/div&gt;
&lt;div style=&quot;text-align: left;&quot;&gt;
------------------- &lt;/div&gt;
&lt;div style=&quot;text-align: left;&quot;&gt;
&amp;nbsp;&lt;/div&gt;
&lt;div style=&quot;text-align: left;&quot;&gt;



*Join IRMA&#39;s robust, highly-active. moderated, global listserv addressing rectal microbicide research and advocacy as well as other interesting new HIV prevention technologies by contacting us at rectalmicro@gmail.com. Joining our listserv automatically makes you a member of IRMA - a network of more than 1,100 advocates, scientists, policy makers and funders from all over the world.


&lt;/div&gt;
&lt;div style=&quot;text-align: left;&quot;&gt;
&amp;nbsp;&lt;/div&gt;
&lt;div style=&quot;text-align: left;&quot;&gt;
*Please look for us on Facebook: www.facebook.com/InternationalRectalMicrobicideAdvocates, and you can follow us on Twitter: @rectalmicro.
 

*Also, please note that shared news items from other sources posted on this blog do not necessarily mean IRMA has taken any position on the article&#39;s content.
&lt;/div&gt;
&lt;br /&gt;
&amp;nbsp;


-------------------&lt;/div&gt;
</content><link rel='replies' type='application/atom+xml' href='http://irma-rectalmicrobicides.blogspot.com/feeds/7370420551522320649/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment/fullpage/post/8936337794651081205/7370420551522320649?isPopup=true' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/8936337794651081205/posts/default/7370420551522320649'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/8936337794651081205/posts/default/7370420551522320649'/><link rel='alternate' type='text/html' href='http://irma-rectalmicrobicides.blogspot.com/2013/06/press-release-more-than-500-endorsers.html' title='Press Release: More than 500 Endorsers Demand Answers on Lubricant Safety'/><author><name>IRMA</name><uri>http://www.blogger.com/profile/09540354568307603424</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjU3XmPGDVEwjx2uBaKfTW37jK_WFhaOTSY7DpOvBTjmksOE5Jx2KcuP_fXEoXiZNtPgPJpcMrYvpPp46JqEy6VnrnD-qnpPaMyriFHDVTPTmPAHNuc8tE5Op0MnE2fK4M5wP-PWK8cCm_a/s72-c/AFC_Logo.jpg.jpg" height="72" width="72"/><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-8936337794651081205.post-6579075121374429489</id><published>2013-06-03T15:49:00.000-05:00</published><updated>2013-06-03T15:50:22.708-05:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="advocacy"/><category scheme="http://www.blogger.com/atom/ns#" term="Africa"/><category scheme="http://www.blogger.com/atom/ns#" term="amfAR"/><category scheme="http://www.blogger.com/atom/ns#" term="And Lube"/><category scheme="http://www.blogger.com/atom/ns#" term="AVAC"/><category scheme="http://www.blogger.com/atom/ns#" term="GLAM"/><category scheme="http://www.blogger.com/atom/ns#" term="IRMA"/><category scheme="http://www.blogger.com/atom/ns#" term="lubricant"/><category scheme="http://www.blogger.com/atom/ns#" term="sexual health"/><title type='text'>Announcing Version 2.0 of the GLAM Toolkit for lube access advocacy in Africa– now in French and English</title><content type='html'>&lt;div dir=&quot;ltr&quot; style=&quot;text-align: left;&quot; trbidi=&quot;on&quot;&gt;
&lt;!--[if gte mso 9]&gt;&lt;xml&gt;
 &lt;o:OfficeDocumentSettings&gt;
  &lt;o:RelyOnVML/&gt;
  &lt;o:AllowPNG/&gt;
 &lt;/o:OfficeDocumentSettings&gt;
&lt;/xml&gt;&lt;![endif]--&gt;&lt;br /&gt;
&lt;div class=&quot;separator&quot; style=&quot;clear: both; text-align: center;&quot;&gt;
&lt;a href=&quot;http://rectalmicrobicides.org/docs/GLAM_Tookit%20E%20060313.pdf&quot; style=&quot;clear: left; float: left; margin-bottom: 1em; margin-right: 1em;&quot;&gt;&lt;img border=&quot;0&quot; height=&quot;320&quot; src=&quot;https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj_BtKfVshyAn78mTl7AtoD5ttms_efJdIV12SshEnywlo7Lp8NY2BqYBTah5BLf7MqpUOb5TL8u7yKvuYzuGs93UOImwpokyXAgiRG-d7d2l_u8KZpGAuEx2jViXrQMHZt8z4x6C_-q5U/s320/GLAM_Tookit+E+cover.jpg&quot; width=&quot;248&quot; /&gt;&lt;/a&gt;&lt;/div&gt;
&lt;!--[if gte mso 9]&gt;&lt;xml&gt;
 &lt;w:WordDocument&gt;
  &lt;w:View&gt;Normal&lt;/w:View&gt;
  &lt;w:Zoom&gt;0&lt;/w:Zoom&gt;
  &lt;w:TrackMoves/&gt;
  &lt;w:TrackFormatting/&gt;
  &lt;w:PunctuationKerning/&gt;
  &lt;w:ValidateAgainstSchemas/&gt;
  &lt;w:SaveIfXMLInvalid&gt;false&lt;/w:SaveIfXMLInvalid&gt;
  &lt;w:IgnoreMixedContent&gt;false&lt;/w:IgnoreMixedContent&gt;
  &lt;w:AlwaysShowPlaceholderText&gt;false&lt;/w:AlwaysShowPlaceholderText&gt;
  &lt;w:DoNotPromoteQF/&gt;
  &lt;w:LidThemeOther&gt;EN-US&lt;/w:LidThemeOther&gt;
  &lt;w:LidThemeAsian&gt;X-NONE&lt;/w:LidThemeAsian&gt;
  &lt;w:LidThemeComplexScript&gt;X-NONE&lt;/w:LidThemeComplexScript&gt;
  &lt;w:Compatibility&gt;
   &lt;w:BreakWrappedTables/&gt;
   &lt;w:SnapToGridInCell/&gt;
   &lt;w:WrapTextWithPunct/&gt;
   &lt;w:UseAsianBreakRules/&gt;
   &lt;w:DontGrowAutofit/&gt;
   &lt;w:SplitPgBreakAndParaMark/&gt;
   &lt;w:DontVertAlignCellWithSp/&gt;
   &lt;w:DontBreakConstrainedForcedTables/&gt;
   &lt;w:DontVertAlignInTxbx/&gt;
   &lt;w:Word11KerningPairs/&gt;
   &lt;w:CachedColBalance/&gt;
  &lt;/w:Compatibility&gt;
  &lt;m:mathPr&gt;
   &lt;m:mathFont m:val=&quot;Cambria Math&quot;/&gt;
   &lt;m:brkBin m:val=&quot;before&quot;/&gt;
   &lt;m:brkBinSub m:val=&quot;&amp;#45;-&quot;/&gt;
   &lt;m:smallFrac m:val=&quot;off&quot;/&gt;
   &lt;m:dispDef/&gt;
   &lt;m:lMargin m:val=&quot;0&quot;/&gt;
   &lt;m:rMargin m:val=&quot;0&quot;/&gt;
   &lt;m:defJc m:val=&quot;centerGroup&quot;/&gt;
   &lt;m:wrapIndent m:val=&quot;1440&quot;/&gt;
   &lt;m:intLim m:val=&quot;subSup&quot;/&gt;
   &lt;m:naryLim m:val=&quot;undOvr&quot;/&gt;
  &lt;/m:mathPr&gt;&lt;/w:WordDocument&gt;
&lt;/xml&gt;&lt;![endif]--&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;
 &lt;w:LatentStyles DefLockedState=&quot;false&quot; DefUnhideWhenUsed=&quot;true&quot;
  DefSemiHidden=&quot;true&quot; DefQFormat=&quot;false&quot; DefPriority=&quot;99&quot;
  LatentStyleCount=&quot;267&quot;&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;0&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Normal&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;heading 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 7&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 8&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 9&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 7&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 8&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 9&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;35&quot; QFormat=&quot;true&quot; Name=&quot;caption&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;10&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Title&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;1&quot; Name=&quot;Default Paragraph Font&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;11&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Subtitle&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;22&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Strong&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;20&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Emphasis&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;59&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Table Grid&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; UnhideWhenUsed=&quot;false&quot; Name=&quot;Placeholder Text&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;1&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;No Spacing&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; UnhideWhenUsed=&quot;false&quot; Name=&quot;Revision&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;34&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;List Paragraph&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;29&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Quote&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;30&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Intense Quote&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;19&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Subtle Emphasis&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;21&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Intense Emphasis&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;31&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Subtle Reference&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;32&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Intense Reference&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;33&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Book Title&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;37&quot; Name=&quot;Bibliography&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; QFormat=&quot;true&quot; Name=&quot;TOC Heading&quot;/&gt;
 &lt;/w:LatentStyles&gt;
&lt;/xml&gt;&lt;![endif]--&gt;&lt;!--[if gte mso 10]&gt;
&lt;style&gt;
 /* Style Definitions */
 table.MsoNormalTable
 {mso-style-name:&quot;Table Normal&quot;;
 mso-tstyle-rowband-size:0;
 mso-tstyle-colband-size:0;
 mso-style-noshow:yes;
 mso-style-priority:99;
 mso-style-qformat:yes;
 mso-style-parent:&quot;&quot;;
 mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-para-margin-top:0in;
 mso-para-margin-right:0in;
 mso-para-margin-bottom:10.0pt;
 mso-para-margin-left:0in;
 line-height:115%;
 mso-pagination:widow-orphan;
 font-size:11.0pt;
 font-family:&quot;Calibri&quot;,&quot;sans-serif&quot;;
 mso-ascii-font-family:Calibri;
 mso-ascii-theme-font:minor-latin;
 mso-fareast-font-family:&quot;Times New Roman&quot;;
 mso-fareast-theme-font:minor-fareast;
 mso-hansi-font-family:Calibri;
 mso-hansi-theme-font:minor-latin;}
&lt;/style&gt;
&lt;![endif]--&gt;&lt;span style=&quot;font-family: Times,&amp;quot;Times New Roman&amp;quot;,serif;&quot;&gt;&lt;span style=&quot;color: black; font-size: 11pt;&quot;&gt;Today
IRMA, in collaboration with &lt;/span&gt;&lt;a href=&quot;http://www.amfar.org/&quot;&gt;&lt;b style=&quot;mso-bidi-font-weight: normal;&quot;&gt;&lt;span style=&quot;font-size: 11pt;&quot;&gt;amfAR&lt;/span&gt;&lt;/b&gt;&lt;/a&gt;&lt;span style=&quot;color: black; font-size: 11pt;&quot;&gt; and &lt;/span&gt;&lt;a href=&quot;http://www.blogger.com/www.avac.org&quot;&gt;&lt;b style=&quot;mso-bidi-font-weight: normal;&quot;&gt;&lt;span style=&quot;font-size: 11pt;&quot;&gt;AVAC&lt;/span&gt;&lt;/b&gt;&lt;/a&gt;&lt;span style=&quot;color: black; font-size: 11pt;&quot;&gt;,
is excited to release a re-designed Version 2.0 &lt;span style=&quot;mso-spacerun: yes;&quot;&gt;&amp;nbsp;&lt;/span&gt;of the &lt;i style=&quot;mso-bidi-font-style: normal;&quot;&gt;&lt;b&gt;GLAM
Toolkit: Advocacy to improve access to safe, condom-compatible lubricant in
Africa&lt;/b&gt;. &lt;/i&gt;The Toolkit is now available in French in addition to English – making
it more useful for Francophone speakers in Africa – and the new design makes it
easier for advocates to use.&lt;br /&gt;&lt;br /&gt;And
it looks great!&lt;br /&gt;&lt;br /&gt;The
&lt;b&gt;&lt;i style=&quot;mso-bidi-font-style: normal;&quot;&gt;Toolkit&lt;/i&gt;&lt;/b&gt;&amp;nbsp;provides background on
the status of lubricant (lube) access in Africa and suggests potential
strategies for civil society and government partners to secure and
distribute&amp;nbsp;sustainable supplies of safe, condom-compatible lube. Global
Lube Access Mobilisation (GLAM) is a campaign of IRMA’s &lt;/span&gt;&lt;a href=&quot;http://irma-rectalmicrobicides.blogspot.fr/p/project-arm-africa-for-rectal.html&quot;&gt;&lt;b style=&quot;mso-bidi-font-weight: normal;&quot;&gt;&lt;span style=&quot;font-size: 11pt;&quot;&gt;Project ARM&lt;/span&gt;&lt;/b&gt;&lt;/a&gt;&lt;span style=&quot;color: black; font-size: 11pt;&quot;&gt; (Africa for Rectal Microbicides) initiative.&lt;br /&gt;&lt;br /&gt;They
are available on the IRMA blog &lt;/span&gt;&lt;a href=&quot;http://www.irma-rectalmicrobicides.blogspot.com/p/project-arm-africa-for-rectal.html&quot;&gt;&lt;b style=&quot;mso-bidi-font-weight: normal;&quot;&gt;&lt;span style=&quot;font-size: 11pt;&quot;&gt;here&lt;/span&gt;&lt;/b&gt;&lt;/a&gt;&lt;span style=&quot;color: black; font-size: 11pt;&quot;&gt;
where you can also learn more about GLAM and Project ARM. And the Toolkits can be downloaded as PDFs in &lt;a href=&quot;http://rectalmicrobicides.org/docs/GLAM_Tookit_F_060313.pdf&quot;&gt;&lt;b&gt;French&lt;/b&gt;&lt;/a&gt; and &lt;a href=&quot;http://rectalmicrobicides.org/docs/GLAM_Tookit%20E%20060313.pdf&quot;&gt;&lt;b&gt;English&lt;/b&gt;&lt;/a&gt; from the IRMA website.&lt;br /&gt;&lt;br /&gt;In April, IRMA, amfAR and AVAC announced three grants to organizations
in Liberia, Zambia and Nigeria to campaign &lt;/span&gt;&lt;span style=&quot;color: #333333; font-size: 11pt;&quot;&gt;for access to safe,
condom-compatible lubricants in their communities. Learn more about these
grants &lt;/span&gt;&lt;span style=&quot;font-size: 12pt;&quot;&gt;&lt;a href=&quot;http://www.irma-rectalmicrobicides.blogspot.com/2013/04/three-organisations-receive-support-to.html&quot;&gt;&lt;b style=&quot;mso-bidi-font-weight: normal;&quot;&gt;&lt;span style=&quot;font-size: 11pt;&quot;&gt;here&lt;/span&gt;&lt;/b&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=&quot;color: #333333; font-size: 11pt;&quot;&gt;.&lt;/span&gt; &lt;/span&gt;&lt;br /&gt;
&lt;br /&gt;
-------------------&lt;br /&gt;
&lt;br /&gt;
*Join IRMA&#39;s robust, highly-active. moderated, global listserv addressing rectal microbicide research and advocacy as well as other interesting new HIV prevention technologies by contacting us at rectalmicro@gmail.com. Joining our listserv automatically makes you a member of IRMA - a network of more than 1,&lt;span style=&quot;font-family: Times,&amp;quot;Times New Roman&amp;quot;,serif;&quot;&gt;2&lt;/span&gt;00 advocates, scientists, policy makers and funders from all over the world.&lt;br /&gt;
&lt;br /&gt;
*Please look for us on Facebook: www.facebook.com/InternationalRectalMicrobicideAdvocates, and you can follow us on Twitter: @rectalmicro.&lt;br /&gt;
&lt;br /&gt;
&amp;nbsp;*Also, please note that shared news items from other sources posted on this blog do not necessarily mean IRMA has taken any position on the article&#39;s content.
 


-------------------&lt;/div&gt;
</content><link rel='replies' type='application/atom+xml' href='http://irma-rectalmicrobicides.blogspot.com/feeds/6579075121374429489/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment/fullpage/post/8936337794651081205/6579075121374429489?isPopup=true' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/8936337794651081205/posts/default/6579075121374429489'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/8936337794651081205/posts/default/6579075121374429489'/><link rel='alternate' type='text/html' href='http://irma-rectalmicrobicides.blogspot.com/2013/06/announcing-version-20-of-glam-toolkit.html' title='Announcing Version 2.0 of the GLAM Toolkit for lube access advocacy in Africa– now in French and English'/><author><name>NewPrevTech</name><uri>http://www.blogger.com/profile/05705781012925480028</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj_BtKfVshyAn78mTl7AtoD5ttms_efJdIV12SshEnywlo7Lp8NY2BqYBTah5BLf7MqpUOb5TL8u7yKvuYzuGs93UOImwpokyXAgiRG-d7d2l_u8KZpGAuEx2jViXrQMHZt8z4x6C_-q5U/s72-c/GLAM_Tookit+E+cover.jpg" height="72" width="72"/><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-8936337794651081205.post-7444977692231709808</id><published>2013-05-29T07:09:00.001-05:00</published><updated>2013-05-29T07:09:32.083-05:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="activists"/><category scheme="http://www.blogger.com/atom/ns#" term="advocacy"/><category scheme="http://www.blogger.com/atom/ns#" term="community engagement"/><category scheme="http://www.blogger.com/atom/ns#" term="education"/><category scheme="http://www.blogger.com/atom/ns#" term="hiv prevention"/><category scheme="http://www.blogger.com/atom/ns#" term="IRMA"/><category scheme="http://www.blogger.com/atom/ns#" term="rectal microbicide"/><category scheme="http://www.blogger.com/atom/ns#" term="Women&#39;s Health"/><title type='text'>Don&#39;t Upset This Rectal Microbicide Advocate!</title><content type='html'>&lt;div dir=&quot;ltr&quot; style=&quot;text-align: left;&quot; trbidi=&quot;on&quot;&gt;
&lt;div class=&quot;separator&quot; style=&quot;clear: both; text-align: center;&quot;&gt;
&lt;a href=&quot;https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjUWBC3TmoGJvTpKFYBDxRRe4U0ouV94DsFXTFG8azWz7Z-4HlQWxh3ujcSacHgqAlJmDRMjyVqe6-PqscEk0Hh78-gmKjFdM59HIKtLKZZIw-1SRWuZd44yNW8Qd9aJ2wUCntFZFPk3go/s1600/Photo03171431_1.jpg&quot; imageanchor=&quot;1&quot; style=&quot;clear: left; float: left; margin-bottom: 1em; margin-right: 1em;&quot;&gt;&lt;img border=&quot;0&quot; height=&quot;320&quot; src=&quot;https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjUWBC3TmoGJvTpKFYBDxRRe4U0ouV94DsFXTFG8azWz7Z-4HlQWxh3ujcSacHgqAlJmDRMjyVqe6-PqscEk0Hh78-gmKjFdM59HIKtLKZZIw-1SRWuZd44yNW8Qd9aJ2wUCntFZFPk3go/s320/Photo03171431_1.jpg&quot; width=&quot;240&quot; /&gt;&lt;/a&gt;&lt;/div&gt;
by Mike Peters&lt;br /&gt;
IRMA Intern &lt;br /&gt;
&lt;br /&gt;
A couple of weeks ago, I returned to Ohio for a weekend excursion.&amp;nbsp; The director of the Women&#39;s Studies program at my university informed me that I was named Graduate Student of the Year for Women&#39;s Studies and that there was a short awards ceremony that I should attend.&amp;nbsp; In preparation for this ceremony I was asked to dress nice, write a short bio of myself for the Dean of Liberal Arts to read, and to briefly say a few grateful words at the ceremony.&lt;br /&gt;
&lt;br /&gt;
As excited and grateful as I was about this honor, I could not help but wonder what my interaction with the Dean of Liberal Arts would be like.&amp;nbsp; Perhaps some background information is necessary here.&amp;nbsp; My university is in Ohio, and Ohio, like so many other states, is facing a lot of economic issues in education.&amp;nbsp; During my last year on campus extreme budget cutbacks were made to Liberal Arts (while the basketball stadium and the Student Union were remodeled, and the basketball team was taking a trip to Italy).&amp;nbsp; Not only were these budget cuts devastating, but they were disturbing.&amp;nbsp; Six program directors, all women, were informed that they were being forced out of their directorships and required to teach additional classes.&amp;nbsp; These women, from fields that happened to focus on minority issues (Women&#39;s Studies, African and African-American Studies, International Studies, and so on), were to also be replaced&amp;nbsp; by a new dean of interdisciplinary studies that happened to be a white, heterosexual male as a cost-saving measure and way to increase course enrollment revenue.&lt;br /&gt;
&lt;br /&gt;
Now, perhaps the male that would be replacing them had a strong background in interdisciplinary studies and could discuss minority issues with some level authority and expertise.&amp;nbsp; It was still utterly disturbing that these women were being removed from their leadership roles when they were all six some of the most respected educators on campus.&amp;nbsp; I suppose this is where my relationship with the Dean gets a little tricky.&amp;nbsp; In response to these budget cuts, I worked with three other graduate students as we led multiple protests and demonstrations of civil disobedience on campus – including flooding the Dean&#39;s office and taking over an intercom system to read &lt;i&gt;The Vagina Monologues&lt;/i&gt; to the entire campus.&amp;nbsp; So my worry about standing with the Dean and listening to him comment on me was well-founded.&lt;br /&gt;
&lt;br /&gt;
Excitedly, I wrote up a short bio of my educational background and my work new work with IRMA and sent it off to my program director.&amp;nbsp; On the trip there I worked tirelessly to remind myself to be respectful, not to worry, and to make sure I remembered to thank my various professors for their impact on my work.&lt;br /&gt;
&lt;br /&gt;
On the day of the event my fiancé and I arrived at the auditorium and I was immediately informed that my bio had been edited, because it did not seem family-friendly enough as it used words like &quot;anal&quot;, &quot;rectal&quot;, and &quot;sex&quot;.&amp;nbsp; Horrified by this reality, I was shuffled on stage and to my seat.&amp;nbsp; Given that I was being honored for Women&#39;s Studies I would be the last person receiving my award, since starting with a &quot;W&quot; the program always was at the end for liberal arts ceremonies, which gave me time to either get my visually-angered self calmed down or to let my anger at this injustice grow.&amp;nbsp; I chose the latter.&lt;br /&gt;
&lt;br /&gt;
From my standpoint, and from my program director&#39;s viewpoint I might add, ignoring research and discussion because the word &quot;anal&quot; appears is not only ignorant, but is downright dangerous, as any member of IRMA certainly knows.&amp;nbsp; Besides, this is the work that I am doing with my degree, it ought to be celebrated.&lt;br /&gt;
&lt;br /&gt;
So I sat… and sat… and sat.&amp;nbsp; And then the dean called me up to receive my award.&amp;nbsp; He read my censored bio as I smiled for the crowd.&amp;nbsp; Then he asked me to come to the podium to say a few grateful things:&lt;br /&gt;
&lt;br /&gt;
&quot;I&#39;m really happy and thankful to be here today.&amp;nbsp; I&#39;m also really happy that the Dean has given me a chance to talk about my work.&amp;nbsp; Right now I am working for IRMA, International Rectal Microbicide Advocates, to advocate for the development of rectal and vaginal microbicides in the global fight against HIV.&amp;nbsp; I&#39;m very thankful that the education I received here has given me the ability to not be silent, and to actively advocate for proper sexual education as well as access to condoms and safe lubricants for vaginal and anal sex.&amp;nbsp; I mean let&#39;s be honest, HIV is still around and unprotected anal sex is major driver of this epidemic because we don&#39;t talk about it as actively as we should.&amp;nbsp; Thanks for hearing me out today.&quot;&lt;br /&gt;
&lt;br /&gt;
Nobody freaked out.&amp;nbsp; The Dean shook my hand and I received my award.&amp;nbsp; No one walked out or ridiculed me; in fact a few folks told me that they admired my passion.&amp;nbsp; And in all seriousness, I was incredibly thankful to have the opportunity to speak about IRMA to people that likely had not heard of it before.&amp;nbsp; Though to be fair, I had better not ask the Dean for a recommendation letter any time soon.&lt;br /&gt;
&lt;br /&gt;
-------------------&lt;br /&gt;
&lt;br /&gt;
*Join IRMA&#39;s robust, highly-active. moderated, global listserv addressing rectal microbicide research and advocacy as well as other interesting new HIV prevention technologies by contacting us at rectalmicro@gmail.com. Joining our listserv automatically makes you a member of IRMA - a network of more than 1,200 advocates, scientists, policy makers and funders from all over the world.&lt;br /&gt;
&lt;br /&gt;
*Please look for us on Facebook: www.facebook.com/InternationalRectalMicrobicideAdvocates, and you can follow us on Twitter: @rectalmicro.&lt;br /&gt;
&lt;br /&gt;
*Also, please note that shared news items from other sources posted on this blog do not necessarily mean IRMA has taken any position on the article&#39;s content.&lt;br /&gt;
&lt;br /&gt;
-------------------&lt;/div&gt;
</content><link rel='replies' type='application/atom+xml' href='http://irma-rectalmicrobicides.blogspot.com/feeds/7444977692231709808/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment/fullpage/post/8936337794651081205/7444977692231709808?isPopup=true' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/8936337794651081205/posts/default/7444977692231709808'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/8936337794651081205/posts/default/7444977692231709808'/><link rel='alternate' type='text/html' href='http://irma-rectalmicrobicides.blogspot.com/2013/05/dont-upset-this-rectal-microbicide.html' title='Don&#39;t Upset This Rectal Microbicide Advocate!'/><author><name>NewPrevTech</name><uri>http://www.blogger.com/profile/05705781012925480028</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjUWBC3TmoGJvTpKFYBDxRRe4U0ouV94DsFXTFG8azWz7Z-4HlQWxh3ujcSacHgqAlJmDRMjyVqe6-PqscEk0Hh78-gmKjFdM59HIKtLKZZIw-1SRWuZd44yNW8Qd9aJ2wUCntFZFPk3go/s72-c/Photo03171431_1.jpg" height="72" width="72"/><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-8936337794651081205.post-8148993088629737060</id><published>2013-05-07T09:00:00.000-05:00</published><updated>2013-05-07T09:00:08.822-05:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="advocacy"/><category scheme="http://www.blogger.com/atom/ns#" term="AIDS Foundation of Chicago"/><category scheme="http://www.blogger.com/atom/ns#" term="anal sex"/><category scheme="http://www.blogger.com/atom/ns#" term="funding"/><category scheme="http://www.blogger.com/atom/ns#" term="Give OUT"/><category scheme="http://www.blogger.com/atom/ns#" term="hiv prevention"/><category scheme="http://www.blogger.com/atom/ns#" term="IRMA"/><category scheme="http://www.blogger.com/atom/ns#" term="Jim Pickett"/><category scheme="http://www.blogger.com/atom/ns#" term="rectal microbicide"/><title type='text'>Give Some LOVE to IRMA for Give OUT Day</title><content type='html'>&lt;div dir=&quot;ltr&quot; style=&quot;text-align: left;&quot; trbidi=&quot;on&quot;&gt;
&lt;h2 style=&quot;text-align: left;&quot;&gt;
Condoms are getting some help!&amp;nbsp;&lt;/h2&gt;
&lt;br /&gt;
&lt;iframe allowfullscreen=&quot;&quot; frameborder=&quot;0&quot; height=&quot;315&quot; src=&quot;http://www.youtube.com/embed/GgfeQ0guxts&quot; width=&quot;420&quot;&gt;&lt;/iframe&gt;&lt;br /&gt;
&lt;div dir=&quot;ltr&quot; style=&quot;text-align: left;&quot; trbidi=&quot;on&quot;&gt;
&lt;br /&gt;
&lt;br /&gt;
Dear IRMA members and readers of this blog - &lt;br /&gt;
&lt;br /&gt;
&lt;a href=&quot;http://giveout.razoo.com/story/Aids-Foundation-Of-Chicago?referral_code=share&quot; target=&quot;_blank&quot;&gt;&lt;b&gt;Give OUT Day&lt;/b&gt;&lt;/a&gt; shines a spotlight on organizations that empower LGBTQ communities across the country, and the &lt;a href=&quot;http://www.aidschicago.org/&quot; target=&quot;_blank&quot;&gt;&lt;b&gt;AIDS Foundation of Chicago &lt;/b&gt;&lt;/a&gt;(AFC) is among these charities.&lt;br /&gt;
&lt;br /&gt;
We’re using this campaign to highlight the next generation of HIV prevention: rectal microbicides. Though they’re still in development, these agents can be added to things like lubricants that will prevent the transmission of HIV, revolutionizing the way we protect ourselves and others. Condoms are getting some help!&lt;br /&gt;
&lt;br /&gt;
This will greatly benefit gay and bisexual men, transgender individuals, and women because rectal microbicides are developed specifically for anal intercourse—a common human behavior. We need to expand the ways we protect ourselves against HIV, and rectal microbicides are quite promising. With the support of AFC’s global advocacy initiative—&lt;a href=&quot;http://www.rectalmicrobicides.org/&quot; target=&quot;_blank&quot;&gt;&lt;b&gt;International Rectal Microbicide Advocates&lt;/b&gt;&lt;/a&gt;—scientists have achieved an enormous amount of progress, and we’re tremendously excited about the future.&lt;br /&gt;
&lt;br /&gt;
You have an opportunity to support advocacy efforts that will be instrumental in making rectal microbicides a reality for all who need them.&lt;br /&gt;
&lt;br /&gt;
Learn more by downloading &lt;a href=&quot;http://www.aidschicago.org/inside-story/671-give-out-day-a-spotlight-on-rectal-microbicides&quot; target=&quot;_blank&quot;&gt;&lt;b&gt;this podcast on rectal microbicides&lt;/b&gt;&lt;/a&gt;, and visit our &lt;a href=&quot;http://giveout.razoo.com/story/Aids-Foundation-Of-Chicago?referral_code=share&quot; target=&quot;_blank&quot;&gt;&lt;b&gt;Give OUT page&lt;/b&gt;&lt;/a&gt; to make a contribution today.&lt;br /&gt;
&lt;br /&gt;
Thanks,&lt;br /&gt;
Jim Pickett&lt;br /&gt;
Chair, International Rectal Microbicide Advocates&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
-------------------&lt;br /&gt;
&lt;br /&gt;
*Join IRMA&#39;s robust, highly-active. moderated, global listserv addressing rectal microbicide research and advocacy as well as other interesting new HIV prevention technologies by contacting us at rectalmicro@gmail.com. Joining our listserv automatically makes you a member of IRMA - a network of more than 1,200 advocates, scientists, policy makers and funders from all over the world.&lt;br /&gt;
&lt;br /&gt;
*Please look for us on Facebook: www.facebook.com/InternationalRectalMicrobicideAdvocates, and you can follow us on Twitter: @rectalmicro.&lt;br /&gt;
&lt;br /&gt;
*Also, please note that shared news items from other sources posted on this blog do not necessarily mean IRMA has taken any position on the article&#39;s content.&lt;br /&gt;
&lt;br /&gt;
-------------------&lt;/div&gt;
&lt;/div&gt;
</content><link rel='replies' type='application/atom+xml' href='http://irma-rectalmicrobicides.blogspot.com/feeds/8148993088629737060/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment/fullpage/post/8936337794651081205/8148993088629737060?isPopup=true' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/8936337794651081205/posts/default/8148993088629737060'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/8936337794651081205/posts/default/8148993088629737060'/><link rel='alternate' type='text/html' href='http://irma-rectalmicrobicides.blogspot.com/2013/05/give-some-love-to-irma-for-give-out-day.html' title='Give Some LOVE to IRMA for Give OUT Day'/><author><name>NewPrevTech</name><uri>http://www.blogger.com/profile/05705781012925480028</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://img.youtube.com/vi/GgfeQ0guxts/default.jpg" height="72" width="72"/><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-8936337794651081205.post-7353722795129977972</id><published>2013-05-06T15:27:00.000-05:00</published><updated>2013-05-06T15:27:04.152-05:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="condoms"/><category scheme="http://www.blogger.com/atom/ns#" term="female condom"/><category scheme="http://www.blogger.com/atom/ns#" term="hiv prevention"/><category scheme="http://www.blogger.com/atom/ns#" term="IRMA"/><category scheme="http://www.blogger.com/atom/ns#" term="Jim Pickett"/><category scheme="http://www.blogger.com/atom/ns#" term="new prevention technologies"/><category scheme="http://www.blogger.com/atom/ns#" term="rectal microbicide"/><category scheme="http://www.blogger.com/atom/ns#" term="sexual health"/><category scheme="http://www.blogger.com/atom/ns#" term="video"/><title type='text'>VIDEO: IRMA&#39;s Jim Pickett - Condoms Not Enough in HIV Fight</title><content type='html'>&lt;div dir=&quot;ltr&quot; style=&quot;text-align: left;&quot; trbidi=&quot;on&quot;&gt;
&quot;Using condoms for your entire sexual life works for some people. And for others, it doesn&#39;t.&quot;&amp;nbsp; &lt;br /&gt;
&lt;br /&gt;
Video via &lt;a href=&quot;http://www.youtube.com/user/BeTheGeneration?feature=watch&quot;&gt;&lt;b&gt;Be The Generation&lt;/b&gt;&lt;/a&gt;&lt;br /&gt;
&lt;br /&gt;
IRMA chair Jim Pickett discusses the need for new ways to prevent HIV, like rectal microbicides.&lt;br /&gt;
&lt;br /&gt;
&lt;iframe allowfullscreen=&quot;&quot; frameborder=&quot;0&quot; height=&quot;225&quot; src=&quot;http://www.youtube.com/embed/fM7ktbiJPRc&quot; width=&quot;400&quot;&gt;&lt;/iframe&gt;

&lt;br /&gt;
-------------------&lt;br /&gt;
&lt;br /&gt;
&amp;nbsp;*Join IRMA&#39;s robust, highly-active. moderated, global listserv addressing rectal microbicide research and advocacy as well as other interesting new HIV prevention technologies by contacting us at rectalmicro@gmail.com. Joining our listserv automatically makes you a member of IRMA - a network of more than 1,200 advocates, scientists, policy makers and funders from all over the world.&lt;br /&gt;
&lt;br /&gt;
*Please look for us on Facebook: www.facebook.com/InternationalRectalMicrobicideAdvocates, and you can follow us on Twitter: @rectalmicro.&lt;br /&gt;
&lt;br /&gt;
&amp;nbsp;*Also, please note that shared news items from other sources posted on this blog do not necessarily mean IRMA has taken any position on the article&#39;s content.&lt;br /&gt;
&lt;br /&gt;
-------------------&lt;/div&gt;
</content><link rel='replies' type='application/atom+xml' href='http://irma-rectalmicrobicides.blogspot.com/feeds/7353722795129977972/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment/fullpage/post/8936337794651081205/7353722795129977972?isPopup=true' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/8936337794651081205/posts/default/7353722795129977972'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/8936337794651081205/posts/default/7353722795129977972'/><link rel='alternate' type='text/html' href='http://irma-rectalmicrobicides.blogspot.com/2013/05/video-irmas-jim-pickett-condoms-not.html' title='VIDEO: IRMA&#39;s Jim Pickett - Condoms Not Enough in HIV Fight'/><author><name>IRMA</name><uri>http://www.blogger.com/profile/09540354568307603424</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://img.youtube.com/vi/fM7ktbiJPRc/default.jpg" height="72" width="72"/><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-8936337794651081205.post-6974942209029780740</id><published>2013-05-02T09:57:00.002-05:00</published><updated>2013-05-02T09:57:46.834-05:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="activists"/><category scheme="http://www.blogger.com/atom/ns#" term="advocacy"/><category scheme="http://www.blogger.com/atom/ns#" term="anal health"/><category scheme="http://www.blogger.com/atom/ns#" term="female health"/><category scheme="http://www.blogger.com/atom/ns#" term="IRMA"/><category scheme="http://www.blogger.com/atom/ns#" term="Microbicide Trials Network"/><category scheme="http://www.blogger.com/atom/ns#" term="Microbicides"/><category scheme="http://www.blogger.com/atom/ns#" term="Population Council"/><category scheme="http://www.blogger.com/atom/ns#" term="rectal microbicide"/><category scheme="http://www.blogger.com/atom/ns#" term="Rectal Revolution"/><category scheme="http://www.blogger.com/atom/ns#" term="video"/><title type='text'>Facilitator&#39;s Guide for &quot;The Rectal Revolution is Here&quot; Video - English Version NOW Available</title><content type='html'>&lt;div dir=&quot;ltr&quot; style=&quot;text-align: left;&quot; trbidi=&quot;on&quot;&gt;
&lt;div class=&quot;separator&quot; style=&quot;clear: both; text-align: center;&quot;&gt;
&lt;a href=&quot;https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiUtRwtAqWWgh2-LeI0zPYbfpwJdX65-sKgJ8nAhA75utFuvBiTr41Mi0cEIvURHYOHe7SPiVykQWRIEdvZNVWvy1cNSE27ziwtP1T6bwpRKhZGP0qyD7gVraaaaKE7Mz-5qFazck5wfKI/s1600/facilitators+guide+image.png&quot; imageanchor=&quot;1&quot; style=&quot;clear: left; float: left; margin-bottom: 1em; margin-right: 1em;&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiUtRwtAqWWgh2-LeI0zPYbfpwJdX65-sKgJ8nAhA75utFuvBiTr41Mi0cEIvURHYOHe7SPiVykQWRIEdvZNVWvy1cNSE27ziwtP1T6bwpRKhZGP0qyD7gVraaaaKE7Mz-5qFazck5wfKI/s1600/facilitators+guide+image.png&quot; /&gt;&lt;/a&gt;&lt;/div&gt;
As many of our readers&amp;nbsp; know – in December IRMA, the Microbicide Trials Network, and Population Council launched the video “The Rectal Revolution is Here: An introduction to rectal microbicide clinical trials.” The 14-minute video includes researchers, advocates, and trial participants and discusses the need for rectal microbicides and the role of clinical trials in developing products that are safe and effective. It is available on YouTube in &lt;a href=&quot;http://tinyurl.com/RectalRevEnglish&quot; target=&quot;_blank&quot;&gt;&lt;strong&gt;English&lt;/strong&gt;&lt;/a&gt;, &lt;a href=&quot;http://tinyurl.com/RectalRevSpanish&quot; target=&quot;_blank&quot;&gt;&lt;strong&gt;Spanish&lt;/strong&gt;&lt;/a&gt;, and &lt;a href=&quot;http://tinyurl.com/RectalRevThai&quot; target=&quot;_blank&quot;&gt;&lt;strong&gt;Thai&lt;/strong&gt;&lt;/a&gt; and has been watched by several thousand viewers already. &lt;br /&gt;
&lt;br /&gt;
The team has produced a facilitator’s guide to accompany the video, and the English version&amp;nbsp;can be&amp;nbsp;downloaded&amp;nbsp;&lt;a href=&quot;http://www.rectalmicrobicides.org/docs/RR_Guide_English_FINAL.pdf&quot; target=&quot;_blank&quot;&gt;&lt;strong&gt;here&lt;/strong&gt;&lt;/a&gt;.&lt;br /&gt;
&lt;br /&gt;
The &lt;a href=&quot;http://www.rectalmicrobicides.org/docs/RR_Guide_English_FINAL.pdf&quot; target=&quot;_blank&quot;&gt;&lt;strong&gt;guide&lt;/strong&gt;&lt;/a&gt; is meant to be used as a preparation tool for people leading community discussions, workshops, and/or recruitment sessions who will be showing the educational video. You will find simple, clear background information on rectal microbicide research and the clinical trial process as well as helpful hints on using the video. &lt;br /&gt;
&lt;br /&gt;
We are still finalizing versions in Spanish and Thai – and will post them as soon as they are ready to go. &lt;br /&gt;
&lt;br /&gt;
Many, many thanks to our partners at MTN and Population Council for 
their help and expertise with this guide, our Video Advisory Committee 
that provided invaluable feedback, our fabulous graphic designer from 
Toolbox, Inc., and to our intrepid Spanish and Thai translation teams!&lt;br /&gt;
&lt;br /&gt;
If you would like an electronic copy of the video that you can keep on your computer or a flashdrive to be used for presentations, send a note to &lt;a href=&quot;mailto:rectalmicro@gmail.com&quot;&gt;&lt;strong&gt;rectalmicro@gmail.com&lt;/strong&gt;&lt;/a&gt;.&lt;br /&gt;
&lt;br /&gt;
We hope you find this guide helpful!&lt;br /&gt;
&lt;br /&gt;
-------------------&lt;br /&gt;
&lt;br /&gt;
*Join IRMA&#39;s robust, highly-active. moderated, global listserv addressing rectal microbicide research and advocacy as well as other interesting new HIV prevention technologies by contacting us at rectalmicro@gmail.com. Joining our listserv automatically makes you a member of IRMA - a network of more than 1,200 advocates, scientists, policy makers and funders from all over the world.&lt;br /&gt;
&lt;br /&gt;
*Please look for us on Facebook: www.facebook.com/InternationalRectalMicrobicideAdvocates, and you can follow us on Twitter: @rectalmicro.&lt;br /&gt;
&lt;br /&gt;
*Also, please note that shared news items from other sources posted on this blog do not necessarily mean IRMA has taken any position on the article&#39;s content.&lt;br /&gt;
&lt;br /&gt;
-------------------&lt;/div&gt;
</content><link rel='replies' type='application/atom+xml' href='http://irma-rectalmicrobicides.blogspot.com/feeds/6974942209029780740/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment/fullpage/post/8936337794651081205/6974942209029780740?isPopup=true' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/8936337794651081205/posts/default/6974942209029780740'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/8936337794651081205/posts/default/6974942209029780740'/><link rel='alternate' type='text/html' href='http://irma-rectalmicrobicides.blogspot.com/2013/05/facilitators-guide-for-rectal.html' title='Facilitator&#39;s Guide for &quot;The Rectal Revolution is Here&quot; Video - English Version NOW Available'/><author><name>NewPrevTech</name><uri>http://www.blogger.com/profile/05705781012925480028</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiUtRwtAqWWgh2-LeI0zPYbfpwJdX65-sKgJ8nAhA75utFuvBiTr41Mi0cEIvURHYOHe7SPiVykQWRIEdvZNVWvy1cNSE27ziwtP1T6bwpRKhZGP0qyD7gVraaaaKE7Mz-5qFazck5wfKI/s72-c/facilitators+guide+image.png" height="72" width="72"/><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-8936337794651081205.post-8063589588672123210</id><published>2013-04-30T12:05:00.000-05:00</published><updated>2013-04-30T12:05:54.592-05:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="activists"/><category scheme="http://www.blogger.com/atom/ns#" term="advocacy"/><category scheme="http://www.blogger.com/atom/ns#" term="anal intercourse"/><category scheme="http://www.blogger.com/atom/ns#" term="anal sex"/><category scheme="http://www.blogger.com/atom/ns#" term="IRMA"/><category scheme="http://www.blogger.com/atom/ns#" term="lubricant"/><category scheme="http://www.blogger.com/atom/ns#" term="research"/><category scheme="http://www.blogger.com/atom/ns#" term="sexual health"/><category scheme="http://www.blogger.com/atom/ns#" term="Women&#39;s Health"/><title type='text'>TIME SENSITIVE: Have You (or Your Organization) Endorsed Our Global Call to Action on Lubricant Safety Yet?</title><content type='html'>&lt;div dir=&quot;ltr&quot; style=&quot;text-align: left;&quot; trbidi=&quot;on&quot;&gt;
&lt;div class=&quot;separator&quot; style=&quot;clear: both; text-align: center;&quot;&gt;
&lt;a href=&quot;https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgCHf8fRx96I4-2mYAsqGy0VJoN1jaZjZ2BaMCBQaqSZMyGj_g0MVsgL2EfjREOE1LZFV59xrnhXYtSitG3ZVHlw3hKiEVwC7Sh4CFWWC04jpZuE2C5xfiy_D2YFuIEtzWzV5Xfi3gspYo/s1600/flagglobe.jpg&quot; imageanchor=&quot;1&quot; style=&quot;clear: left; float: left; margin-bottom: 1em; margin-right: 1em;&quot;&gt;&lt;img border=&quot;0&quot; height=&quot;200&quot; src=&quot;https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgCHf8fRx96I4-2mYAsqGy0VJoN1jaZjZ2BaMCBQaqSZMyGj_g0MVsgL2EfjREOE1LZFV59xrnhXYtSitG3ZVHlw3hKiEVwC7Sh4CFWWC04jpZuE2C5xfiy_D2YFuIEtzWzV5Xfi3gspYo/s200/flagglobe.jpg&quot; width=&quot;200&quot; /&gt;&lt;/a&gt;&lt;/div&gt;
Have you and/or your organization endorsed the Global Call to Action on Lubricant Safety yet? (lists or endorsers&amp;nbsp;in formation below.)&lt;br /&gt;
&lt;br /&gt;
&lt;h3 style=&quot;text-align: left;&quot;&gt;
We are going to be closing the call soon, so please make your move on lube safety NOW.&lt;/h3&gt;
&lt;br /&gt;
&lt;strong&gt;&lt;a href=&quot;https://www.surveymonkey.com/s/CalltoActionLubeSafety&quot; target=&quot;_blank&quot;&gt;Click here to read the Call and to&amp;nbsp;endorse.&lt;/a&gt;&lt;/strong&gt;&lt;br /&gt;
&lt;br /&gt;
We must KNOW whether water-based and silicone-based lubricants used during sex are safe or not, whether they cause harm, or not. Right now we don’t know – but we DO have some data that has raised some concerns. These concerns must be addressed through research, the questions we have must be answered.&lt;br /&gt;
&lt;br /&gt;
&lt;strong&gt;&lt;a href=&quot;https://www.surveymonkey.com/s/CalltoActionLubeSafety&quot; target=&quot;_blank&quot;&gt;Make your voice heard – endorse the Call.&lt;/a&gt;&lt;/strong&gt; &lt;br /&gt;
&lt;br /&gt;
&lt;strong&gt;ORGANIZATIONS who have endorsed the Call = 159 to date&lt;/strong&gt;&lt;br /&gt;
&lt;br /&gt;
1.&amp;nbsp; Abra Advanced Research International Pte Ltd, Singapore&lt;br /&gt;
2.&amp;nbsp; ACON, Australia&lt;br /&gt;
3.&amp;nbsp; Act for Change, Ghana&lt;br /&gt;
4.&amp;nbsp; Act Up/East Bay, USA&lt;br /&gt;
5.&amp;nbsp; ActionAIDS, USA&lt;br /&gt;
6.&amp;nbsp; Adam&#39;s Love, Thailand&lt;br /&gt;
7.&amp;nbsp; ADEFHO, Cameroon&lt;br /&gt;
8.&amp;nbsp; Adhikaar, India&lt;br /&gt;
9.&amp;nbsp; Affirmative Action, Cameroon&lt;br /&gt;
10. African Alliance for HIV Prevention, South Africa&lt;br /&gt;
11. African Men for Sexual Health and Rights (AMSHeR), South Africa&lt;br /&gt;
12. Afrique Arc En Ciel, Togo&lt;br /&gt;
13. AIDES, France&lt;br /&gt;
14. AIDS Community Research Initiative of America, USA&lt;br /&gt;
15. AIDS Foundation of Chicago, USA&lt;br /&gt;
16. AIDS Project Los Angeles, USA&lt;br /&gt;
17. AIDS Services for the Monadnock Region, USA&lt;br /&gt;
18. AIDS United, USA&lt;br /&gt;
19. AKPAKA Axel, Benin&lt;br /&gt;
20. ALPHA Pittsburgh, Inc., USAALPHA Pittsburgh, Inc.&lt;br /&gt;
21. ALTERNATIVE CÔTE D&#39;IVOIRE, Cote D’Ivoire&lt;br /&gt;
22. Anova Health Institute, South Africa&lt;br /&gt;
23. Asia Pacific Coalition on Male Sexual Health, Thailand&lt;br /&gt;
24. Asia Pacific Network of Sex Workers, Thailand&lt;br /&gt;
25. Astitva - An Organisation for the Support and Development of Sexual Minorities, India&lt;br /&gt;
26. Australian Federation of AIDS Organisations, Australia&lt;br /&gt;
27. AVAC, USA&lt;br /&gt;
28. Blue Diamond Society, Nepal&lt;br /&gt;
29. Canadian AIDS Society, Canada&lt;br /&gt;
30. Canadian AIDS Treatment Information Exchange (CATIE), Canada&lt;br /&gt;
31. Canadian HIV/AIDS Legal Network, Canada&lt;br /&gt;
32. Caribbean Association of Midwest America, USA&lt;br /&gt;
33. Case/UH Microbicide Clinical Trials Community Advisory Committee, USA&lt;br /&gt;
34. Center for Applied Research on Men and Health (CARMAH), Vietnam&lt;br /&gt;
35. Centre for Human Rights and Rehabilitation (CHRR), Malawi&lt;br /&gt;
36. Centre for the Development of People, Malawi&lt;br /&gt;
37. Chengdu Tongle, China&lt;br /&gt;
38. Chicago Female Condom Campaign, USA&lt;br /&gt;
39. Chicago Women&#39;s AIDS Project, USA&lt;br /&gt;
40. Citizen News Service – CNS, India&lt;br /&gt;
41. Club des 7jours, Togo&lt;br /&gt;
42. C-NET+, Belize&lt;br /&gt;
43. Coalition Internationale Sida PLUS, France&lt;br /&gt;
44. COCQ-SIDA, Canada&lt;br /&gt;
45. COMMUNITY AND FAMILY AID FOUNDATION-GHANA, Ghana&lt;br /&gt;
46. Community Information Center, USA&lt;br /&gt;
47. CONCEPTO VIH-SIDA E ITS, Mexico&lt;br /&gt;
48. Davryan Laboratories, Inc (Probe lubricants), USA&lt;br /&gt;
49. Desmond Tutu HIV Foundation, South Africa&lt;br /&gt;
50. Diversity And Solidairty Trust, Sri Lanka&lt;br /&gt;
51. DUH Demonstration for Universal Healthcare, USA&lt;br /&gt;
52. Epicentro, Peru&lt;br /&gt;
53. Equal Opportunities, Tajikistan&lt;br /&gt;
54. Evolve, Cameroon&lt;br /&gt;
55. Family Planning Council, USA&lt;br /&gt;
56. Fenway Institute at Fenway Health, USA&lt;br /&gt;
57. Freedom and Roam Uganda, Uganda&lt;br /&gt;
58. Fundacion Manodiversa Bolivia, Bolivia&lt;br /&gt;
59. Gala Initiative Uganda, Uganda&lt;br /&gt;
60. GALAEI, USA&lt;br /&gt;
61. Gay City Health Project, USA&lt;br /&gt;
62. Gay Men’s Health Crisis, USA&lt;br /&gt;
63. Gay Men&#39;s Sexual Health Alliance, Canada&lt;br /&gt;
64. Gel Works Pty Ltd, Australia&lt;br /&gt;
65. Global Forum on MSM &amp;amp; HIV (MSMGF), USA&lt;br /&gt;
66. Global Network of People Living with HIV, North American (GNP+NA), USA&lt;br /&gt;
67. Global Network of Sex Work Projects, UK&lt;br /&gt;
68. Global Research and Advocacy Group (GRAG), Senegal&lt;br /&gt;
69. GlobalGayz.com, USA&lt;br /&gt;
70. GrenCHAP Inc., Grenada&lt;br /&gt;
71. GWLmuda, Indonesia&lt;br /&gt;
72. Health Digest Foundation, Ghana&lt;br /&gt;
73. HealthHIV, USA&lt;br /&gt;
74. Heroes Project, India&lt;br /&gt;
75. HIV Prevention Justice Alliance, USA&lt;br /&gt;
76. House of Joe, USA&lt;br /&gt;
77. Housing Works, Inc., USA&lt;br /&gt;
78. Humanity First Cameroon, Cameroon&lt;br /&gt;
79. Hyacinth AIDS Foundation, USA&lt;br /&gt;
80. India HIV/AIDS Alliance, India&lt;br /&gt;
81. Interagency Coalition on AIDS and Development, Canada&lt;br /&gt;
82. International Center for Advocacy on Right to Health, Nigeria&lt;br /&gt;
83. International Planned Parenthood Federation, UK&lt;br /&gt;
84. International Rectal Microbicide Advocates (IRMA), USA&lt;br /&gt;
85. International Youth Council-Nigeria, Nigeria&lt;br /&gt;
86. IRMA ALC - América Latina y el Caribe, Peru&lt;br /&gt;
87. IRMA Nigeria, Nigeria&lt;br /&gt;
88. ISHTAR-MSM, Kenya&lt;br /&gt;
89. Iskorak, Croatia&lt;br /&gt;
90. Jamaica AIDS Support for Life, Jamaica&lt;br /&gt;
91. Johns Hopkins Center for Public Health and Human Rights, USA&lt;br /&gt;
92. Joint Adherent Brothers and Sisters Against Aids, Uganda&lt;br /&gt;
93. Los Angeles County HIV Drug &amp;amp; Alcohol Task Force, USA&lt;br /&gt;
94. Louisiana Latino Health Coalition for HIV/AIDS Awareness, USA&lt;br /&gt;
95. MAACA, INC, USA&lt;br /&gt;
96. Maritime Life Precious Foundation, Ghana&lt;br /&gt;
97. Men Against AIDS Youth Group, Kenya&lt;br /&gt;
98. Men For Health and Gender Justice Organisation, Botswana&lt;br /&gt;
99. Microbicide Trials Network, USA&lt;br /&gt;
100.&amp;nbsp; Minnesota AIDS Project, USA&lt;br /&gt;
101.&amp;nbsp; MUSC/Lowcountry AIDS Services Consumer Advisory Board, USA&lt;br /&gt;
102.&amp;nbsp; NAM Publications (Aidsmap), UK&lt;br /&gt;
103.&amp;nbsp; National Black Gay Men&#39;s Advocacy Coalition, USA&lt;br /&gt;
104.&amp;nbsp; National Minority AIDS Council, USA&lt;br /&gt;
105.&amp;nbsp; Naz Male Health Alliance, Pakistan&lt;br /&gt;
106.&amp;nbsp; New HIV Vaccine and Microbicide Advocacy Society, Nigeria&lt;br /&gt;
107.&amp;nbsp; Okaloosa AIDS support &amp;amp; Informational Services, Inc. (OASIS), USA&lt;br /&gt;
108.&amp;nbsp; PEMA Kenya, Kenya&lt;br /&gt;
109.&amp;nbsp; Penitentiary Initiative, Ukraine&lt;br /&gt;
110.&amp;nbsp; People Like Us (PLUS) Kolkata, India&lt;br /&gt;
111.&amp;nbsp; PeterCares House, USA&lt;br /&gt;
112.&amp;nbsp; POCAAN (People of Color Against AIDS Network), USA&lt;br /&gt;
113.&amp;nbsp; Positive Mind &amp;amp; Body Support Group Network, USA&lt;br /&gt;
114.&amp;nbsp; Positive Women&#39;s Network USA, USA&lt;br /&gt;
115.&amp;nbsp; Presbyterian AIDS Network, USA&lt;br /&gt;
116.&amp;nbsp; Pride Equality, Sierra Leone&lt;br /&gt;
117.&amp;nbsp; Pro Health Initiative, Nigeria&lt;br /&gt;
118.&amp;nbsp; Professionals in Pride Kenya (PPK), Kenya&lt;br /&gt;
119.&amp;nbsp; Project Inform, USA&lt;br /&gt;
120.&amp;nbsp; PT Foundation, Malaysia&lt;br /&gt;
121.&amp;nbsp; Puerto Rico Community Network for Clinical Research on AIDS, Puerto Rico&lt;br /&gt;
122.&amp;nbsp; Queer Alliance Nigeria, Nigeria&lt;br /&gt;
123.&amp;nbsp; QUEEROCRACY, USA&lt;br /&gt;
124.&amp;nbsp; Rainbow Community Kampuceah, Cambodia&lt;br /&gt;
125.&amp;nbsp; Rainbow Sunrise Mapambazuko, DR Congo&lt;br /&gt;
126.&amp;nbsp; Rainbow-Ethiopia in Exile (REE), USA&lt;br /&gt;
127.&amp;nbsp; Real Opportunities Network, Ghana&lt;br /&gt;
128.&amp;nbsp; San Antonio AIDS Foundation, USA&lt;br /&gt;
129.&amp;nbsp; San Francisco AIDS Foundation, USA&lt;br /&gt;
130.&amp;nbsp; SEA-AIDS (Asia Pacific eForum on HIV), India&lt;br /&gt;
131.&amp;nbsp; SIBALT, Russia&lt;br /&gt;
132.&amp;nbsp; SID&#39;ADO, Cameroon&lt;br /&gt;
133.&amp;nbsp; Society Against Sexual Orientation Discrimination (SASOD), Guyana&lt;br /&gt;
134.&amp;nbsp; SOMOSGAY, Paraguay&lt;br /&gt;
135.&amp;nbsp; START at Westminster, USA&lt;br /&gt;
136.&amp;nbsp; Stichting AidsCare, The Netherlands&lt;br /&gt;
137.&amp;nbsp; Tamba Pwani, Kenya&lt;br /&gt;
138.&amp;nbsp; Tanzania Sisi Kwa Sisi Foundation, Tanzania&lt;br /&gt;
139.&amp;nbsp; Terrence Higgins Trust, UK&lt;br /&gt;
140.&amp;nbsp; Test Positive Aware Network, USA&lt;br /&gt;
141.&amp;nbsp; The Center for Sexual Pleasure and Health, USA&lt;br /&gt;
142.&amp;nbsp; The Initiative for Equal Rights, Nigeria&lt;br /&gt;
143.&amp;nbsp; The Mpowerment Project, USA&lt;br /&gt;
144.&amp;nbsp; The Yes Yes Company Ltd, UK&lt;br /&gt;
145.&amp;nbsp; Total Health Empowerment and Development (THEDI), Nigeria&lt;br /&gt;
146.&amp;nbsp; Treatment Action Group, USA&lt;br /&gt;
147.&amp;nbsp; Trigg Laboratories, Inc., USA&lt;br /&gt;
148.&amp;nbsp; Uganda Health and Science Press Association, Uganda&lt;br /&gt;
149.&amp;nbsp; UNITED AND STRONG INC, Saint Lucia&lt;br /&gt;
150.&amp;nbsp; Vivir. Participacion, Incidencia y Transparencia, A.C., Mexico&lt;br /&gt;
151.&amp;nbsp; Vote For Health Campaign, India&lt;br /&gt;
152.&amp;nbsp; We For Civil Equality NGO, Armenia&lt;br /&gt;
153.&amp;nbsp; William Way LGBT Community Center, USA&lt;br /&gt;
154.&amp;nbsp; Women`s Health, HIV and AIDS Southern Africa, Zimbabwe&lt;br /&gt;
155.&amp;nbsp; Womenplus Against TB and HIV in Kenya, Kenya&lt;br /&gt;
156.&amp;nbsp; Women&#39;s Health and Equal Rights Initiative, Nigeria&lt;br /&gt;
157.&amp;nbsp; Woodhull Sexual Freedom Alliance, USA&lt;br /&gt;
158.&amp;nbsp; World AIDS Forum, Australia&lt;br /&gt;
159.&amp;nbsp; Youth Voices Count, Thailand&lt;br /&gt;
&lt;br /&gt;
&lt;strong&gt;&lt;a href=&quot;https://www.surveymonkey.com/s/CalltoActionLubeSafety&quot;&gt;Endorse.&lt;/a&gt;&lt;/strong&gt;&lt;br /&gt;
&lt;br /&gt;
&lt;strong&gt;INDIVIDUALS who have endorsed the Call = 310 to date&lt;/strong&gt;&lt;br /&gt;
&lt;br /&gt;
1.&amp;nbsp; Adam Fairris, UK&lt;br /&gt;
2.&amp;nbsp; Ako Cyriaque Yapo, Senegal&lt;br /&gt;
3.&amp;nbsp; Alan Johnson, USA&lt;br /&gt;
4.&amp;nbsp; Alapini Max, Benin&lt;br /&gt;
5.&amp;nbsp; Alberto Abello, USA&lt;br /&gt;
6.&amp;nbsp; Alex Carballo-Dieguez, USA&lt;br /&gt;
7.&amp;nbsp; Alicia Gauvin, USA&lt;br /&gt;
8.&amp;nbsp; Allison Boyd, USA&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;br /&gt;
9.&amp;nbsp; Amoussou Damien, Togo&lt;br /&gt;
10.&amp;nbsp; Andrew Reynolds, USA&lt;br /&gt;
11.&amp;nbsp; Angel Luis Hernández, Puerto Rico&lt;br /&gt;
12.&amp;nbsp; Ann Jones, USA&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;br /&gt;
13.&amp;nbsp; Ann Joseph, USA&lt;br /&gt;
14.&amp;nbsp; Anna Forbes, USA&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;br /&gt;
15.&amp;nbsp; Anna Saeger, USA&lt;br /&gt;
16.&amp;nbsp; Anne Lehocky, USA&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;br /&gt;
17.&amp;nbsp; Antonio Gonzalez, USA&lt;br /&gt;
18.&amp;nbsp; Arick Buckles, United States&lt;br /&gt;
19.&amp;nbsp; Ben Bavinton, Australia&lt;br /&gt;
20.&amp;nbsp; Ben Clapham, USA&lt;br /&gt;
21.&amp;nbsp; Ben Wilcock, Australia&lt;br /&gt;
22.&amp;nbsp; Bertram Johnson, United States&lt;br /&gt;
23.&amp;nbsp; Beth Galaska Burzuk, USA&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;br /&gt;
24.&amp;nbsp; Bi Petex, Uganda&lt;br /&gt;
25.&amp;nbsp; Bisi Alimi, United Kingdom&lt;br /&gt;
26.&amp;nbsp; Blake Smith, UK&lt;br /&gt;
27.&amp;nbsp; Bobby Ramakant, India&lt;br /&gt;
28.&amp;nbsp; Brian Kanyemba, South Africa&lt;br /&gt;
29.&amp;nbsp; Brian M. Green, USA&lt;br /&gt;
30.&amp;nbsp; Brian White, South Africa&lt;br /&gt;
31.&amp;nbsp; Briana Morgan, United States&lt;br /&gt;
32.&amp;nbsp; Brooke Willis, USA&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;br /&gt;
33.&amp;nbsp; Butch McKay, USA&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;br /&gt;
34.&amp;nbsp; Cameron Wolf, USA&lt;br /&gt;
35.&amp;nbsp; Caren Kirkland, USA&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;br /&gt;
36.&amp;nbsp; Carlos Vela, Peru&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;br /&gt;
37.&amp;nbsp; Carrie E .Foote, USA&lt;br /&gt;
38.&amp;nbsp; Cassandra Warren, USA&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;br /&gt;
39.&amp;nbsp; Cassie Bayside, Australia&lt;br /&gt;
40.&amp;nbsp; Celina Londono, USA&lt;br /&gt;
41.&amp;nbsp; Champion Phiri, South Africa&lt;br /&gt;
42.&amp;nbsp; Chanthorn Phorng, Cambodia&lt;br /&gt;
43.&amp;nbsp; Charlene Dezzutti, USA&lt;br /&gt;
44.&amp;nbsp; Charles, Uganda&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;br /&gt;
45.&amp;nbsp; Chheav Aphyra, Cambodia&lt;br /&gt;
46.&amp;nbsp; Chiranjivi Amgai, Nepal&lt;br /&gt;
47.&amp;nbsp; Chris Bartlett, USA&lt;br /&gt;
48.&amp;nbsp; Christian Rumu, United States&lt;br /&gt;
49.&amp;nbsp; Christopher B. Duerkes, USA&lt;br /&gt;
50.&amp;nbsp; Chull Sesugh Stanley, Nigeria&lt;br /&gt;
51.&amp;nbsp; Clare Collins, USA&lt;br /&gt;
52.&amp;nbsp; Clayton Ruley, USA&lt;br /&gt;
53.&amp;nbsp; Collins Seymah Smith, Ghana&lt;br /&gt;
54.&amp;nbsp; Cory Silverberg, Canada&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;br /&gt;
55.&amp;nbsp; Courtney McCrellias, USA&lt;br /&gt;
56.&amp;nbsp; Dahlia Ferlito, USA&lt;br /&gt;
57.&amp;nbsp; Dan Kilbane, USA&lt;br /&gt;
58.&amp;nbsp; Dana Loxley, Australia&amp;nbsp;&amp;nbsp; &lt;br /&gt;
59.&amp;nbsp; Dana Nelson, USA&lt;br /&gt;
60.&amp;nbsp; Daniel MacDonald, USA&lt;br /&gt;
61.&amp;nbsp; Daramola Christianah, Nigeria&lt;br /&gt;
62.&amp;nbsp; Darrel Johnson, United States&lt;br /&gt;
63.&amp;nbsp; David Acosta, USA&lt;br /&gt;
64.&amp;nbsp; David G Ostrow, USA&lt;br /&gt;
65.&amp;nbsp; David Kuria, Kenya&lt;br /&gt;
66.&amp;nbsp; David Phillips, USA&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;br /&gt;
67.&amp;nbsp; Deb Tolenaar, USA&lt;br /&gt;
68.&amp;nbsp; Deirdre Grant, USA&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;br /&gt;
69.&amp;nbsp; Denis Efremov, Russia&lt;br /&gt;
70.&amp;nbsp; Derrick Mapp, USA&lt;br /&gt;
71.&amp;nbsp; Don Pults, USA &lt;br /&gt;
72.&amp;nbsp; Donald MacIver, USA&lt;br /&gt;
73.&amp;nbsp; Donn Colby, Vietnam&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;br /&gt;
74.&amp;nbsp; Doug Brown, UK&lt;br /&gt;
75.&amp;nbsp; Doug McColeman, Canada&lt;br /&gt;
76.&amp;nbsp; Douglas Masinde, Kenya&lt;br /&gt;
77.&amp;nbsp; Douglas Warzyn, USA&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;br /&gt;
78.&amp;nbsp; Douomong Yotta Serge, Cameroon&lt;br /&gt;
79.&amp;nbsp; Dr Stuart Koe, Singapore&lt;br /&gt;
80.&amp;nbsp; Dr. Michael W. Plankey, USA&lt;br /&gt;
81.&amp;nbsp; Dredge Kang, USA&lt;br /&gt;
82.&amp;nbsp; Drew&amp;nbsp; Nannini, United States&lt;br /&gt;
83.&amp;nbsp; Duncan Japhta Khothatso Moeketse, South Africa&lt;br /&gt;
84.&amp;nbsp; Durueke Florita, Nigeria&lt;br /&gt;
85.&amp;nbsp; Dustin Kight, USA&lt;br /&gt;
86.&amp;nbsp; Ed Wolf, USA&lt;br /&gt;
87.&amp;nbsp; Edie O&#39;Connor, United States&lt;br /&gt;
88.&amp;nbsp; Edward Fuchs, USA&lt;br /&gt;
89.&amp;nbsp; Edward Iwanicki, USA&lt;br /&gt;
90.&amp;nbsp; Eniko Akom, USA&lt;br /&gt;
91.&amp;nbsp; Eric Arnold Fopossi, Cameroon&lt;br /&gt;
92.&amp;nbsp; Eric Evans, USA&lt;br /&gt;
93.&amp;nbsp; Eric M Glare, Australia&amp;nbsp;&amp;nbsp; &lt;br /&gt;
94.&amp;nbsp; Erich Schneider Ormeño, Peru&lt;br /&gt;
95.&amp;nbsp; Erik Libey, USA&lt;br /&gt;
96.&amp;nbsp; Erik Streeter, USA&lt;br /&gt;
97.&amp;nbsp; Ernest MOSEKI, Botswana&lt;br /&gt;
98.&amp;nbsp; Essiomle Ethie, Togo&lt;br /&gt;
99.&amp;nbsp; Eva Westley, United States&lt;br /&gt;
100.&amp;nbsp; Fiona Hale, UK&lt;br /&gt;
101.&amp;nbsp; Gabriel Boichat, Spain&lt;br /&gt;
102.&amp;nbsp; Gail Broder, USA&lt;br /&gt;
103.&amp;nbsp; Garland Wood, USA&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;br /&gt;
104.&amp;nbsp; Garry Brough, UK&lt;br /&gt;
105.&amp;nbsp; Gary Paul Wright, USA&lt;br /&gt;
106.&amp;nbsp; Gbekou, Togo&lt;br /&gt;
107.&amp;nbsp; Gennady Roshchupkin, Russia&lt;br /&gt;
108.&amp;nbsp; George Kerr, USA&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;br /&gt;
109.&amp;nbsp; George Miller-Zauner, USA&lt;br /&gt;
110.&amp;nbsp; George Pappas, USA&lt;br /&gt;
111.&amp;nbsp; George Reginald Freeman, Sierra Leone&lt;br /&gt;
112.&amp;nbsp; George Victor O, Kenya&lt;br /&gt;
113.&amp;nbsp; Georges S., Togo&lt;br /&gt;
114.&amp;nbsp; Georges Sideris, France&lt;br /&gt;
115.&amp;nbsp; Gerard Nkundimana, Rwanda&amp;nbsp;&amp;nbsp; &lt;br /&gt;
116.&amp;nbsp; Gina Brown, USA&lt;br /&gt;
117.&amp;nbsp; Glenn Kornblum, USA&amp;nbsp;&amp;nbsp; &lt;br /&gt;
118.&amp;nbsp; Gregg Kimball, USA&lt;br /&gt;
119.&amp;nbsp; Hanna Hjord, USA&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;br /&gt;
120.&amp;nbsp; Hannah Graves, Canada&lt;br /&gt;
121.&amp;nbsp; Heidi Nass, USA&lt;br /&gt;
122.&amp;nbsp; Heidi Wesbrock, USA&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;br /&gt;
123.&amp;nbsp; Helen, USA&lt;br /&gt;
124.&amp;nbsp; Henrieese Roberts, USA&lt;br /&gt;
125.&amp;nbsp; Hugo Dann, Canada&lt;br /&gt;
126.&amp;nbsp; Ian Lemieux, US&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;br /&gt;
127.&amp;nbsp; Ivan Cruickshank, Jamaica&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;br /&gt;
128.&amp;nbsp; J. Jeff McConnell, USA&amp;nbsp; &lt;br /&gt;
129.&amp;nbsp; Jace Dyckman, USA&lt;br /&gt;
130.&amp;nbsp; Jack Cox, USA&lt;br /&gt;
131.&amp;nbsp; Jade Patten, USA&lt;br /&gt;
132.&amp;nbsp; James Carrington, United States&lt;br /&gt;
133.&amp;nbsp; James Komar, United States&lt;br /&gt;
134.&amp;nbsp; Jamie Roberts, USA&lt;br /&gt;
135.&amp;nbsp; Jamie Sims, USA&lt;br /&gt;
136.&amp;nbsp; Jason Jacobs, USA&lt;br /&gt;
137.&amp;nbsp; Jason King , USA&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;br /&gt;
138.&amp;nbsp; Jean-Michel Brevelle, USA&lt;br /&gt;
139.&amp;nbsp; Jeff Berry, USA&lt;br /&gt;
140.&amp;nbsp; Jeffrey Pope, USA&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;br /&gt;
141.&amp;nbsp; Jennifer A. Hawley, USA&lt;br /&gt;
142.&amp;nbsp; Jeremy Kwan, Malaysia&lt;br /&gt;
143.&amp;nbsp; Jerome Galea, USA&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;br /&gt;
144.&amp;nbsp; Jeton Ademaj, USA&lt;br /&gt;
145.&amp;nbsp; Jim Cosenza, USA&lt;br /&gt;
146.&amp;nbsp; Jim Eigo, USA&lt;br /&gt;
147.&amp;nbsp; Jim Merrell, USA&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;br /&gt;
148.&amp;nbsp; Jim Pickett, USA&lt;br /&gt;
149.&amp;nbsp; Joan Tallada, Spain&lt;br /&gt;
150.&amp;nbsp; John Andrews, USA&lt;br /&gt;
151.&amp;nbsp; John Hamiga, USA&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;br /&gt;
152.&amp;nbsp; John Kashiha, Tanzania&lt;br /&gt;
153.&amp;nbsp; John McAllister, Botswana&lt;br /&gt;
154.&amp;nbsp; John Peller, USA&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;br /&gt;
155.&amp;nbsp; Jorge Gutierrez, USA&lt;br /&gt;
156.&amp;nbsp; Jorge Yon, Peru&lt;br /&gt;
157.&amp;nbsp; Joseph Alfano, USA&lt;br /&gt;
158.&amp;nbsp; Joseph Walker, USA&lt;br /&gt;
159.&amp;nbsp; Joyce Hunter, USA&lt;br /&gt;
160.&amp;nbsp; Jules Eloundou Atamba, Cameroon&lt;br /&gt;
161.&amp;nbsp; Julian Sanjivan, USA&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;br /&gt;
162.&amp;nbsp; Julie Davids, United States&lt;br /&gt;
163.&amp;nbsp; Kadiri Audu, Nigeria&lt;br /&gt;
164.&amp;nbsp; Karen Creary, USA&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;br /&gt;
165.&amp;nbsp; Karon Stephen, France&lt;br /&gt;
166.&amp;nbsp; Kasha Jacqueline, Uganda&lt;br /&gt;
167.&amp;nbsp; Kate Alexander, USA&lt;br /&gt;
168.&amp;nbsp; Kate Morrow, USA&lt;br /&gt;
169.&amp;nbsp; Kay Marshall, USA&lt;br /&gt;
170.&amp;nbsp; Kees Rümke, The Netherlands&lt;br /&gt;
171.&amp;nbsp; Keith Gereffi, USA&lt;br /&gt;
172.&amp;nbsp; Kelly Curran, USA&lt;br /&gt;
173.&amp;nbsp; Kennedy Otieno Olango, Kenya&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;br /&gt;
174.&amp;nbsp; Kenny, USA&lt;br /&gt;
175.&amp;nbsp; Kent Klindera, United States&lt;br /&gt;
176.&amp;nbsp; Kevin DeLuca, USA&lt;br /&gt;
177.&amp;nbsp; Kevin McKenzie, USA&lt;br /&gt;
178.&amp;nbsp; Kieta D. Mutepfa, USA &lt;br /&gt;
179.&amp;nbsp; Krishna Stone, USA&lt;br /&gt;
180.&amp;nbsp; Kyon Saucier, USA&lt;br /&gt;
181.&amp;nbsp; Larry Baxter, Canada&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;br /&gt;
182.&amp;nbsp; Laurel Sprague, United States&lt;br /&gt;
183.&amp;nbsp; Laxmi Narayan Tripathi, India&lt;br /&gt;
184.&amp;nbsp; Leo Schenk, The Netherlands&lt;br /&gt;
185.&amp;nbsp; Lillibeth Gonzalez, USA&lt;br /&gt;
186.&amp;nbsp; Linda Watson, Canada&lt;br /&gt;
187.&amp;nbsp; Loren Jones, United States&lt;br /&gt;
188.&amp;nbsp; Luis Galarza, Ecuador&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;br /&gt;
189.&amp;nbsp; Mac-Darling Cobbinah, Ghana&amp;nbsp;&amp;nbsp; &lt;br /&gt;
190.&amp;nbsp; Maheswar Satpathy, Australia&amp;nbsp; &lt;br /&gt;
191.&amp;nbsp; Marc-André LeBlanc, Canada&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;br /&gt;
192.&amp;nbsp; Marcelo Maia, USA&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;br /&gt;
193.&amp;nbsp; Margaret Onah, Nigeria&lt;br /&gt;
194.&amp;nbsp; Marie Camacho, USA&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;br /&gt;
195.&amp;nbsp; Marie Omorodion, USA&lt;br /&gt;
196.&amp;nbsp; Mark Hubbard, USA&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;br /&gt;
197.&amp;nbsp; Mark Ing, USA&amp;nbsp; &lt;br /&gt;
198.&amp;nbsp; Mark S. King, USA&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;br /&gt;
199.&amp;nbsp; Marlon Woodward, USA&lt;br /&gt;
200.&amp;nbsp; Martha Tholanah, Zimbabwe&lt;br /&gt;
201.&amp;nbsp; Mary Brewster, United States&lt;br /&gt;
202.&amp;nbsp; Mathew Rodriguez, USA&lt;br /&gt;
203.&amp;nbsp; Matt Bray, USA&lt;br /&gt;
204.&amp;nbsp; Matthew Franck, USA&lt;br /&gt;
205.&amp;nbsp; Matthew Rose, USA&lt;br /&gt;
206.&amp;nbsp; Matthew Vaughan, Thailand&lt;br /&gt;
207.&amp;nbsp; Melanie A Reese, USA&lt;br /&gt;
208.&amp;nbsp; Michael Louella , USA&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;br /&gt;
209.&amp;nbsp; Michael Luciano, USA&lt;br /&gt;
210.&amp;nbsp; Michael Moore, USA&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;br /&gt;
211.&amp;nbsp; Michael Trigg, USA&lt;br /&gt;
212.&amp;nbsp; Mike Kennedy, Australia&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;br /&gt;
213.&amp;nbsp; Mike Peters, USA&lt;br /&gt;
214.&amp;nbsp; Mombunza Azuba, DR CONGO&lt;br /&gt;
215.&amp;nbsp; Monique Newell, USA&amp;nbsp; &lt;br /&gt;
216.&amp;nbsp; Morenike Ukpong, Nigeria&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;br /&gt;
217.&amp;nbsp; Muriel Visser, France&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;br /&gt;
218.&amp;nbsp; Mykaila Ostrom, USA&lt;br /&gt;
219.&amp;nbsp; Mykal Welch, Belize&lt;br /&gt;
220.&amp;nbsp; N. Nash, USA&lt;br /&gt;
221.&amp;nbsp; Naigaga Lillian Mutengu, Uganda&lt;br /&gt;
222.&amp;nbsp; Nathan Solomon, USA&amp;nbsp; &lt;br /&gt;
223.&amp;nbsp; Nicholas Bates, Australia&lt;br /&gt;
224.&amp;nbsp; Nnamani Ikechukwu Sammy, Nigeria&lt;br /&gt;
225.&amp;nbsp; Olumide Makanjuola, Nigeria&lt;br /&gt;
226.&amp;nbsp; Omullo Paul, Kenya&lt;br /&gt;
227.&amp;nbsp; Orbit Clanton, USA&lt;br /&gt;
228.&amp;nbsp; Otis Richardson, USA&lt;br /&gt;
229.&amp;nbsp; Patricia Segura, Peru&lt;br /&gt;
230.&amp;nbsp; Patrick French, USA&lt;br /&gt;
231.&amp;nbsp; Paul Causey, Thailand&lt;br /&gt;
232.&amp;nbsp; Pedro Goicochea, USA&lt;br /&gt;
233.&amp;nbsp; Penny DeNoble, USA&lt;br /&gt;
234.&amp;nbsp; Pham Thi Hanh Van, Vietnam&lt;br /&gt;
235.&amp;nbsp; Phillis Washington, USA&lt;br /&gt;
236.&amp;nbsp; Pilot Mathambo, Botswana&lt;br /&gt;
237.&amp;nbsp; Prince N. Bahati, Kenya&lt;br /&gt;
238.&amp;nbsp; Ramon Nunez III, USA&lt;br /&gt;
239.&amp;nbsp; Rebecca Giguere, USA&amp;nbsp; &lt;br /&gt;
240.&amp;nbsp; Remigus Emodi, Nigeria&lt;br /&gt;
241.&amp;nbsp; Rev. Charles Straight, USA&lt;br /&gt;
242.&amp;nbsp; Ricardo Jimenez, USA&lt;br /&gt;
243.&amp;nbsp; Richard Coover, USA&lt;br /&gt;
244.&amp;nbsp; Rita Lisa Labbett, US&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;br /&gt;
245.&amp;nbsp; Rob Camp, Spain&lt;br /&gt;
246.&amp;nbsp; Robert Aponte, USA&lt;br /&gt;
247.&amp;nbsp; Robert Birch, Canada&lt;br /&gt;
248.&amp;nbsp; Roger Cunha, USA&lt;br /&gt;
249.&amp;nbsp; Roger Pebody, UK&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;br /&gt;
250.&amp;nbsp; Roger Prasad, Canada&lt;br /&gt;
251.&amp;nbsp; Roger Tatoud, UK&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;br /&gt;
252.&amp;nbsp; Roy Wadia, India&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;br /&gt;
253.&amp;nbsp; Rukia Ahmed, Kenya&lt;br /&gt;
254.&amp;nbsp; S. Wakefield, USA&lt;br /&gt;
255.&amp;nbsp; Santiago Palomino, Peru&lt;br /&gt;
256.&amp;nbsp; Sasha Gear, South Africa&lt;br /&gt;
257.&amp;nbsp; Scot More, USA&lt;br /&gt;
258.&amp;nbsp; Scott Robertson, Zambia&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;br /&gt;
259.&amp;nbsp; Sedar, Benin&lt;br /&gt;
260.&amp;nbsp; Sergio Farfan, USA&lt;br /&gt;
261.&amp;nbsp; Shawn Decker, United States&lt;br /&gt;
262.&amp;nbsp; Shayna Buhler, Canada&lt;br /&gt;
263.&amp;nbsp; Shivani Thaker, USA&lt;br /&gt;
264.&amp;nbsp; Shreena, India&amp;nbsp; &lt;br /&gt;
265.&amp;nbsp; Sibusiso, South Africa&lt;br /&gt;
266.&amp;nbsp; Simon Odiwuor, Kenya&lt;br /&gt;
267.&amp;nbsp; Siobhan Fee, UK&lt;br /&gt;
268.&amp;nbsp; Solomon, Kenya&lt;br /&gt;
269.&amp;nbsp; Srun Srorn, Cambodia&lt;br /&gt;
270.&amp;nbsp; Steave Nemande, Cameroon&lt;br /&gt;
271.&amp;nbsp; Stephen Karpiak PhD, United States&lt;br /&gt;
272.&amp;nbsp; Stephen McGill, Liberia&lt;br /&gt;
273.&amp;nbsp; Stephen Miller-Zauner, USA&lt;br /&gt;
274.&amp;nbsp; Steve Miralles, Peru&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;br /&gt;
275.&amp;nbsp; Steven S. Muchnick, PhD&lt;br /&gt;
276.&amp;nbsp; Stuart Koe, Singapore&lt;br /&gt;
277.&amp;nbsp; Sue Saltmarsh, USA&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;br /&gt;
278.&amp;nbsp; Suman Nepal, Nepal&lt;br /&gt;
279.&amp;nbsp; Suraj Madoori, USA&lt;br /&gt;
280.&amp;nbsp; Susan Forrest, USA&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;br /&gt;
281.&amp;nbsp; Susan Lloyd Yolen, USA&lt;br /&gt;
282.&amp;nbsp; Susie Hoffman, USA&lt;br /&gt;
283.&amp;nbsp; Sylvie Rouby, France&amp;nbsp;&amp;nbsp; &lt;br /&gt;
284.&amp;nbsp; Tendai F Mbengeranwa Mhaka, Zimbabwe&lt;br /&gt;
285.&amp;nbsp; Terence Roethlein, United States&lt;br /&gt;
286.&amp;nbsp; Teresa Springer, USA&lt;br /&gt;
287.&amp;nbsp; TG Green, USA&lt;br /&gt;
288.&amp;nbsp; Thandi Maluka, South Africa&lt;br /&gt;
289.&amp;nbsp; Theresa Rubin, USA&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;br /&gt;
290.&amp;nbsp; Thomas Haig, Canada&lt;br /&gt;
291.&amp;nbsp; Tiedjou Joseph Achille, Cameroon&lt;br /&gt;
292.&amp;nbsp; Timothy Frasca, USA&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;br /&gt;
293.&amp;nbsp; Timothy Kee, United States&lt;br /&gt;
294.&amp;nbsp; Titcha Ho, USA &lt;br /&gt;
295.&amp;nbsp; Trenado, France&lt;br /&gt;
296.&amp;nbsp; Trevor Pearson, USA&lt;br /&gt;
297.&amp;nbsp; Troy, USA&lt;br /&gt;
298.&amp;nbsp; Tung Duy Bui, Thailand&lt;br /&gt;
299.&amp;nbsp; Udom Likhitwonnawut, Thailand&lt;br /&gt;
300.&amp;nbsp; Vanessa Smith, USA&lt;br /&gt;
301.&amp;nbsp; Victor Rollins, Bahamas&lt;br /&gt;
302.&amp;nbsp; Vikram, USA&lt;br /&gt;
303.&amp;nbsp; Wanda Brendle-Moss, USA&lt;br /&gt;
304.&amp;nbsp; Wanda Commander, USA&lt;br /&gt;
305.&amp;nbsp; Will Wilson, USA&lt;br /&gt;
306.&amp;nbsp; William Booth, Canada&lt;br /&gt;
307.&amp;nbsp; Wolf Graf, Australia&lt;br /&gt;
308.&amp;nbsp; Yolanda, USA&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;br /&gt;
309.&amp;nbsp; Zoe Duby, South Africa&lt;br /&gt;
310.&amp;nbsp; Zoran Dominkovic, Croatia&lt;br /&gt;
&lt;br /&gt;
&lt;strong&gt;&lt;a href=&quot;https://www.surveymonkey.com/s/CalltoActionLubeSafety&quot;&gt;Endorse.&lt;/a&gt;&lt;/strong&gt;&amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
-------------------&lt;br /&gt;
&lt;br /&gt;
*Join IRMA&#39;s robust, highly-active. moderated, global listserv addressing rectal microbicide research and advocacy as well as other interesting new HIV prevention technologies by contacting us at rectalmicro@gmail.com. Joining our listserv automatically makes you a member of IRMA - a network of more than 1,200 advocates, scientists, policy makers and funders from all over the world.&lt;br /&gt;
&lt;br /&gt;
*Please look for us on Facebook: www.facebook.com/InternationalRectalMicrobicideAdvocates, and you can follow us on Twitter: @rectalmicro.&lt;br /&gt;
&lt;br /&gt;
*Also, please note that shared news items from other sources posted on this blog do not necessarily mean IRMA has taken any position on the article&#39;s content.&lt;br /&gt;
&lt;br /&gt;
-------------------&lt;/div&gt;
</content><link rel='replies' type='application/atom+xml' href='http://irma-rectalmicrobicides.blogspot.com/feeds/8063589588672123210/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment/fullpage/post/8936337794651081205/8063589588672123210?isPopup=true' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/8936337794651081205/posts/default/8063589588672123210'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/8936337794651081205/posts/default/8063589588672123210'/><link rel='alternate' type='text/html' href='http://irma-rectalmicrobicides.blogspot.com/2013/04/time-sensitive-have-you-or-your.html' title='TIME SENSITIVE: Have You (or Your Organization) Endorsed Our Global Call to Action on Lubricant Safety Yet?'/><author><name>NewPrevTech</name><uri>http://www.blogger.com/profile/05705781012925480028</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgCHf8fRx96I4-2mYAsqGy0VJoN1jaZjZ2BaMCBQaqSZMyGj_g0MVsgL2EfjREOE1LZFV59xrnhXYtSitG3ZVHlw3hKiEVwC7Sh4CFWWC04jpZuE2C5xfiy_D2YFuIEtzWzV5Xfi3gspYo/s72-c/flagglobe.jpg" height="72" width="72"/><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-8936337794651081205.post-881906942345041717</id><published>2013-04-17T14:30:00.001-05:00</published><updated>2013-04-17T14:34:01.958-05:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="activists"/><category scheme="http://www.blogger.com/atom/ns#" term="advocacy"/><category scheme="http://www.blogger.com/atom/ns#" term="Africa"/><category scheme="http://www.blogger.com/atom/ns#" term="African Union"/><category scheme="http://www.blogger.com/atom/ns#" term="hiv prevention"/><category scheme="http://www.blogger.com/atom/ns#" term="IRMA"/><category scheme="http://www.blogger.com/atom/ns#" term="lubricant"/><category scheme="http://www.blogger.com/atom/ns#" term="Project ARM"/><category scheme="http://www.blogger.com/atom/ns#" term="rectal microbicide"/><category scheme="http://www.blogger.com/atom/ns#" term="research"/><category scheme="http://www.blogger.com/atom/ns#" term="sexual health"/><title type='text'>African Common Position Paper Highlights Importance of Condom-Compatible Lubes and Rectal Microbicide Research</title><content type='html'>&lt;div dir=&quot;ltr&quot; style=&quot;text-align: left;&quot; trbidi=&quot;on&quot;&gt;
&lt;div class=&quot;separator&quot; style=&quot;clear: both; text-align: center;&quot;&gt;
&lt;a href=&quot;https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjD9oC65f6OC3SOX99o08bQvpmjGmh9vppLS4TVXCUFNTA3vHPHfntjHDy1jolaVV93SP27jz401u0QRcODccXSYNKCo_fxoi1Hoyo7FcDhEcI_LscIOk8PEDHHdyI-fwjvhYLVC1CsCoE/s1600/ICPD-AIDS-Accountability-Phillipa-Tucker-BOb-Munyati-Nomvuyo-Mabusela-Jpeg-300x264.jpg&quot; imageanchor=&quot;1&quot; style=&quot;clear: left; float: left; margin-bottom: 1em; margin-right: 1em;&quot;&gt;&lt;img border=&quot;0&quot; height=&quot;176&quot; src=&quot;https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjD9oC65f6OC3SOX99o08bQvpmjGmh9vppLS4TVXCUFNTA3vHPHfntjHDy1jolaVV93SP27jz401u0QRcODccXSYNKCo_fxoi1Hoyo7FcDhEcI_LscIOk8PEDHHdyI-fwjvhYLVC1CsCoE/s200/ICPD-AIDS-Accountability-Phillipa-Tucker-BOb-Munyati-Nomvuyo-Mabusela-Jpeg-300x264.jpg&quot; width=&quot;200&quot; /&gt;&lt;/a&gt;&lt;/div&gt;
Our friends at &lt;strong&gt;&lt;a href=&quot;http://aidsaccountability.org/&quot; target=&quot;_blank&quot;&gt;AIDS Accountability International&lt;/a&gt;&lt;/strong&gt; (AAI), in conjunction with The African Union Commission (AUC), recognised the need for greater African civil society organisation representation in the International Conference on Population Development (ICPD) process. So, tt was decided to create the African Common Position (ACP) on ICPD to reflect and include the perspectives, recommendations and expertise of African stakeholders.&lt;br /&gt;
&lt;br /&gt;
The full ACP is available &lt;a href=&quot;http://aidsaccountability.org/wp-content/uploads/2013/04/AAI-AUC-Ford-Civil-Society-African-Common-Position-Paper-on-ICPD-2013-April.pdf&quot;&gt;&lt;strong&gt;here&lt;/strong&gt;&lt;/a&gt;. &lt;strong&gt;&lt;/strong&gt;To sign on and endorse the Civil Society African Common Position please click &lt;a href=&quot;http://aidsaccountability.org/?page_id=8169&quot;&gt;&lt;strong&gt;here&lt;/strong&gt;&lt;/a&gt;.&lt;br /&gt;
&lt;br /&gt;
IRMA is excited to report that the need for safe, accessible, condom compatible lubricants as well as support for rectal microbicide research&amp;nbsp;in Africa&amp;nbsp;have been highlighted in the just completed African Common Position Paper (ACP) on ICPD. Our &lt;strong&gt;&lt;a href=&quot;http://rectalmicrobicides.org/ProjectARMreport2012.pdf&quot; target=&quot;_blank&quot;&gt;Project ARM - Africa for Rectal Microbicides&lt;/a&gt;&lt;/strong&gt; effort is having an impact!&lt;br /&gt;
&lt;br /&gt;
The&amp;nbsp;specific sections on lube and rectal microbicides are as follows: &lt;br /&gt;
&lt;blockquote class=&quot;tr_bq&quot;&gt;
4.4.10. Recognise the need for further research into the role of anal and vaginal sexual lubricants for use as a tool to prevent HIV, STI’s and unplanned pregnancies, as well as its safety for users and compatibility with various other ingredients and condom varieties. Commit to making access to quality and affordable lubricants a reality for all people, as well as commit to funding for training and support for condom compatible lubricant use;&lt;br /&gt;
&lt;br /&gt;
4.4.11. Train all health care workers, as well as procurement and head office ministry staff on new and evolving SRHR commodities especially with regard to HIV treatment and prevention technologies, this includes but is not limited to understanding the current vaginal and rectal micro-biocide and pre exposure prophylaxis fields in general and their specific programming implications for women and girls.&lt;/blockquote&gt;
&lt;br /&gt;
IRMA encourages you, or your organisation, to endorse the ACP. Click &lt;a href=&quot;http://aidsaccountability.org/?page_id=8169&quot;&gt;&lt;strong&gt;here&lt;/strong&gt;&lt;/a&gt;&amp;nbsp;to endorse.&lt;br /&gt;
&lt;br /&gt;
Special thanks to IRMA member Tian Johsnon, one of&amp;nbsp;the architects of &lt;strong&gt;&lt;a href=&quot;http://rectalmicrobicides.org/ProjectARMreport2012.pdf&quot; target=&quot;_blank&quot;&gt;Project ARM&lt;/a&gt;&lt;/strong&gt;. His&amp;nbsp;extraordinary leadership helped to make this happen. Kudos Tian!&lt;br /&gt;
Download&amp;nbsp;the full  African Common Position Paper &lt;a href=&quot;http://aidsaccountability.org/wp-content/uploads/2013/04/AAI-AUC-Ford-Civil-Society-African-Common-Position-Paper-on-ICPD-2013-April.pdf&quot;&gt;&lt;strong&gt;here&lt;/strong&gt;&lt;/a&gt;.&lt;br /&gt;
&lt;br /&gt;
------------------- &lt;br /&gt;
&lt;br /&gt;
*Join IRMA&#39;s robust, highly-active. moderated, global listserv addressing rectal microbicide research and advocacy as well as other interesting new HIV prevention technologies by contacting us at rectalmicro@gmail.com. Joining our listserv automatically makes you a member of IRMA - a network of more than 1,200 advocates, scientists, policy makers and funders from all over the world. &lt;br /&gt;
&lt;br /&gt;
*Please look for us on Facebook: www.facebook.com/InternationalRectalMicrobicideAdvocates, and you can follow us on Twitter: @rectalmicro. &lt;br /&gt;
&lt;br /&gt;
*Also, please note that shared news items from other sources posted on this blog do not necessarily mean IRMA has taken any position on the article&#39;s content. &lt;br /&gt;
&lt;br /&gt;
-------------------&lt;/div&gt;
</content><link rel='replies' type='application/atom+xml' href='http://irma-rectalmicrobicides.blogspot.com/feeds/881906942345041717/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment/fullpage/post/8936337794651081205/881906942345041717?isPopup=true' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/8936337794651081205/posts/default/881906942345041717'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/8936337794651081205/posts/default/881906942345041717'/><link rel='alternate' type='text/html' href='http://irma-rectalmicrobicides.blogspot.com/2013/04/african-common-position-paper.html' title='African Common Position Paper Highlights Importance of Condom-Compatible Lubes and Rectal Microbicide Research'/><author><name>NewPrevTech</name><uri>http://www.blogger.com/profile/05705781012925480028</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjD9oC65f6OC3SOX99o08bQvpmjGmh9vppLS4TVXCUFNTA3vHPHfntjHDy1jolaVV93SP27jz401u0QRcODccXSYNKCo_fxoi1Hoyo7FcDhEcI_LscIOk8PEDHHdyI-fwjvhYLVC1CsCoE/s72-c/ICPD-AIDS-Accountability-Phillipa-Tucker-BOb-Munyati-Nomvuyo-Mabusela-Jpeg-300x264.jpg" height="72" width="72"/><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-8936337794651081205.post-6300644271602141234</id><published>2013-04-15T09:08:00.001-05:00</published><updated>2013-04-15T09:13:13.087-05:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="activists"/><category scheme="http://www.blogger.com/atom/ns#" term="advocacy"/><category scheme="http://www.blogger.com/atom/ns#" term="Africa"/><category scheme="http://www.blogger.com/atom/ns#" term="amfAR"/><category scheme="http://www.blogger.com/atom/ns#" term="anal intercourse"/><category scheme="http://www.blogger.com/atom/ns#" term="And Lube"/><category scheme="http://www.blogger.com/atom/ns#" term="AVAC"/><category scheme="http://www.blogger.com/atom/ns#" term="GLAM"/><category scheme="http://www.blogger.com/atom/ns#" term="Global Lube Access Mobilisation"/><category scheme="http://www.blogger.com/atom/ns#" term="IRMA"/><category scheme="http://www.blogger.com/atom/ns#" term="IRMA Nigeria"/><category scheme="http://www.blogger.com/atom/ns#" term="lubricant"/><category scheme="http://www.blogger.com/atom/ns#" term="Project ARM"/><category scheme="http://www.blogger.com/atom/ns#" term="sexual behavior"/><title type='text'>Three Organisations Receive Support to Improve Lubricant Access in Africa</title><content type='html'>&lt;div dir=&quot;ltr&quot; style=&quot;text-align: left;&quot; trbidi=&quot;on&quot;&gt;
&lt;div class=&quot;separator&quot; style=&quot;clear: both; text-align: left;&quot;&gt;
&lt;a href=&quot;https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiCuPLZYLxq6XW97zCUZ-5mS_dVDyhO4FqAyxANZitONp4Q4oetjvrEvTIZeSZZW0Hty-_UfQsNAt0ByLv_esqau1YUcDs-e_ZVZ4SoEP9b6423ynm8l8-xuc-z07Sr_1sCXgT3WSlsI6w/s1600/560310_444731152205270_1342811112_n.jpg&quot; imageanchor=&quot;1&quot; style=&quot;clear: left; float: left; margin-bottom: 1em; margin-right: 1em;&quot;&gt;&lt;img border=&quot;0&quot; height=&quot;200&quot; src=&quot;https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiCuPLZYLxq6XW97zCUZ-5mS_dVDyhO4FqAyxANZitONp4Q4oetjvrEvTIZeSZZW0Hty-_UfQsNAt0ByLv_esqau1YUcDs-e_ZVZ4SoEP9b6423ynm8l8-xuc-z07Sr_1sCXgT3WSlsI6w/s200/560310_444731152205270_1342811112_n.jpg&quot; width=&quot;155&quot; /&gt;&lt;/a&gt;&lt;strong&gt;&lt;a href=&quot;http://www.rectalmicrobicides.org/&quot; target=&quot;_blank&quot;&gt;IRMA&lt;/a&gt;&lt;/strong&gt;*, &lt;strong&gt;&lt;a href=&quot;http://www.amfar.org/&quot; target=&quot;_blank&quot;&gt;amfAR&lt;/a&gt;&lt;/strong&gt;*, and &lt;strong&gt;&lt;a href=&quot;http://www.avac.org/&quot; target=&quot;_blank&quot;&gt;AVAC&lt;/a&gt;&lt;/strong&gt;* are delighted to announce that IRMA Nigeria (in partnership with International Center on Advocacy for the Right to Health), Stop AIDS in Liberia (SAIL), and an organisation in Zambia** have been awarded &lt;strong&gt;&lt;a href=&quot;http://irma-rectalmicrobicides.blogspot.com/p/project-arm-africa-for-rectal.html&quot; target=&quot;_blank&quot;&gt;Global Lube Access Mobilisation&lt;/a&gt;&lt;/strong&gt; (GLAM) funding to campaign for access to safe, condom-compatible lubricants in their communities.&lt;/div&gt;
&lt;br /&gt;
Throughout the world, and especially in Africa, safe, condom-compatible lubricant (water- and silicone-based) is inaccessible for most people who engage in anal intercourse.&amp;nbsp; It is also inaccessible for women who engage in vaginal intercourse.&amp;nbsp; A number of analyses in various settings indicate that the use of oil-based products is the most common form of lubrication - and is known to significantly reduce condom effectiveness.&amp;nbsp; Faced with the lack of condom-compatible lubricants, people often resort to such products as body lotion, soap, cooking oil, spit, pre-cum, antibiotic creams, and even motor oil to provide lubrication during anal intercourse.&amp;nbsp;This lack of appropriate lubricant products for people who practice anal and vaginal intercourse is unacceptable, when we know that they can keep condoms from breaking and slipping. &lt;br /&gt;
&lt;br /&gt;
In December 2012, IRMA, amfAR, and AVAC launched &quot;The GLAM Toolkit - Advocacy to improve access to safe, condom-compatible lubricant in Africa, Version 1.0&quot;.&amp;nbsp; The Toolkit is &lt;a href=&quot;http://www.rectalmicrobicides.org/docs/GLAM_Tookit_Version1.0_FINAL.pdf&quot; target=&quot;_blank&quot;&gt;&lt;strong&gt;available here&lt;/strong&gt;&lt;/a&gt; and offers tools and ideas for civil society and government partners to secure affordable and sustainable condom-compatible lubricant.&amp;nbsp; Tools include a fact sheet, case studies, the results of a review of African National and Strategic Plans on HIV/AIDS, and a list of proposed advocacy activities.&lt;br /&gt;
&lt;div class=&quot;separator&quot; style=&quot;clear: both; text-align: center;&quot;&gt;
&lt;a href=&quot;https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgxWJCP2JT8rDcUtFZfpIVWwNNTaAOmezkDXd5tFAbsuTvjniuxYJ4j1SlTgITP4r8viMqQUjtjyHtC-PHjvH_02BNZWWQWVwONT7-Wn2x2HN2_5JMh-m4qFfmcAAi2zSz_5vIBvylTN00/s1600/255590_491855024159549_1078737861_n.jpg&quot; imageanchor=&quot;1&quot; style=&quot;clear: right; float: right; margin-bottom: 1em; margin-left: 1em;&quot;&gt;&lt;img border=&quot;0&quot; height=&quot;180&quot; src=&quot;https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgxWJCP2JT8rDcUtFZfpIVWwNNTaAOmezkDXd5tFAbsuTvjniuxYJ4j1SlTgITP4r8viMqQUjtjyHtC-PHjvH_02BNZWWQWVwONT7-Wn2x2HN2_5JMh-m4qFfmcAAi2zSz_5vIBvylTN00/s320/255590_491855024159549_1078737861_n.jpg&quot; width=&quot;320&quot; /&gt;&lt;/a&gt;&lt;/div&gt;
After the Toolkit launch, the group released a request for proposals targeted to community advocates and organisations in Africa interested in improving lube access.&amp;nbsp; Eighteen proposals were submitted from 11 African countries.&lt;br /&gt;
&lt;br /&gt;
IRMA Nigeria, SAIL, and a Zambian organisation received the highest scores in a thorough evaluation process and began their lube access advocacy projects in April.&amp;nbsp; We wish them the best, and will keep you apprised of their efforts.&amp;nbsp; It is the hope the other groups will be able to learn from their work, and that one day all Africans who need safe, condom-compatible lubricants have easy, unfettered access to these critical commodities.&lt;br /&gt;
&lt;br /&gt;
In the meantime, &lt;a href=&quot;http://www.rectalmicrobicides.org/docs/GLAM_Tookit_Version1.0_FINAL.pdf&quot; target=&quot;_blank&quot;&gt;&lt;strong&gt;download a copy of the GLAM Toolkit&lt;/strong&gt;&lt;/a&gt; to see what activities you can implement now in your own community.&amp;nbsp; Charting a course now for condom-compatible lube will assist in reducing the spread of HIV and other STIs, as well as pave the way for the eventuality of rectal microbicide access.&lt;br /&gt;
&lt;br /&gt;
&lt;strong&gt;&lt;a href=&quot;http://irma-rectalmicrobicides.blogspot.com/p/project-arm-africa-for-rectal.html&quot; target=&quot;_blank&quot;&gt;Learn more about GLAM here.&lt;/a&gt;&lt;/strong&gt;&lt;br /&gt;
&lt;br /&gt;
*IRMA - International Rectal Microbicide Advocates&lt;br /&gt;
*amfAR - The Foundation for AIDS Research&lt;br /&gt;
*AVAC - Global Advocacy for HIV Prevention&lt;br /&gt;
&lt;br /&gt;
**At the request of the grantee, the organisation wishes to remain anonymous.&lt;br /&gt;
&lt;br /&gt;
------------------- 
&lt;br /&gt;
*Join IRMA&#39;s robust, highly-active. moderated, global listserv addressing rectal microbicide research and advocacy as well as other interesting new HIV prevention technologies by contacting us at rectalmicro@gmail.com. Joining our listserv automatically makes you a member of IRMA - a network of more than 1,100 advocates, scientists, policy makers and funders from all over the world. &lt;br /&gt;
&lt;br /&gt;
*Please look for us on Facebook: www.facebook.com/InternationalRectalMicrobicideAdvocates, and you can follow us on Twitter: @rectalmicro. &lt;br /&gt;
&lt;br /&gt;
*Also, please note that shared news items from other sources posted on this blog do not necessarily mean IRMA has taken any position on the article&#39;s content. &lt;br /&gt;
&lt;br /&gt;
-------------------&lt;/div&gt;
</content><link rel='replies' type='application/atom+xml' href='http://irma-rectalmicrobicides.blogspot.com/feeds/6300644271602141234/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment/fullpage/post/8936337794651081205/6300644271602141234?isPopup=true' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/8936337794651081205/posts/default/6300644271602141234'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/8936337794651081205/posts/default/6300644271602141234'/><link rel='alternate' type='text/html' href='http://irma-rectalmicrobicides.blogspot.com/2013/04/three-organisations-receive-support-to.html' title='Three Organisations Receive Support to Improve Lubricant Access in Africa'/><author><name>NewPrevTech</name><uri>http://www.blogger.com/profile/05705781012925480028</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiCuPLZYLxq6XW97zCUZ-5mS_dVDyhO4FqAyxANZitONp4Q4oetjvrEvTIZeSZZW0Hty-_UfQsNAt0ByLv_esqau1YUcDs-e_ZVZ4SoEP9b6423ynm8l8-xuc-z07Sr_1sCXgT3WSlsI6w/s72-c/560310_444731152205270_1342811112_n.jpg" height="72" width="72"/><thr:total>0</thr:total></entry></feed>